Stephen G. Swisher, M.D., F.A.C.S.
Department of Thoracic and Cardiovascular Surgery, Division of Surgery
About Dr. Swisher
Dr. Stephen Swisher is head of the Division of Surgery and a professor of the Department of Thoracic and Cardiovascular Surgery at the University of Texas MD Anderson Cancer Center. He is also co-leader of the lung cancer initiative in its recently announced Moon Shots Program - the boldest-ever effort to dramatically reduce deaths to cancer.
Dr. Swisher earned his medical degree from the University of California at San Diego School of Medicine and his first academic appointment at UCLA Medical Center as a clinical instructor in the Division of Surgery. He came to Houston in 1994 for a residency in cardiothoracic surgery at MD Anderson and St. Luke's Episcopal Hospital/Texas Heart Institute, focusing on thoracic surgical oncology. In 1996 he joined the MD Anderson faculty as assistant professor in the Department of Thoracic and Cardiovascular Surgery. He has continually risen through the faculty ranks, achieving associate professor in 2001 and early promotion to professor in 2005. He was named chair of his department in 2007 and was awarded the Robert F. Fly Professorship of Surgical Oncology. In 2014 he was named head of the Division of Surgery and awarded the Charles A. LeMaistre Distinguished Chair in Thoracic Oncology.
Dr. Swisher is repeatedly listed among the top doctors and surgeons in Texas and the nation. He is author of more than 350 peer-reviewed publications and is internationally recognized for his pioneering gene therapy clinical trials in lung and esophageal cancer. His research has been supported by the Department of Defense and the National Institutes of Health/National Cancer Institute.
Dr. Swisher is a member of numerous professional organizations and has served on many national and institutional committees. He is currently a member of the Lung Cancer Working Group of the Southwest Oncology Group, an ALCHEMIST Core Committee member of NCI's Cancer Therapy Evaluation Program and a member of the NCI Thoracic Malignancies Steering Committee.
Meet Stephen Swisher, M.D.
Physician Perspective: Lung Cancer
Present Title & Affiliation
Primary Appointment
Division Head, Department of Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Endowed Distinguished Chair Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
An author of more than 260 peer-reviewed publications, Dr. Swisher is internationally recognized for his pioneering gene therapy clinical trials in lung and esophageal cancer using adenovirus-p53 and adenovirus-TNFa. His current translational research efforts focus on developing a novel small molecule treatment of lung cancer (Stat-3 inhibitor oncrasin-72) and revealing the prognostic and therapeutic role of the biomarker PKR/eIF2a. His research has been supported by the Department of Defense and the National Institutes of Health/National Cancer Institute (NCI).
Dr. Swisher is a member of numerous professional organizations and has served on many national and institutional committees. He is currently vice chair of the Lung Committee in SWOG, an NCI-supported cancer clinical trial cooperative group, and a member of the Lung Cancer Working Group of the American Society of Clinical Oncologists.
Clinical Interests
Dr. Swisher's clinical practice involves complex lung and esophageal cancer cases. As a clinician investigator, he focuses on integrating multimodality approaches in esophageal and lung cancer and evaluating novel gene therapy strategies in the clinic. Enrolling patients in clinical trials is a top priority for him, and his participation in multidisciplinary conferences helps advance this program.
Education & Training
Degree-Granting Education
| 1986 | University of California at San Diego School of Medicine, San Diego, California, US, MD |
| 1982 | Stanford University, Stanford, California, US, BA in History & Biology |
Postgraduate Training
| 1994-1996 | Fellow, Cardiothoracic Surgery, The University of Texas MD Anderson Cancer Center and St. Lukes Episcopal Hospital/Texas Heart Institute, Houston, Texas |
| 1991-1991 | Registrar, General Surgery, Nottingham University Hospital, Nottingham |
| 1990-1993 | Resident, General Surgery, University of California at Los Angeles Medical Center, Los Angeles, California |
| 1988-1990 | Fellow, Surgical Oncology, University of California at Los Angeles Medical Center, Los Angeles, California |
| 1987-1988 | Resident, University of California at Los Angeles Medical Center, Los Angeles, California |
| 1986-1987 | Intern, General Surgery, University of California at Los Angeles Medical Center, Los Angeles, California |
Licenses & Certifications
| 1997 | American Board of Thoracic Surgery |
| 1994 | Texas State Board of Medical Examiners |
| 1987 | National Board of Medical Examiners |
Experience & Service
Faculty Academic Appointments
Robert F. Fly Professorship of Surgical Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2013
Associate Professor, Department of Thoracic and Cardiovascular Surgery, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, 2002 - 2005
Assistant Professor, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1996 - 2001
Junior Faculty Associate, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1995 - 1996
Clinical Instructor, Department of Surgery, University of California, Los Angeles, CA, 1993 - 1994
Administrative Appointments/Responsibilities
Division Head, Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - Present
Department Chair ad interim, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Division Head ad interim, Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2014
Steering Committee Member, Department of Thoracic and Cardiovascular Surgery, Institute of Personalized Cancer Therapy, Houston, TX, 2008 - 2013
Jr. Faculty Dev. Program / Clinical Navigator, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2007 - 2008
Department Chair, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2014
APN/PA Departmental Liaison, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2007
Director, Esophageal Cancer Program, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2002 - 2005
Faculty, Department of Virology Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 1998 - 2005
Other Professional Positions
Committee Member, NCI-CCCT Thoracic Malignancy Steering Committee, Frederick, MD, 2014 - 2018
Vice Chairman, SWOG Lung Committee, San Antonio, TX, 2013 - 2018
Lung Cancer Working Group Committee Member, American Society of Clinical Oncology, Houston, TX, 2011 - 2012
Steering Committee Member, GlaxoSmithKline, Houston, TX, 2009 - 2015
Member, Gastro Esophageal Cancer Foundation, Houston, TX, 2008 - 2011
Committee Member, GlaxoSmith Kline MAGRIT Steering Committee, Brentford, 2008 - 2015
Member, International Association for the Study of Lung Cancer Fellow Award Committee, Aurora, CO, 2006
Editor, International Association for the Study of Lung Cancer Search Committee, Aurora, CA, 2005
External Reviewer, National Comprehensive Cancer Network Clinical Trial Concepts, Jenkintown, PA, 2005 - 2009
Member, NCI Subcommittee-AATS Scientific and Government Relations Committee, Bethesda, MD, 2004
Member, American College of Radiological Imaging Network, Arlington, VA, 2004
Member, National Comprehensive Cancer Network Esophageal Gastric Panel, Jenkintown, PA, 2004
Member, Aventis, Bridgewater, NJ, 1999 - 2001
Member, Ethicon, Cornelia, GA, 1999 - 2001
Member, Bristol-Myers, New York, NY, 1999 - 2002
Member, Alza, Mountain View, CA, 1998 - 2001
Intramural Institutional Committee Activities
committee member, Joint Steering Committee (JSC) for our Artidis Strategic Alliance, The University of Texas MD Anderson Cancer Center | ARTIDIS, 2025 - Present
Co-Chair, KCCC Surgery Work Group, The University of Texas MD Anderson Cancer Center, 2025 - Present
Committee Member, Service Line Advisory Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Committee member, Research Enterprise Evolution Initiative - Research Themes and Program Development, MD Anderson Cancer Center, 2025 - Present
Committee member, IMPACT Center Executive Steering Group, The University of Texas MD Anderson Cancer Center, 2025 - Present
Committee Member, Prostate Center Demonstration Project, The University of Texas MD Anderson Cancer Center, 2025 - Present
Committee member, Service Line Executive Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Co-Chair, Alcohol Advisory Taskforce Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Committee member, Capacity Management Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Committee member, Supply Chain Executive Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Committee member, Brown Foundation Award for Excellence in Oncology Nursing Selection Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Committee member, Tenure Track Review Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Committee member, Lymphoma/Myeloma Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Extramural Institutional Committee Activities
Committee member, IG-RABIT Semi-Annual Advisory Group, Image Guided Cancer Therapy Program/ The University of Texas at MD Anderson Cancer Center, 2025 - Present
SSO member representative, Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer Guidelines, American Society of Clinical Oncology, 2025 - Present
Committee member, ARS AUC Steering Committee, American Radium Society, 2022 - Present
Committee Member, Division Heads Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Mentee, Mentoring Up Program, The University of Texas MD Anderson Cancer Center, 2017 - Present
Ad Hoc Committee Member, Division of Surgery Education Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present
Committee Member, Shared Governance Commitee, The University of Texas MD Anderson Cancer Center, 2016 - Present
Committee Member, Integrated Practice Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2017
Co-Chair, Division Heads Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2018
Committee Member, Strategic Initiative: Outpatient Flow Steering Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2018
Committee Member, Strategic Initiative: Sustainability/Efficiency Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Committee Member, Strategic Initiative: People We Serve, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Committee Member, Strategic Initiative: People Who Serve, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Ad Hoc Committee Member, DoS Cancer Network Operations Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Committee Member, Strategic Initiative: Cancer Network Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2018
Ad Hoc Committee Member, Pavilion Project, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Executive Sponsor, Strategic Initiative: Administrative/Operational Efficiency Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Committee Member, EHR Executive Core Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Committee Member, USNWR Safety Workgroup, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Committee Member, Women Faculty Programs Advisory Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2023
Co-Chair, DoCM Division Head Search Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Committee Meeting, OR Subcommittee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Committee Member, Executive Clinical Operations Team Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2017
Committee Member, Institutional Research Executive Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Committee Member, Strategic Framework Steering Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Committee Member, Meaningful Use Physicians Steering Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Co-Chair, Innovative Clinical Care Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Member, Molecular Testing Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, Center for Global Cancer Early Detection, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, Acute Care Services Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Member, Division of Surgery Safety Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Chair, Division of Surgery Executive Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Committee Member, PRS Budget & Finance Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Division of Surgery Educational Initiatives Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Member, PRS Executive Council, The University of Texas MD Anderson Cancer Center, 2012 - Present
Committee Chair, Division of Surgery Executive Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Integration of Clinical Research and Patient Care Working Group, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Member, GI Executive Council, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Committee Member, Executive IACS Moon Shot Executive Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Committee Member, IT Working Group, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Member, BATTLE Program, The University of Texas MD Anderson Cancer Center, 2011 - 2014
Member, Institutional Clinical Executive Committee (ICEC), The University of Texas MD Anderson Cancer Center, 2011 - 2013
Committee Chairman, Department of Thoracic Head & Neck Medical Oncology / Thoracic Section Chief Search Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2011
Member, Surgical Services Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Chair, Clinical Productivity Work Group, The University of Texas MD Anderson Cancer Center, 2011 - 2013
Sub-Committee Chair, Institutional Expense Analysis Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Chair, Development of TCVS relationship with Regional Care Centers, The University of Texas MD Anderson Cancer Center, 2010 - 2013
Committee Member, Ad hoc Institutional Expense Analysis Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Committee Member, Department of Pathology Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2012
Member, Clinical Council, The University of Texas MD Anderson Cancer Center, 2010 - 2012
Committee member, Twenty Four Hour Medical Coverage Steering Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2012
Committee Member, SCD Steering Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Committee Member, Emergency Services Executive Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Member, ICCE Outcomes Reporting Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2011
Committee Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2009
Committee Chairman, Department of Anesthesiology Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Committee Member, Division of Surgery Executive Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2012
Member, CCSG Lung Cancer Program, The University of Texas MD Anderson Cancer Center, 2008 - Present
Member, Thoracic Protocol Review Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Reviewer, Mid-tenure Review Committee, The University of Texas MD Anderson Cancer Center, 2004
Member, Education and Academic Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2012
Member, Executive Committee (Academics), Division of Surgery, The University of Texas MD Anderson Cancer Center, 2003
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2003 - 2004
Elected Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2002 - 2005
Member, Faculty Achievement Awards Subcommittee, The University of Texas MD Anderson Cancer Center, 2001
Member, PRS Compensation and Fringe Benefits Committee, The University of Texas MD Anderson Cancer Center, 1999 - 2009
Member, W.M. Keck Center Cancer Gene Therapy Vector Core Subcommittee, The University of Texas MD Anderson Cancer Center, 1998 - 2007
Member, Research Seminar Committee, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1998 - 2008
Secondary Peer Reviewer, Thoracic and Cardiovascular Surgery Department, The University of Texas MD Anderson Cancer Center, 1998 - Present
Member, Medical Practice Subcommittee, The University of Texas MD Anderson Cancer Center, 1997 - 2005
Editorial Activities
Member of Editorial Review Board, Translational Lung Cancer Research, 2016 - 2019
Board Member, Targeted Therapies in Oncology, 2013 - 2015
Section Editor, Annals of Surgical Oncology, 2011 - 2018
Editorial Board Member, World Journal of Surgery, 2010 - Present
Board Member, Annals of Surgical Oncology, 2009 - 2011
Editorial Board Member, Current Problems in Surgery, 2009 - 2011
Editorial Board Member, World Journal of Gastrointestinal Surgery, 2009 - 2010
Associate Section Editor, Annals of Surgical Oncology, 2008 - 2011
Editorial Board Member, Journal of Clinical Oncology, 2008 - 2013
Board Reviewer, American Society of Gastointestinal Oncology, 2003 - 2011
Board Reviewer, International Society of Gastrointestinal Cancer, 2003 - Present
Editorial Board Member, Molecular Cancer, 2001 - 2011
Editorial Board Member, Clinical Lung Cancer, 1998 - Present
Honors & Awards
| 2025 - Present | Ranked Top 1% in the Nation: 2025 Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey, Press Ganey |
| 2025 - Present | Clinician team ranked top 10%- 2025 Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey, Press Ganey |
| 2025 - Present | Multidisciplinary Lung Cancer/Perioperative Immunotherapy Lung Cancer Team, University of Texas at MD Anderson Cancer Center |
| 2025 - Present | 2025 Texas Super Doctors, Texas Monthly Magazine |
| 2025 - Present | Excellence in Leadership for Goal of Care, MD Anderson Cancer Center |
| 2025 - Present | ACP Award 2025, American College of Physicians |
| 2024 - 2025 | Houstonia Top Doctor, Selected by Peer Recognition, Houstonia Top Doctor |
| 2023 - Present | Texas Super Doctors, Texas Monthly 2023 |
| 2023 - Present | Top Doctors, Recognized by Excellence, Top Doctors |
| 2022 - 2023 | Top Doctors, Regional, Top Doctor Magazine |
| 2022 - Present | Texas Super Doctors, Texas Monthly |
| 2022 - Present | Top Doctors, Castle Connolly, Top Doctors |
| 2020 - 2023 | America's Most Honored Doctors - Top 1%, American Registry, LLC |
| 2019 | Press Ganey Top Provider - Top 10%, Press Ganey |
| 2019 | Top Perfomer, The University of Texas MD Anderson Cancer Center |
| 2018 | Houston's Top Doctors |
| 2017 | Hope Award 2017, Rexanna Foundation |
| 2016 | Top Doctors, Houston Chronicle |
| 2016 | America's Most Honored Businesses - Top 10%, American Registry, LLC |
| 2016 | Best Boss Award, M.D. Anderson Cancer Center |
| 2016 - 2023 | America's Most Honored Professionals - Top 1%, American Registry, LLC |
| 2015 | Newsweek Magazine's America's Top Doctors for Cancer, Newsweek Magazine |
| 2014 | Top 10 Doctors by Metro Area, Vitals |
| 2013 - 2014 | Southeastern Texas Top Doctors, Castle Connolly |
| 2013 | Patients' Choice Award, American Registry, LLC |
| 2012 - 2023 | Top Doctors, US News & World Report |
| 2009 - 2023 | America's Top Doctors, Castle Connolly |
| 2009 | Who's Who Among Executives and Professionals Throughout the World |
| 2009 - 2023 | Top Doctors Houston, Texas Magazine |
| 2007 - 2023 | Who's Who in America, 61st Edition |
| 2007 - 2023 | America's Top Doctors for Cancer, Castle Connolly Medical Ltd |
| 2006 - 2023 | Texas Super Doctors, Texas Monthly |
| 2006 - 2023 | Texas Top Doctors, Texas Monthly |
| 2005 - 2023 | Best Doctors in America |
| 2004 - 2023 | Guide to America's Top Surgeons, SLD Industries |
| 2004 | Honorary Member, Society of Thoracic Radiology |
| 2002 - 2006 | The Surgery Chief Resident Surgical Training Award to the Thoracic Surgery Department at M.D. Anderson, University of Texas - Houston Medical School |
| 2000 | Burroughs Welcome Clinical Scientist Award in Translational Research, MDACC nominee |
| 1998 | Honorary Member, Peruvian Society of Medical Oncology |
| 1993 | Golden Scalpel Chief Award, UCLA Medical Center Resident |
| 1989 | Presidential Award (alternate), Society for Leukocyte Biology |
| 1986 | Surgery Honors, UCSD Medical School |
| 1986 | Lange Publications Award, UCSD Medical School |
| 1982 | Phi Beta Kappa, Stanford University |
| 1982 | Fairclough Award (Classics), Stanford University |
| 1982 | Department Distinctions (Biology/History), Stanford University |
| 1977 | Yale Book Award, Menlo School |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Division of Surgery Update. Invited. Division of Internal Medicine Executive Council meeting. Houston, Texas, US.
- 2020. Perioperative Opioids: Thoracic Surgery. Thoracic Surgery Town Hall. Houston, TX, US.
- 2019. OligometastaticDisease in Non-Small Cell Lung Cancer. Conference. OligometastaticDisease in Non-Small Cell Lung Cancer. Houston, TX, US.
- 2018. Implementing Change and New Standard of Care in Surgery. Conference. Implementing Change and New Standard of Care in Surgery. Houston, TX, US.
- 2018. Management of Patients with Pet CR after Neoadjuvant Chemoradiation for Esophageal Cancer + Salvage Esophagectomy. Conference. Management of Patients with Pet CR after Neoadjuvant Chemoradiation for Esophageal Cancer + Salvage Esophagectomy. Houston, TX, US.
- 2017. Final Results of NRG Oncology RTOG 0246: An Organ Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiatio. Conference. Final Results of NRG Oncology RTOG 0246: An Organ Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiatio. Houston, TX, US.
- 2015. Who is a Candidate for Resection of Stage IIIA NSCLC. Conference. Who is a Candidate for Resection of Stage IIIA NSCLC. Houston, TX, US.
- 2015. Lung Cancer Moon Shot Updates. Conference. Lung Cancer Moon Shot Updates. Houston, TX, US.
- 2013. Lung Cancer Moon Shot Program. Conference. Lung Cancer Moon Shot Program. Houston, TX, US.
- 2008. Tailoring Multimodality Treatment for Gastroesophageal Junction Adenocarcinoma. Conference. Tailoring Multimodality Treatment for Gastroesophageal Junction Adenocarcinoma. Houston, TX, US.
- 2007. Personalized Risk Assessment and Management. Conference. Personalized Risk Assessment and Management. Houston, TX, US.
- 2007. Case Presentations Moderator. Conference. Case Presentations Moderator. Houston, TX, US.
- 2007. Opening Remarks for "The Heart of Leadership". Conference. Opening Remarks for "The Heart of Leadership". Houston, TX, US.
- 2006. Pro Debater, Does multi-modality therapy add to esophagectomy?. Conference. Pro Debater, Does multi-modality therapy add to esophagectomy?. Houston, TX, US.
- 2005. Multidisciplinary Management of Esophageal Cancer. Conference. Multidisciplinary Management of Esophageal Cancer. Houston, TX, US.
- 2003. Gene Therapy for Lung Cancer. Conference. Gene Therapy for Lung Cancer. Houston, TX, US.
Regional Presentations
- 2023. Stage III NSCLC Role of Surgery. Invited. Grand Rounds. Chicago, IL, US.
- 2015. Surgery - Planned vs Salvage Treatment. Conference. Surgery - Planned vs Salvage Treatment. San Antonio, TX, US.
- 2014. Stage III NSCLC Management. Conference. Stage III NSCLC Management. Austin, TX, US.
- 2012. New Lung Cancer Staging System. Conference. New Lung Cancer Staging System. Dallas, TX, US.
- 2010. Revised Staging for Lung Cancer: Implications for Surgical Treatment. Conference. Revised Staging for Lung Cancer: Implications for Surgical Treatment. Austin, TX, US.
- 2004. PET is Better than CT Scan or EUS at Identifying Pathologic Responders Following Preoperative Chemoradiation in Esophageal Cancer. Conference. PET is Better than CT Scan or EUS at Identifying Pathologic Responders Following Preoperative Chemoradiation in Esophageal Cancer. San Antonio, TX, US.
National Presentations
- 2025. Esopheal/Lung Cancer Multimodality. Invited. Oncology Review 2025. San Diego, California, US.
- 2025. SANO is the future. Invited. GTSC meeting. Bonita Springs, Florida, US.
- 2025. AZ webinar 3: Borderline resectable Stage III NSCLC (Case-based format, surgical vs non-surgical approaches). OnlineOnly. 2024 AATS Webinar Series: Advances in the care and treatment of patients with Stage I-III NSCLC (supported by AZ), US.
- 2025. Update on Lung Cancer Screening and Prognostic Modeling. Invited. 21st Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2025. Neoadjuvant and Adjuvant Chemotherapy, Immunotherapy, and Radiation Therapy for States I-IIIA Resectable Non-Small Cell Lung Cancer. Panelist. ASCO. Online, US.
- 2025. Oligomet Consensus. Panelist. The Society of Thoracic Surgeons- panel discussion. online, US.
- 2024. Multimodality Paradigm Shifts in Localized Lung Cancer. Invited. 27th Annual West Hawaii Cancer Symposium. Kona, HI, US.
- 2024. Difficult Cases in Oligometastases. Invited. 106th Annual Meeting. Palm Springs, CA, US.
- 2024. Oligometastic Lung Cancer: Current Treatment and Controversies. Invited. ARS Annual meeting. Palm Springs, CA, US.
- 2024. Treatment of Primary NSCLC with Curative Intent: How to select between Lobar vs Sublobar Resection vs SBRT. Invited. 20th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2023. Stage III NSCLCIs Surgery Still Relevant?. Invited. 19th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2022. Multidisciplinary Management of Lung Cancer. Invited. 25th Annual West Hawaii Cancer Symposium. Kona, HI, US.
- 2022. “ What Have We Learned in Oligometastatic Disease”. Invited. Hawaii Lunch Cancer Summit. Kona, HI, US.
- 2022. Factors in deciding surgery vs radiation for early-stage lung cancer. Invited. Hawaii Lung Cancer Summit. Kona, HI, US.
- 2022. Remaining Questions on Neoadjuvant Therapy. Invited. Hawaii Lunch Cancer Summit. Kona, HI, US.
- 2021. Surgical Role for Metastatic Disease/Modern Controversies. Invited. 103rd Annual Meeting. Virtual, US.
- 2021. Chair - Multimodality of Advanced Lung Cancer Track. Conference. Chair - Multimodality of Advanced Lung Cancer Track. Worldwide Virtual Event, US.
- 2021. Moderator - ACS Cancer Surgery Standards - Pulmonary Resection. Conference. Moderator - ACS Cancer Surgery Standards - Pulmonary Resection. Houston, TX, US.
- 2020. Locally Advanced Lung Cancer: Why Surgery is Still Relevant. Invited. American Society of Clinical Oncology. Online, US.
- 2020. Evolving Front Line Therapy for Stage 3 NSCLC; Results of teh PACIFIC Trial. Conference. Evolving Front Line Therapy for Stage 3 NSCLC; Results of teh PACIFIC Trial. Steamboat Springs, CO, US.
- 2020. Evolving Front-Line Therapy for Stage III NSCLC: Results of the Pacific Trial. Invited. 18th Oncology Update Advances and Controversies. Steamboat, CO, US.
- 2019. Novel Treatments in Lung Cancer. Conference. American Cancer Society & University of Hawaii Cancer Center. Kona, HI, US.
- 2019. What to do with Esophageal Cancer that disappears afer preoperative Chermoradiotherapy?. Conference. What to do with Esophageal Cancer that disappears afer preoperative Chermoradiotherapy?. Naples, FL, US.
- 2019. Lung Cancer Committee Meeting. Conference. Lung Cancer Committee Meeting. Phoenix, AZ, US.
- 2019. Survival Outcomes for Local Therapy of Oligometastatic NSCLC: Surgery or Radiation Therapy?. Conference. Survival Outcomes for Local Therapy of Oligometastatic NSCLC: Surgery or Radiation Therapy?. Breckenridge, CO, US.
- 2019. Results of Local Therapy for Oligometastatic NSCLC: Surgery or Radiation Therapy. Invited. 17th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2018. Current State of Neoadjuvant Treatment in Lung Cancers. Conference. Current State of Neoadjuvant Treatment in Lung Cancers. Rockville,, MD, US.
- 2018. Moderator - Lung Session. Conference. Moderator - Lung Session. Steamboat Springs, CO, US.
- 2018. Rsults of Local Therapy for Oligometastatic NSCLC: Surgery or Radiation Therapy. Conference. Results of Local Therapy for Oligometastatic NSCLC: Surgery or Radiation Therapy. Steamboat Springs, CO, US.
- 2017. Advances in the Management of Lung Cancer. Conference. Advances in the Management of Lung Cancer. Hualalai, Kona, HI, US.
- 2017. Surgical Approaches for Locally Advanced NSCLC. Conference. Surgical Approaches for Locally Advanced NSCLC. Huntington Beach, CA, US.
- 2017. Final Results of NRG Oncology RTOG 0246: An Organ Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. Conference. Final Results of NRG Oncology RTOG 0246: An Organ Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. Houston, TX, US.
- 2017. Moderator - Lung Session. Conference. Moderator - Lung Session. Steamboat Springs, CO, US.
- 2016. What Happened to That Trial? RTOG 0246. Conference. What Happened to That Trial? RTOG 0246. Tucson, AZ, US.
- 2015. Novel Treatment Approaches in Lung Cancer. Conference. Novel Treatment Approaches in Lung Cancer. Kailua-Kona, HI, US.
- 2015. Surgery for Squamous Cell Cancer of the Esophagus: Only for Salvage or as Part of Combined Modality Therapy?. Conference. Surgery for Squamous Cell Cancer of the Esophagus: Only for Salvage or as Part of Combined Modality Therapy?. Seattle, WA, US.
- 2015. Is it time for a Thoracic Surgery Clinical Trials Network?. Conference. Is it time for a Thoracic Surgery Clinical Trials Network?. Naples, FL, US.
- 2015. Cooperative group trials- "The Menu". Conference. Cooperative group trials- "The Menu". Naples, FL, US.
- 2015. General Thoracic Session: Lung Cancer II. Conference. General Thoracic Session: Lung Cancer II. San Diego, CA, US.
- 2015. Debate: PRO/GO Persistent N2 Disease Following Induction Therapy. Conference. Debate: PRO/GO Persistent N2 Disease Following Induction Therapy. San Diego, CA, US.
- 2015. Current Recommendations for Lung Cancer Screening: Are We Making Progress?. Conference. MDACC. Steamboat Springs, CO, US.
- 2014. Indications and Outcomes for Salvage Esophagectomy Following Chemoradiation. Conference. Indications and Outcomes for Salvage Esophagectomy Following Chemoradiation. New York, NY, US.
- 2014. Techniques and Outcomes of Free Jujunal Interpositions. Conference. Techniques and Outcomes of Free Jujunal Interpositions. New York, NY, US.
- 2014. Lung Committee Working Group Meeting. Conference. Lung Committee Working Group Meeting. Chicago, IL, US.
- 2014. Integrated Approach to Staging and Restaging. Conference. Physician's Educaiton Resource. Huntington Beach, CA, US.
- 2014. The Development of a Multidisciplinary Approach to Cancer Care. Conference. The Development of a Multidisciplinary Approach to Cancer Care. Boston, MA, US.
- 2014. Lung Committee Working Group Meeting. Conference. Lung Committee Working Group Meeting. San Francisco, CA, US.
- 2014. Clinical Management Panel - Stage IIIA Lung Cancer. Conference. Clinical Management Panel - Stage IIIA Lung Cancer. Litchfield Park, AZ, US.
- 2014. That's a Great Idea for a Trial....what next? How we do it at MD Anderson. Conference. That's a Great Idea for a Trial....what next? How we do it at MD Anderson. Litchfield Park, AZ, US.
- 2014. Clinical Trials - Reflections o Old and Plans for New. Conference. Clinical Trials - Reflections o Old and Plans for New. Orlando, FL, US.
- 2014. Current Recommendations for Lung Cancer Screening: Are We Making Any Progress. Conference. Current Recommendations for Lung Cancer Screening: Are We Making Any Progress. Steamboat Springs, CO, US.
- 2014. Salvage Esophagectomy for Advanced or Persistent Disease. Conference. Salvage Esophagectomy for Advanced or Persistent Disease. Portland, OR, US.
- 2013. Lung Committee Working Group Meeting. Conference. Lung Committee Working Group Meeting. Chicago, IL, US.
- 2013. Surgery for Early Stage NSCLC. Conference. Surgery for Early Stage NSCLC. Orlando, FL, US.
- 2013. Challenging Thoracic Case Presentations with Interactive Audience Participation. Conference. Challenging Thoracic Case Presentations with Interactive Audience Participation. Orlando, FL, US.
- 2013. Mediastinoscopy. Conference. Mediastinoscopy. Huntington Beach, CA, US.
- 2013. Case Based Panel Discussion: Staging adn Management of Early Stage NSCLV. Conference. Case Based Panel Discussion: Staging adn Management of Early Stage NSCLV. Huntington Beach, CA, US.
- 2013. Surgical Management of Superior Sulcus Tumors for Seminars in Thoracic & Cardiovascular Surgery. Conference. Surgical Management of Superior Sulcus Tumors for Seminars in Thoracic & Cardiovascular Surgery. Minneapolis, MN, US.
- 2013. Thoracoscopic Robotic or Open Lobectomy for Lung Cancer (TROLL). Conference. Thoracoscopic Robotic or Open Lobectomy for Lung Cancer (TROLL). San Francisco, CA, US.
- 2013. SWOG Trials Update. Conference. SWOG Trials Update. Naples, FL, US.
- 2013. Anastomotic Selection and Pearls. Conference. Anastomotic Selection and Pearls. Los Angeles, CA, US.
- 2013. Final Results of RTOG 0246: A Phase II Study of Selective Surgical Resection for Locoregionally Advanced Esophageal Cancer Treated With Paclitaxel Based Chemoradiation Regimen. Conference. Final Results of RTOG 0246: A Phase II Study of Selective Surgical Resection for Locoregionally Advanced Esophageal Cancer Treated With Paclitaxel Based Chemoradiation Regimen. San Francisco, CA, US.
- 2013. Resection of Recurrent Esophageal Cancer After Definitive Chemoradiation. Conference. Resection of Recurrent Esophageal Cancer After Definitive Chemoradiation. Steamboat Springs, CO, US.
- 2012. Lung Committee Working Group Meeting. Conference. Lung Committee Working Group Meeting. Chicago, IL, US.
- 2012. Lung Committee Working Group Meeting. Conference. Lung Committee Working Group Meeting, US.
- 2012. Lung Cancer Committee Meeting. Conference. Lung Cancer Committee Meeting. Chicago, IL, US.
- 2012. Management of the Lung Cancer Patient with Oligometastatic Disease. Conference. Management of the Lung Cancer Patient with Oligometastatic Disease. Hualalai, Kona, HI, US.
- 2012. Salvage Esophagectomy for Advanced or Persistent Disease. Conference. Salvage Esophagectomy for Advanced or Persistent Disease. Chicago, IL, US.
- 2012. Mediastinoscopy. Conference. Mediastinoscopy. Huntington Beach, CA, US.
- 2012. Optimizing NSCLC Staging: EBUS vs. Mediastinoscopy. Conference. Optimizing NSCLC Staging: EBUS vs. Mediastinoscopy. Huntington Beach, CA, US.
- 2012. Thoracic Surgeon's Retreat. Conference. Thoracic Surgeon's Retreat. San Francisco, CA, US.
- 2012. Cooperative Group Trials - SWOG. Conference. Cooperative Group Trials - SWOG. San Diego, CA, US.
- 2012. Multi-Modality Therapy for Advanced Esophageal Cancer. Conference. Multi-Modality Therapy for Advanced Esophageal Cancer. Steamboat Springs, CO, US.
- 2012. Novel Local Therapies for Early Stage Esophagel Cancer. Conference. Novel Local Therapies for Early Stage Esophagel Cancer. Steamboat Springs, CO, US.
- 2011. Surgical Management of Metastatic Disease: Where Are We in 2011. Conference. Surgical Management of Metastatic Disease: Where Are We in 2011. San Francisco, CA, US.
- 2011. Surgical Management of Esophageal Cancer. Conference. Surgical Management of Esophageal Cancer. Miami, FL, US.
- 2011. Esophageal Cancer. Conference. Esophageal Cancer. Los Angeles, CA, US.
- 2011. Current Approaches in the Management of Squamous Cell adn Adenocarcinoma of the Esophagus. Conference. Current Approaches in the Management of Squamous Cell adn Adenocarcinoma of the Esophagus. San Francisco, CA, US.
- 2011. Optimal Therapy for GE Junction Tumors. Conference. Optimal Therapy for GE Junction Tumors. Philadelphia, PA, US.
- 2011. What is the Surgeon's Participation in Contemporary Management of Lung Cancer. Conference. What is the Surgeon's Participation in Contemporary Management of Lung Cancer. San Francisco, CA, US.
- 2010. Resection of Breast Metastases. Conference. Scottish Cancer Information Network. Dundee.
- 2010. 3 Step Strategy in Esophageal Cancer. Conference. Scotland Cancer Information Network. Dundee.
- 2010. Moderator in Basic Science Forum. Conference. Southern Thoracic Surgical Association. Orlando, FL, US.
- 2010. Clinical Applications of the New Staging System for Lung Cancer. Conference. 6th Annual Oncology Congress. San Francisco, CA, US.
- 2010. Clinical Applications of the New Staging System for Lung Cancer. Conference. New York Medical College. San Francisco, CA, US.
- 2010. Stage vs Molecular Markers in Selecting Adjuvant Therapy for STage IIA NSCLC. Conference. 11th International Lung Cancer Congress. Rancho Palos Verdes, CA, US.
- 2010. Comparison of the 2010 AJCC TNM staging system with a modified lymph node ratio staging system in 7233 gastric cancer patients. Conference. 2010 Annual Meeting. Chicago, IL, US.
- 2009. Improved Long-Term Outcome with Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. Conference. STSA 56th Annual Meeting. Marco Island, FL, US.
- 2009. Neoadjuvant Approaches to Advanced Thoracic Malignancies. Conference. 12th Annual West Hawaii Cancer Symposium. Hualalai, Kona, HI, US.
- 2009. Specialized Surgical Expertise: Indications, Results. Conference. 13th World Conference on Lung Cancer. San Francisco, CA, US.
- 2009. Maximizing Perioperative Outcome after Neoadjuvant Therapy. Conference. 13th World Conference on Lung Cancer. San Francisco, CA, US.
- 2009. New Strategies for Surgical Management Curative Tactics for Regionally Advanced and Oligometastatic Disease. Conference. 5th Annual Symposium. Boston, ME, US.
- 2009. When Are Sublobar Resections Appropriate?. Conference. 10th International Lung Cancer Congress. Kohala Coast, HI, US.
- 2009. Neoadjuvant Chemotherapy for Locally Advanced NSCLC. Conference. 9th Annual Oncology Update: Advances & Controversies. Park City, UT, US.
- 2008. A Case-Based Review of Lung Cancer Treatment. Conference. 2008 RSNA Lung Cancer Refresher Course. Chicago, IL, US.
- 2008. Is Surgery Still Necessary After Chemoradiation of Esophageal Cancer. Conference. MDACC and MDAPN Fourth Annual Symposium. Boston, MA, US.
- 2008. Surgical Subsets in Stage III Non-Small Cell Lung Cancer. Conference. MDACC and MDAPN Fourth Annual Symposium. Boston, MA, US.
- 2008. Is Surgery Still Necessary After Chemoradiation of Esophageal Cancer. Conference. MDACC and MDAPN Fourth Annual Symposium. Boston, MA, US.
- 2008. Does Endobronchial Ultrasonography Have a Place in the Thoracic Surgeon's Armamentarium?. Conference. American Association for Thoracic Surgery. San Diego, CA, US.
- 2008. The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: an International Studty of the Impact of Extent of Surgical Resection. Conference. Amercian Surgical Association. New York, NY, US.
- 2008. Tailoring Multimodality Treatment for Gastroesophageal Junction Adenocarcinoma. Conference. American Society of Clinical Oncology - GI Symposium. Orlando, FL, US.
- 2007. Role of Surgery in Combined Modality Therapy. Conference. University of California Davis Thoracic Oncology Conference. San Francisco, CA, US.
- 2007. Esophageal Cancer. Conference. Esophageal Cancer. San Francisco, CA, US.
- 2007. A Phase II Study of a Paclitaxel Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: initial Reporting of RTOG 0246. Conference. American Society for Therapeutic Radiology and Oncology. Los Angeles, CA, US.
- 2007. MTP: Non-Surgical Approaches (RFA). Conference. International Association for the Study of Lung Cancer 12th World Conference on Lung Cancer. Seoul.
- 2007. Invasive Staging of Lung Cancer Is Essential. Conference. The Eighth International Lung Cancer Congress. Maui, HI, US.
- 2007. Molecular biomarkers of prediction and prognosis in patients with localized gastroesophageal cancers. Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2007. Debate Pro-Role of Surgery in Locally Advanced NSCLC: Debating Outcome of RTOG 9309. Conference. The Eighth International Lung Cancer Congress. Maui, HI, US.
- 2007. Faculty Participant. Conference. General Thoracic Surgical Club's 20th Annual Meeting. Captiva Island, FL, US.
- 2007. Current state of the art treatment approaches to NSCLC round table discussion and controversial cases. Conference. 7th Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2006. Optimal surgery of esophageal cancer. Conference. Gastrointestinal Symposium. Cincinnati, OH, US.
- 2006. Proposed modification of nodal status in AJCC Esophageal Cancer Staging System. Conference. Southern Thoracic Surgical Association's 53rd Annual Meeting. Tuscon, AZ, US.
- 2006. Review Course in Thoracic Surgery for Certification and Maintenance of Certification. Conference. 92nd Annual Clinical Congress of the American College of Surgeons. Chicago, IL, US.
- 2006. Diagnosis and management of patients with locally advanced esophageal cancer. Conference. CME Symposium, Update on the Management of Gastrointestinal Malignancies. La Jolla, CA, US.
- 2006. Pro Debater, Esophagectomies should only be performed in high-volume centers. Conference. American Association for Thoracic Surgery's 86th Annual Meeting. Philadelphia, PA, US.
- 2006. Program No. 20 of the General Thoracic Surgery Simultaneous Scientific Session. Conference. American Association for Thoracic Surgery 86th Annual Meeting. Philadelphia, PA, US.
- 2006. Meet the Professor Breakfast. Conference. Society of Surgical Oncology's 59th Annual Cancer Symposium. San Diego, CA, US.
- 2006. Surgery for Stage I NSCLC in North America. Conference. Clinical Trials Workshop on Stereotactic Radiation Therapy and Surgery for Lung Cancer. Maui, HI, US.
- 2006. Faculty Speaker. Conference. 6th Annual The Oncology Update: Advances and Controversies. Park City, UT, US.
- 2005. The Role of PET in Patients with Lung Cancer - Referring Physicians Perspective. Conference. The Role of PET in Patients with Lung Cancer - Referring Physicians Perspective. Boston, MA, US.
- 2005. Role of PKR in Radiation Resistance. Conference. 2nd Annual Esophageal Cancer and Barrett's Metaplasia Research Summit. Las Vegas, NV, US.
- 2005. FDG-PET Imaging in the Management of Esophageal Cancer. Conference. 2nd Annual "Update on the Management of Gastrointestinal Malignancies". San Diego, CA, US.
- 2005. FDG-PET Imaging in Esophageal Cancer. Conference. 2005 Annual Conference on Academy of Molecular Imaging. Orlando, FL, US.
- 2004. Impact of Pathologic Response on pTNM Esophageal Cancer Staging System Following Preoperative Chemoradiation (CRT). Conference. Southern Surgical Association Meeting. West Palm Beach, FL, US.
- 2004. Multimodality Approaches to Esophageal and Gastroesophageal Junction Cancers. Conference. American College of Surgeons Annual Meeting. New Orleans, LA, US.
- 2004. Adenoviral MDA-7 Induces Apoptosis in P53 Resistant Lung Cancer Cells. Conference. Society of University Surgeons. St. Louis, MO, US.
- 2004. PET Predicts Pathologic Response and Long-term Survival Following Preoperative Chemoradiation in Esophageal Cancer. Conference. American Society of Clinical Oncology - GI Symposium. San Francisco, CA, US.
- 2003. Gastrointestinal (non-colorectal) Cancer. Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2003. CPT-11-Taxotere-5-FU Regimen for Induction and Concurrent Chemoradiotherapy Prior to Surgery in Patients with Resectable Esophageal or GEJ Carcinoma. Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2002. Adenoviral MDA-7 Induces Apoptosis in Lung Cancer Cells Through Mitochondrial Permeability Transition. Conference. American Association of Thoracic Surgeons. Washington, US.
- 2002. Ad-p53 Gene Therapy Trials in Lung Cancer. Conference. 2nd Annual Opinion Leader Summit: Targeted Therapies in the Treatment of Lung Cancer. Scottsdale, AZ, US.
- 2001. Is Surgical Salvage Indicated for Recurrent Esophageal Tumors following Definitive Chemoradiation?. Conference. American Association of Thoracic Surgeons. San Diego, CA, US.
- 2001. Lung Cancer: Progress, Biology, and Clinical Implications; Immunobiology and Biologic Therapies. Conference. American Society of Clinical Oncology. San Francisco, CA, US.
- 2001. New Concepts in the Biology and Treatment of Cancer. Conference. Japan/US Cancer Therapy Symposium "New Concepts in the Biology and Treatment of Cancer". La Jolla, CA, US.
- 2001. Treatment Strategies for Resectable Non-small Cell Lung Cancer (NSCLC). Conference. First Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2000. Early Detection and Combined-Modality Treatment of Lung Cancer. Conference. The American College of Chest Physicians (ACCP). San Francisco, CA, US.
- 2000. A Phase II Trial of Adenoviral Mediated p53 Gene Transfer (RPR/INGN 201) in Conjunction with Radiation Therapy in Patients with Localized NSCLC. Conference. American Society of Clinical Oncology Annual Meeting. New Orleans, LA, US.
- 2000. Apoptosis in Lung Cancer Cells. Conference. FASEB 2000 Experimental Biology. San Diego, CA, US.
- 2000. Intergroup S9900: Surgical and Other Issues. Conference. Non-Small Cell Lung Cancer Multi-Modality Program. Miami Beach, FL, US.
- 2000. Treatment of Advanced Lung Cancer with Adenoviral p53. Conference. Millennium Conference on Nucleic Acids. Clearwater, FL, US.
- 1999. Multidisciplinary Approach to Resectable Non-Small Cell Lung Cancer. Conference. Frontiers of Oncology Annual Conference. Manhassett, NY, US.
- 1999. Gene Therapy for Lung Cancer: Fact or Fiction. Conference. Thoracic Malignancies Conference. Cedar Rapids, IA, US.
- 1999. Esophagectomy for Esophageal Cancer. Conference. Western Thoracic Surgical Association. Squaw Valley, CA, US.
- 1998. Non-Small Cell Lung Cancer - Resectable Disease. Conference. Medical and Clinical Directors Conference. Coronado, CA, US.
- 1998. Adenoviral Mediated p53 Gene Transfer in Patients with Advanced Non-Small Cell Lung Cancer. Conference. 41st Annual Clinical Conference, New Frontiers Research, US.
- 1998. Multimodality Therapy of Lung Cancer. Conference. Chemotherapy Foundation Symposium. New York, NY, US.
- 1998. Thoracic Surgery in Patients with Non-Small Cell Lung Cancer After Neoadjuvant Therapy. Conference. 10th Annual Lung Cancer Symposium. Orange, CA, US.
- 1998. Adenoviral p53 Gene Transfer in Non-Small Cell Lung Cancer. Conference. ASTRO and Oncology's 40th Annual Meeting. Phoenix, AZ, US.
- 1998. Gene Therapy of Lung Cancer. Conference. Third Annual VA Oncology Conference. San Antonio, TX, US.
- 1998. ASCO '98 Review: Gene Therapy Trials. Conference. American Society of Clinical Oncology. Flint, MI, US.
- 1998. Adenoviral Mediated p53 Gene Transfer in Patients with Advanced Non-Small Cell Lung Cancer. Conference. American Society of Clinical Oncology. Los Angeles, CA, US.
- 1998. Multimodality Therapy of Resectable Non-Small Cell Lung Cancer: Role of New Agents. Conference. American Lung Association/American Thoracic Society International Conference. Chicago, IL, US.
- 1998. Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer with p53 Gene Transfer. Conference. American Lung Association/American Thoracic Society International Conference. Chicago, IL, US.
- 1998. Impact of Number of Involved Lymph Nodes on Long-term Survival in Esophageal Cancer. Conference. The Society of Surgical Oncology. San Diego, CA, US.
- 1997. Esophagectomy: Techniques and Indications, Postgraduate Course. Conference. American College of Surgeons. Chicago, IL, US.
- 1997. Adenoviral p53 Treatment in Advanced Non-Small Cell Lung Cancer. Conference. , Society for Biological Therapy, The Cancer Vaccines Session. Pasadena, CA, US.
- 1997. Persistent Transgene Expression Following Repeated Injections of a Recombinant Adenovirus Containing the p53 Wildtype Gene in Patients with Non-Small Cell Lung Cancer. Conference. American Association for Cancer Research. San Diego, CA, US.
- 1997. Short and Long-Term Outcomes Following Esophagogastrectomy in Elderly Patients. Conference. Society of Surgical Oncology. Chicago, IL, US.
- 1996. The Role of Neoadjuvant Therapy and Surgical Resection in Esophageal Cancer. Conference. Pacific Coast Surgical Association. San Diego, CA, US.
- 1995. Blood Transfusions and Decreased Survival in Esophageal Cancer. Conference. Blood Transfusions and Decreased Survival in Esophageal Cancer. Houston, TX, US.
- 1995. Perioperative Blood Product Transfusions Decrease Long-Term Survival in Esophageal Cancer. Conference. Society of Surgical Oncology. Boston, MA, US.
- 1994. Clinical Gene Therapy. Conference. Gene Therapy Conference. Los Angeles, CA, US.
- 1994. Biliary Disease During Pregnancy: A Surgical Disorder. Conference. Southwestern Surgical Congress. Tucson, AZ, US.
- 1994. Management of Pancreatitis Complicating Pregnancy. Conference. Southern California Chapter of the American College of Surgeons. Newport Beach, CA, US.
- 1993. Pancreatitis Associated with Adult Choledochal Cysts. Conference. Society for Surgery of the Alimentary Tract. Boston, MA, US.
- 1990. Pulmonary Macrophage Inhibition of Interleukin-2 Induction of Tumor Infiltrating Lymphocytes. Conference. American Association of Immunology. New Orleans, LA, US.
- 1990. Inhibition of Tumor Infiltrating Lymphocytes by Alveolar Macrophages. Conference. American Association for Cancer Research. Washington, US.
- 1990. Immunopathologic Features of Human Lung Tumors Following Pre-Operative Interleukin-2 Therapy. Conference. American Society of Clinical Oncology. Washington, US.
- 1990. Suppression of Tumor-Infiltrating Lymphocytes by Pulmonary Macrophages. Conference. Surgical Oncology Conference. Los Angeles, CA, US.
- 1990. Alveolar Macrophages Inhibit Tumor Infiltrating Lymphocyte Cytotoxicity. Conference. Society of University Surgeons Residents' Program. Los Angeles, CA, US.
- 1989. IL-4 Down-Regulation of IL-2 Induced IFN-Gamma Protein Production Correlates with IL-4 Suppression of LAK Activity. Conference. Society for Leukocyte Biology. Marcos Island, FL, US.
- 1989. Gamma Interferon and Tumor Necrosis Factor Reverse Interleukin-4 Suppression of Lymphokine-Activated Killer Induction. Conference. American Association for Cancer Research. San Francisco, CA, US.
- 1989. The Role of Secondary Cytokines in IL-4 Inhibition of Lymphokine-Activated Killer Cell Induction. Conference. Surgical Oncology Conference. Los Angeles, CA, US.
International Presentations
- 2023. Approaches and outcomes of sublobar/segmental resection of NSCLC. Invited. XVI Brazilian Congress of Surgical Oncology, BR.
- 2023. Factors determining the selection of SBRT in early stage NSCLC. Invited. XVI Brazilian Congress of Surgical Oncology, BR.
- 2023. Esophageal/GEJ Cancer: Multimodality Approaches. Invited. XVI Brazil Congress of Surgical Oncology, BR.
- 2023. Immunotherapy in early-stage disease, as it relates to surgery. Invited. TOGA Annual Scientific Meeting. Melbourne, AU.
- 2023. Shifting the Dial Forward in Lung Cancer Care: It Takes a Village. Invited. Annual Scientific Meeting. Melbourne, AU.
- 2021. GEJ Adenocarcinoma: Upfront Surgery. Invited. NCI-EGSSP-SSO-ESSO 2021. Cairo, EG.
- 2021. Role of Surgery in Metastatic Disease/Current Controversies. Invited. NCI-EGSSO-SSO-ESSO 2021. Cairo, EG.
- 2021. Novel Treatment Approaches in Lung Cancer. Invited. Institutional Grand Rounds (virtual). Melbourne, AU.
- 2019. Multimodality Treatment of Esophageal Cancer. Conference. Multimodality Treatment of Esophageal Cancer. Cairo, EG.
- 2019. Treatement of PET Complete Response in Esophageal Cancer Ater Chemoradiation. Conference. Treatement of PET Complete Response in Esophageal Cancer Ater Chemoradiation. Cairo, EG.
- 2019. Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Caner. Conference. Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Caner. Cairo, EG.
- 2019. Lung Cancer Moonshot Update. Conference. Lung Cancer Moonshot Update. Cairo, EG.
- 2019. Induction Immunotherapy for Localied Lung Cancer. Conference. Induction Immunotherapy for Localied Lung Cancer. Cairo, EG.
- 2019. Esophageal Cancer Technical Mastery. Conference. Esophageal Cancer Technical Mastery. Toronto, CA.
- 2017. Current Management of Esophageal Cancer. Conference. MDACC & MDACC Espana. Madrid, ES.
- 2016. Moon Shots - Lung Cancer. Conference. Moon Shots - Lung Cancer. Sao Paulo, BR.
- 2015. Salvage Esophagectomy. Conference. Salvage Esophagectomy. Harbin, CN.
- 2014. Chemoradiation is the Definitive Treatment fo Esophageal Cancer. Conference. Chemoradiation is the Definitive Treatment fo Esophageal Cancer. Toronto, CA.
- 2014. Alternate Conduits for Esophageal Reconstruction - The Supercharged Jejunum. Conference. Alternate Conduits for Esophageal Reconstruction - The Supercharged Jejunum. Toronto, CA.
- 2013. Update on Esophageal Cancer. Conference. Update on Esophageal Cancer. Chiang Mai, TH.
- 2013. Thoracic Empyema. Conference. Thoracic Empyema. Chiang Mai, TH.
- 2013. Treatment of Esophageal Strictures. Conference. Treatment of Esophageal Strictures. Chiang Mai, TH.
- 2013. Update on Lung Cancer. Conference. Update on Lung Cancer. Chiang Mai, TH.
- 2012. Update on Esophageal Cancer. Conference. Update on Esophageal Cancer. Brackenhurst, KE.
- 2012. Update on Lung Cancer. Conference. Update on Lung Cancer. Brackenhurst, KE.
- 2012. Treatment of Esophageal Strictures. Conference. Treatment of Esophageal Strictures. Brackenhurst, KE.
- 2012. Thoracic Empyema. Conference. Thoracic Empyema. Brackenhurst, KE.
- 2011. Salvage Esophagectomy for Recurrent Tumors after Definitive Chemoradiotherapy. Conference. Salvage Esophagectomy for Recurrent Tumors after Definitive Chemoradiotherapy. Nagoya, JP.
- 2011. Omental Flap Transfer in Salvage Esophagectomy. Conference. Omental Flap Transfer in Salvage Esophagectomy. Nagoya, JP.
- 2011. Which Categories are Amenable for Surgery After Downstaging?. Conference. Which Categories are Amenable for Surgery After Downstaging?. Amsterdam, NL.
- 2010. Indication of Sleeve Surgery in Patients with Early Stage Lung Cancer. Conference. UAE Cancer Congress 2010. Dubai, AE.
- 2010. Are Pulmonary Metastases Resectable?. Conference. UAE Cancer Congress 2010. Dubai, AE.
- 2007. Chemo RT Alone for Esophageal Cancer. Conference. Japan/U.S. Cancer Therapy Symposium. Sendai, JP.
- 2006. Invited Guest. Conference. Western Surgical Association's Annual Meeting: The 114th Scientific Session. Los Cabos, MX.
- 2005. What Can PET/CT do for the Surgical Oncologist?. Conference. Society of Nuclear Medicine 52nd Annual Meeting. Toronto, CA.
- 2000. Adp53 Treatment of Non-Small Cell Lung Cancer, Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention. Conference. Adp53 Treatment of Non-Small Cell Lung Cancer, Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention. Dublin, IE.
- 2000. Adenoviral Mediated Bak Gene Transfer Induces Apoptosis in Mesothelioma Cell Lines. Conference. American Association for Thoracic Surgery Annual Meeting. Toronto, CA.
- 1999. Surgical Treatment of Esophageal Cancer. Conference. Oncology 2000 Symposium. Sao Paulo, BR.
- 1999. Neo-adjuvant Therapy for Non-Small Cell Lung Cancer. Conference. Oncology 2000 Symposium. Sao Paulo, BR.
- 1999. New Aspects of Combined-Modality for Non-Small Cell Lung Cancer. Conference. 16th Annual Meeting of Japanese Association of Chest Surgeons. Tokyo, JP.
- 1999. Use of Neoadjuvant and Adjuvant Taxol. Conference. Japanese Association of Chest Surgeons Luncheon Seminar. Isaka Kansai, JP.
- 1998. Surgery in the Multimodality Approach to Esophageal Cancer. Conference. Peruvian Medical Oncology Society Conference. Lima, PE.
Formal Peers
- 2021. Novel treatments in Non Small Cell Lung Cancer. Invited. Melbourne, Victoria, AU.
- 2018. Novel Treatments for Non-Small Cell Lung Cancer. Invited. Louisville, KY, US.
- 2017. NCI Thoracic Malignancy Steering Committee Meeting. Invited. Betheseda, MD, US.
- 2015. Salvage Esophagectomy. Invited. Houston, TX, US.
- 2015. Harbin Visiting Professor. Invited. Harbin, China, CN.
- 2014. Distinguished Visiting Faculty Scholar. Invited. Portland, OR, US.
- 2013. Strategy for Health Care Delivery Leadership Workshop. Invited, US.
- 2012. CTPM - Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung Cancer. Invited. Bethesda, MD, US.
- 2012. Salvage Esophagectomy. Invited. Portland, OR, US.
- 2011. Visiting Professor. Invited, US.
- 2011. Esophageal Cancer. Invited. Los Angeles, CA, US.
- 2010. Optimal management of lung cancer. Invited. Mbingo, CM.
- 2006. Novel Treatment Strategies for Esophageal Cancer. Invited. Boston, MA, US.
- 2004. Multidisciplinary Care of Thoracic Malignancies: Thoracic Surgeon's Perspective of the Radiologist's Role. Invited. Rancho Mirage, CA, US.
- 2003. Gene Therapy for Lung Cancer. Invited. Kyoto, JP.
- 2002. Adenoviral p53 Gene Therapy for Lung Cancer. Invited. Portland, OR, US.
- 2001. The Use of p53 Gene Therapy for Patients with Solid Tumors. Invited. Cleveland, OH, US.
- 2000. Adenoviral p53 Treatment of Non Small Cell Lung Cancer. Invited. Berne, CH.
- 1999. Use of Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer. Invited. Tokushuma, JP.
- 1999. Multimodality Therapy of Resectable Non-Small Cell Lung Cancer. Invited. Osaka, JP.
- 1999. Multidisciplinary Approach to Lung Cancer. Invited. Fukuoka, JP.
- 1996. Blood Transfusion and Esophageal Cancer. Invited. Hong Kong, CN.
Grant & Contract Support
| Date: | 2025 - 2030 |
| Title: | Single-Cell Spatial Charting of Molecular and Immune Phenotypes that Define the Transition from Normal-Appearing and Premalignant Phenotypes to Lung Adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00023728 |
| Date: | 2024 - 2029 |
| Title: | Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA287734-01A1 |
| Date: | 2024 - 2029 |
| Title: | A multidimensional atlas of the transition of normal-appearing and premalignant phenotypes to lung adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00021172 |
| Date: | 2023 - 2028 |
| Title: | Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | GRANT13853728 |
| Date: | 2016 - 2023 |
| Title: | Randomized phase III trial of local consolidation therapy (LCT) after nivolumab and ipilimumab for immunotherapy-naïve patients with metastatic non-small cell lung cancer (Lonestar) |
| Funding Source: | Bristol Myers Squibb |
| Role: | Co-I |
| ID: | 2017-0311 |
| Date: | 2016 - 2019 |
| Title: | Development and Validation of Clinical Assays for Predicting Patient Outcomes in Lung Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP140278 |
| Date: | 2015 - 2020 |
| Title: | A Novel STAT3/RNA Polymerase II Inhibitor and Its Predictive Biomarker for Lung Cancer Therapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2015 - 2021 |
| Title: | Overcoming resistance to anti-EGFR therapy by drug repurposing |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA190628 |
| Date: | 2014 - 2018 |
| Title: | NO TITLE PROVIDED |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | PA-13-302 |
| Date: | 2014 - 2017 |
| Title: | SWOG Network Group Operations Cener of the NCTN |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| ID: | 5U10-CA180888 |
| Date: | 2013 - 2016 |
| Title: | Cellular and Molecular Mechanisms of Gastrointestinal |
| Funding Source: | NIH/NCI |
| Role: | Significant |
| ID: | 5-P01-CA130821 |
| Date: | 2012 - 2017 |
| Title: | Quantitative PET/CT Imaging for Tumor Assessment |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | NIH-PO1 CA787778 |
| Date: | 2012 - 2017 |
| Title: | Image Guided Cancer Diagnosis and Therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | R-12-MIRA-1 |
| Date: | 2012 - Present |
| Title: | Full Member Application Affiliated with SWOG |
| Funding Source: | NIH/NCI |
| Role: | Vice Chair |
| ID: | 2-U10-CA32102-33 |
| Date: | 2008 - 2012 |
| Title: | Molecular Biomarkers as Classifers to Individualize Therapy of Esophagus Cancer |
| Funding Source: | NIH/NCI |
| Role: | Consult |
| ID: | CA129906 |
| Date: | 2008 - 2009 |
| Title: | Role of Krueppel Like Factor-4 (KLF4) in Lung Cancer |
| Funding Source: | UT SPORE |
| Role: | PI |
| ID: | 5 P50 CA070907 10(PP-CDP16) |
| Date: | 2007 - 2010 |
| Title: | PKR mediated a chemo-and-radio-resistance in cancer cells |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA124388-01A1 |
| Date: | 2007 - 2012 |
| Title: | PROSPECT - Profiling of resistance patterns & oncogenic signaling pathways in evaluation of cancers of the thorax and therapeutics target identification. Project 2: Molecular Profiling of Non-Small Cell Lung Cancer Tissue Specimens and Serum and Plasma. Samples: Correlation with Patient Response and Tumor Resistance to Chemotherapy |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-I |
| ID: | W81XWH-07-1-0306(Hong) |
| Date: | 2006 - 2008 |
| Title: | Early prediction of pathological response of chemoradiotherapy with FLT PET |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R21 CA12155-01A1 |
| Date: | 2003 - 2005 |
| Title: | MRP: Project 3 - Role of PKR in adenoviral TNF gene therapy strategies in esophageal cancer |
| Funding Source: | UTMDACC Multidisciplinary Research Program |
| Role: | Collaborator |
| Date: | 2000 - 2004 |
| Title: | Tumor-Specific Transgene Expression for Cancer Therapy |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RPG-00-274-01-MGO |
| Date: | 2000 - 2001 |
| Title: | Novel Gene Therapeutics for the Treatment of Lung Cancer Identification & Characterization of Novel Apoptotic Genes by Micro Assay Screening Method |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| ID: | SBIR S/C IR43CA86587-1 |
| Date: | 1999 - 2002 |
| Title: | Phase II of L-NDDP for malignant pleural mesothelioma |
| Funding Source: | Food and Drug Administration |
| Role: | Co-Prinicpal Investigator |
| ID: | FD-R-001670 |
| Date: | 1999 - 2005 |
| Title: | Restoration of Apoptosis in Cancer - Project 3 - Strategies for Cell-Death Manipulation in Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-Principal Investigator- Project 3 |
| ID: | P01 CA78778 |
| Date: | 1999 - 2005 |
| Title: | Restoration of Apoptosis in Cancer - Project 1 - Laboratory Studies |
| Funding Source: | NIH/NCI |
| Role: | Co-Principal Investigator - Project 1 |
| ID: | NIH-PO1 CA78778 |
| Title: | Predictive models to identify risk factors associated with surgical outcomes among thoracic oncology surgical patients |
| Funding Source: | Robert Wood Johnson Foundation |
| Role: | Other Significant Contributor |
Selected Publications
Peer-Reviewed Articles
- Peng, F, Sinjab, A, Dai, Y, Treekitkarnmongkol, W, Yang, S, Gomez Bolanos, L, Zhou, T, Chen, M, Serrano, A, Krishna, A, Karimi, N, Sharma, M, Basi, A, Pei, G, Liao, J, Liu, Y, Feng, J, Rahal, Z, Liu, Y, Jiang, J, Yu, K, Noun, T, Liu, Y, Khan, KB, Cho, KS, Chen, J, Solis Soto, LM, Mazzilli, SA, Dubinett, SM, Cascone, T, Spira, A, Swisher, SG, Jimbo, N, Hayashi, T, Kishikawa, S, Takamochi, K, Itoh, T, Yao, T, Suzuki, K, Kalhor, N, Wistuba, II, Li, M, Moghaddam, SM, Fujimoto, J, Burks, JK, Myers, JN, Akdemir, KC, Wang, L, Kadara, HN. Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions. Cancer cell 44(2):321-339.e13, 2026. e-Pub 2026. PMID: 41202811.
- Marincola Smith, P, Tomita, K, Cass, SH, Hirata, Y, Pan, C, Shen, SE, Wang, X, Wang, XS, Williams, LA, Arvide, M, To, C, Rajaram, R, Rice, DC, Hofstetter, WL, Antonoff, MB, Mehran, RJ, Vaporciyan, AA, Walsh, GL, Maxwell, JE, Snyder, RA, Kim, M, Tzeng, CD, Badgwell, BD, Mansfield, PF, Katz, MH, Swisher, SG, Lee, JE, Ikoma, N. Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers. Annals of surgical oncology 33(2):1332-1342, 2026. e-Pub 2026. PMID: 41057745.
- Hooda, Z, Ries, S, Fabian, T, Freeman, KA, Hofstetter, WL, Hudson, J, Mehran, RJ, Rajaram, R, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Mitchell, KG, Zaku, B, Antonoff, MB. Training left-handed cardiothoracic surgeons in a right-handed world. JTCVS Open 29, 2026. e-Pub 2026.
- Hooda, Z, Werner, R, Ries, S, Eisenberg, M, Hofstetter, WL, Mehran, RJ, Rajaram, R, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Opitz, I, Mitchell, KG, Antonoff, MB. Role of genetic alterations on outcomes for pulmonary resection in oligometastatic non-small cell lung cancer. Journal of Thoracic Disease 17(12):10636-10647, 2025. e-Pub 2025. PMID: 41522142.
- Eisenberg, M, Werner, R, Ries, S, Hofstetter, WL, Mehran, RJ, Papasotiropoulos, T, Rice, DC, Rajaram, R, Steinmann, N, Swisher, SG, Walsh, GL, Vaporciyan, AA, Opitz, I, Antonoff, MB. Extent of resection in surgically resected stage IV non−small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 170(2):359-368.e3, 2025. e-Pub 2025. PMID: 40280541.
- Deboever, N, Al Tashi, Q, Eisenberg, M, Saad, M, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Rice, DC, Roth, JA, Swisher, SG, Vaporciyan, AA, Walsh, GL, Wu, J, Rajaram, R. Machine Learning Prediction of Financial Toxicity in Patients with Resected Lung Cancer. Journal of the American College of Surgeons 241(2):107-116, 2025. e-Pub 2025. PMID: 40028915.
- Hooda, Z, Duan, Z, Ries, S, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Mitchel, KG, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Rajaram, R. Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients. Annals of Thoracic Surgery 120(2):401-410, 2025. e-Pub 2025. PMID: 40222577.
- Wahba G, Swisher SG, Ge PS. A Footlong Esophageal Polyp. Clin Gastroenterol Hepatol, 2025. e-Pub 2025. PMID: 40645390.
- Mitchel, KG, Lee, Y, Deboever, N, Vailati Negrao, M, Tran, HT, Parra Cuentas, ER, Byers, LA, Reuben, A, Federico, L, Bernatchez, C, Wang, J, Antonoff, MB, Vaporciyan, AA, Swisher, SG, Cascone, T, Wistuba, II, Heymach, JV, Gibbons, DL, Zhang, J, McGrail, DJ, Sepesi, B, Haymaker, CL. Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer. Journal for immunotherapy of cancer 13(6), 2025. e-Pub 2025. PMID: 40555561.
- Deboever, N, Eisenberg, M, Niu, J, Graber, WJ, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Swisher, SG, Vaporciyan, AA, Walsh, GL, Giordano, SH, Rajaram, R, Rice, DC. Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB. Journal of surgical oncology 131(5):793-803, 2025. e-Pub 2025. PMID: 39635913.
- Antonoff, MB, Mitchel, KG, Kim, S, Salfity, HV, Kotova, S, Ripley, RT, Neri, AL, Sood, P, Gandhi, SG, Elamin, YY, Donington, J, Jones, DR, David, E, Swisher, SG, Opitz, I, Hayanga, JW, Rocco, G. The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Annals of Thoracic Surgery 119(3):495-508, 2025. e-Pub 2025. PMID: 39797869.
- Altan, M, Li, R, Li, Z, Chen, R, Sheshadri, A, Tran, HT, Little, L, Baguley, J, Sinson, JC, Vokes, N, Gandhi, S, Antonoff, MB, Swisher, SG, Lizee, GA, Reuben, A, Heymach, JV, Zhang, J. High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. Journal for immunotherapy of cancer 12(12), 2024. e-Pub 2024. PMID: 39721752.
- Skoulidis, F, Araujo, HA, Do, MT, Qian, Y, Sun, X, Cobo, AG, Le, JT, Montesion, M, Palmer, R, Jahchan, NS, Juan, J, Min, C, Yu, Y, Pan, X, Arbour, KC, Vokes, N, Schmidt, S, Molkentine, D, Owen, D, Memmott, R, Patil, P, Marmarelis, ME, Awad, MM, Murray, J, Hellyer, JA, Gainor, J, Dimou, A, Bestvina, CM, Shu, CA, Riess, JW, Blakely, CM, Pecot, CV, Mezquita, L, Tabbò, F, Scheffler, M, Digumarthy, S, Mooradian, MJ, Sacher, A, Lau, SC, Saltos, A, Rotow, JK, Johnson, RP, Liu, C, Stewart, TF, Goldberg, SB, Killam, J, Walther, Z, Schalper, K, Davies, KD, Woodcock, MG, Anagnostou, V, Marrone, KA, Forde, PM, Ricciuti, B, Venkatraman, D, Van Allen, EM, Cummings, AL, Goldman, JW, Shaish, H, Kier, M, Katz, S, Aggarwal, C, Ni, Y, Azok, J, Segal, J, Ritterhouse, LL, Neal, JW, Lacroix, L, Elamin, YY, Vailati Negrao, M, Le, X, Lam, VK, Lewis, WE, Kemp, HN, Carter, B, Roth, JA, Swisher, SG, Lee, R, Zhou, T, Poteete, A, Kong, Y, Takehara, T, Paula, AG, Parra Cuentas, ER, Behrens, C, Wistuba, II, Zhang, J, Blumenschein, GR, Gay, CM, Byers, LA, Gibbons, DL, Tsao, A, Lee, JJ, Bivona, T, Camidge, DR, Gray, J, Lieghl, N, Levy, BP, Brahmer, JR, Garassino, MC, Gandara, D, Garon, EB, Rizvi, NA, Scagliotti, G, Wolf, J, Planchard, D, Besse, B, Herbst, RS, Wakelee, HA, Pennell, N, Shaw, AT, Jänne, PA, Carbone, DP, Hellmann, MD, Rudin, CM, Albacker, LA, Mann, H, Zhu, Z, Lai, Z, Stewart, RA, Peters, S, Johnson, M, Wong, KK, Huang, A, Winslow, MM, Rosen, MJ, Winters, IP, Papadimitrakopoulou, VA, Cascone, T, Jewsbury, P, Heymach, JV. CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature 635(8038):462-471, 2024. e-Pub 2024. PMID: 39385035.
- Zhou, N, Leung, CH, William Jr, WN, Weissferdt, A, Pataer, A, Godoy, M, Carter, B, Fossella, FV, Tsao, A, Blumenschein, GR, Le, X, Zhang, J, Skoulidis, F, Kurie, JM, Altan, M, Lu, C, Glisson, BS, Byers, LA, Elamin, YY, Mehran, RJ, Rice, DC, Walsh, GL, Hofstetter, WL, Roth, JA, Tran, HT, Wu, J, Solis Soto, LM, Kadara, HN, Swisher, SG, Vaporciyan, AA, Gibbons, DL, Lin, HY, Jack Lee, J, Heymach, JV, Vailati Negrao, M, Sepesi, B, Cascone, T. Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Journal for immunotherapy of cancer 12(10), 2024. e-Pub 2024. PMID: 39448200.
- Childers CP, Hu CY, Swisher SG, Wong SL, Chang GJ. Estimated Financial Impact of 2021 Office-Visit Work Relative Unit Updates on Surgical Global Periods. JAMA Surg 159(9):1087-1089, 2024. e-Pub 2024. PMID: 38985466.
- Deboever N, Correa AM, Feldman H, Eisenberg M, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival. Ann Surg 280(1):91-97, 2024. e-Pub 2024. PMID: 38568206.
- Antonoff MB, Kui N, Sun R, Deboever N, Hofstetter W, Mehran RJ, Morris VK, Rice DC, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival. J Thorac Cardiovasc Surg 168(1):263-271, 2024. e-Pub 2024. PMID: 37690624.
- Eisenberg M, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?. Ann Thorac Surg, 2024. e-Pub 2024. PMID: 38839027.
- Deboever N, Feldman H, Eisenberg M, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Octreotide's role in the management of post-esophagectomy chylothorax. Dis Esophagus 37(6), 2024. e-Pub 2024. PMID: 38391198.
- Deboever N, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MB. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease. J Thorac Cardiovasc Surg 167(6):1929-1935.e2, 2024. e-Pub 2024. PMID: 37619884.
- Eisenberg MA, Deboever N, Mills AC, Egyud MR, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB. Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer. J Thorac Cardiovasc Surg 167(5):1617-1627, 2024. e-Pub 2024. PMID: 37696428.
- Sewastjanow-Silva, M, Xiao, L, Nogueras Gonzalez, G, Wang, X, Hofstetter, WL, Swisher, SG, Mehran, RJ, Sepesi, B, Bhutani, M, Weston, B, Coronel, E, Waters, R, Rogers, JE, Smith, J, Lyons, L, Reilly, N, Yao, JC, Ajani, JA, Blum Murphy, M. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas. Cancers 16(7), 2024. e-Pub 2024. PMID: 38611056.
- Feldman H, Sepesi B, Leung CH, Lin H, Weissferdt A, Pataer A, William WN Jr, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone T. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 167(4):1444-1453.e4, 2024. e-Pub 2024. PMID: 37816395.
- Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy. J Thorac Cardiovasc Surg 167(3):814-819.e2, 2024. e-Pub 2024. PMID: 37495170.
- Deboever N, Eisenberg MA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram R. Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery. J Thorac Cardiovasc Surg 167(2):478-487.e2, 2024. e-Pub 2024. PMID: 37356476.
- Tran HT, Heeke S, Sujit S, Vokes N, Zhang J, Aminu M, Lam VK, Vaporciyan A, Swisher SG, Godoy MCB, Cascone T, Sepesi B, Gibbons DL, Wu J, Heymach JV. Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. Ann Oncol 35(2):183-189, 2024. e-Pub 2024. PMID: 37992871.
- Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases. J Surg Oncol 129(2):331-337, 2024. e-Pub 2024. PMID: 37876311.
- Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WL. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg 117(2):320-326, 2024. e-Pub 2024. PMID: 37080372.
- Deboever N, Correa AM, Feldman H, Mathur U, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB, Rajaram R. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals. J Thorac Cardiovasc Surg 167(1):329-337.e4, 2024. e-Pub 2024. PMID: 37116780.
- Weissferdt A, Leung CH, Lin H, Sepesi B, William WN, Swisher SG, Cascone T, Lee JJ, Pataer A. Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy. Mod Pathol 37(1):100353, 2024. e-Pub 2024. PMID: 37844869.
- Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rajaram R. Financial Toxicity in Patients With Resected Lung Cancer. Ann Surg 278(6):1038-1044, 2023. e-Pub 2023. PMID: 37249193.
- Eisenberg MA, Deboever N, Swisher SG, Vaporciyan AA, Hetz RA, Antonoff MB. Removing Implicit Bias From Cardiothoracic Surgery Resident Recruitment: Changing the Paradigm. J Surg Res 292:72-78, 2023. e-Pub 2023. PMID: 37595516.
- Conen, D, Ke Wang, M, Popova, E, Chan, MT, Landoni, G, Cata, JP, Reimer, C, McLean, SR, Srinathan, S, Reyes, JT, Grande, AM, Tallada, AG, Sessler, DI, Fleischmann, E, Kabon, B, Voltolini, L, Cruz, P, Maziak, D, Gutiérrez-Soriano, L, McIntyre, WF, Tandon, V, Martínez-Téllez, E, Guerra-Londono, JJ, DuMerton, D, Wong, RH, McGuire, AL, Kidane, B, Roux, DP, Shargall, Y, Wells, JR, Ofori, SN, Vincent, J, Xu, L, Li, Z, Eikelboom, JW, Jolly, SS, Healey, JS, Devereaux, PJ, Wang, MK, Wells, JR, Healey, JS, McIntyre, WF, Sessler, DI, Rajaram, R, Vaporciyan, AA, Mehran, RJ, Sepesi, B, Walsh, GL, Rice, DC, Swisher, SG. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF). The Lancet 402(10413):1627-1635, 2023. e-Pub 2023. PMID: 37640035.
- Zhou N, Niu J, Nelson D, Feldman HA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Walsh GL, Giordano SH, Rajaram R. Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection. Ann Thorac Surg 116(5):1020-1027, 2023. e-Pub 2023. PMID: 36801207.
- Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Circulomic variables predict pathologic staging preoperatively in treatment-naive non-small cell lung cancer. J Thorac Dis 15(10):5507-5516, 2023. e-Pub 2023. PMID: 37969292.
- Chang JY, Lin SH, Dong W, Liao Z, Gandhi SJ, Gay CM, Zhang J, Chun SG, Elamin YY, Fossella FV, Blumenschein G, Cascone T, Le X, Pozadzides JV, Tsao A, Verma V, Welsh JW, Chen AB, Altan M, Mehran RJ, Vaporciyan AA, Swisher SG, Balter PA, Fujimoto J, Wistuba II, Feng L, Lee JJ, Heymach JV. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet 402(10405):871-881, 2023. e-Pub 2023. PMID: 37478883.
- Bayley EM, Ivy ML, Shewale JB, Ge PS, Antonoff MB, Francis AM, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Vaporciyan AA, Walsh GL, Lee JJ, Louie BE, Swisher SG. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed. Ann Surg 277(5):721-726, 2023. e-Pub 2023. PMID: 36052678.
- Offodile AC 2nd, Lin YL, Shah SA, Swisher SG, Jain A, Butler CE, Aliu O. Is the Centralization of Complex Surgical Procedures an Unintended Spillover Effect of Global Capitation? - Insights from the Maryland Global Budget Revenue Program. Ann Surg 277(4):535-541, 2023. e-Pub 2023. PMID: 36512741.
- Shenson, JA, Zafereo, M, Lee, M, Contrera, KJ, Feng, L, Boonsripitayanon, M, Gross, N, Goepfert, RP, Maniakas, A, Wang, JR, Grubbs, L, Vaporciyan, AA, Hofstetter, WL, Swisher, SG, Mehran, RJ, Rice, DC, Sepesi, B, Antonoff, MB, Cabanillas, ME, Busaidy, NL, Dadu, R, Silver, NL. Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head and Neck 45(3):547-554, 2023. e-Pub 2023. PMID: 36524701.
- Mills AC, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Repeated Pulmonary Metastasectomy: Third Operations and Beyond. Ann Thorac Surg 115(3):679-685, 2023. e-Pub 2023. PMID: 35926641.
- Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, William WN Jr, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L, Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Blumenschein G Jr, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG, Vaporciyan AA, Lin HY, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi B. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med 29(3):593-604, 2023. e-Pub 2023. PMID: 36928818.
- Francisco-Cruz, A, Rocha, P, Reuben, A, Krishnan, S, Das, P, Chen, R, Quek, YK, Li, J, Parra Cuentas, ER, Solis Soto, LM, Barua, S, Jiang, M, Segura Lazcano, R, Chow, CW, Behrens, MC, Gumb, C, Little, L, Fukuoka, J, Kalhor, N, Weissferdt, A, Kadara, HN, Heymach, JV, Swisher, SG, Sepesi, B, Uppore Kukkillaya, AR, Moran, C, Zhang, J, Lee, JJ, Fujimoto, J, Futreal, A, Wistuba, II, Peterson, CB, Zhang, J. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non–Small Cell Lung Cancer. Modern Pathology 36(1), 2023. e-Pub 2023. PMID: 36788067.
- Deboever, N, Zhou, N, McGrail, DJ, Tomczak, K, Oliva, JL, Feldman, HA, Parra Cuentas, ER, Zhang, J, Lee, PP, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Rajaram, R, Rice, DC, Roth, JA, Swisher, SG, Vaporciyan, AA, Altan, M, Weissferdt, A, Tsao, A, Haymaker, CL, Sepesi, B. Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations. Frontiers in Oncology 13, 2023. e-Pub 2023. PMID: 37637041.
- Altan, M, Li, QZ, Wang, Q, Vokes, N, Sheshadri, A, Gao, J, Zhu, C, Tran, HT, Gandhi, S, Antonoff, MB, Swisher, SG, Wang, J, Byers, LA, Hassan, NA, Franco Vega, M, Wang, Y, Lee, JJ, Zhang, J, Heymach, JV. Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events. Frontiers in immunology 14, 2023. e-Pub 2023. PMID: 38152395.
- De B, Farooqi AS, Mitchell KG, Ludmir EB, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee JJ, Swisher SG, Gibbons DL, Zhang J, Le X, Elamin YY, Gomez DR, Ning MS, Lin SH, Liao Z, Chang JY, Vaporciyan AA, Heymach JV, Antonoff MB, Gandhi SJ. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO Precis Oncol 7:e2200540, 2023. e-Pub 2023. PMID: 36716413.
- Alhalabi, O, Chen, J, Zhang, Y, Lu, Y, Wang, Q, Ramachandran, S, Tidwell, R, Han, G, Yan, X, Meng, J, Wang, R, Hoang, A, Wang, W, Song, J, Lopez, LP, Andreev-Drakhlin, AY, Siefker-Radtke, AO, Zhang, X, Benedict, WF, Shah, AY, Wang, J, Msaouel, P, Zhang, M, Guo, CC, Czerniak, BA, Behrens, MC, Solis Soto, LM, Papadimitrakopoulou, VA, Lewis, J, Rinsurongkawong, W, Rinsurongkawong, V, Lee, JJ, Roth, JA, Swisher, SG, Wistuba, II, Heymach, JV, Wang, J, Campbell, M, Efstathiou, E, Titus, M, Logothetis, CJ, Ho, TH, Zhang, J, Wang, L, Gao, J. MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nature communications 13(1), 2022. e-Pub 2022. PMID: 35379845.
- Feldman, HA, Zhou, N, Deboever, N, Hofstetter, WL, Mehran, RJ, Rajaram, R, Rice, DC, Roth, JA, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL, Godoy, M, Strange, CD, Antonoff, MB. Intraoperative challenges after induction therapy for non–small cell lung cancer. JTCVS Open 12:372-384, 2022. e-Pub 2022. PMID: 36590745.
- Zhou N, Hofstetter WL, Mitchell KG, Bayley EM, Ajani JA, Antonoff MB, Betancourt SL, Blum-Murphy M, Feldman HA, Lin SH, Maru DM, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Weston BR. Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers. Ann Thorac Surg 114(6):2032-2040, 2022. e-Pub 2022. PMID: 34883083.
- Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi M, Stroehlein JR, Mehran RJ, Walsh G, Vaporciyan A, Swisher SG, Hofstetter W. Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience. Cancers (Basel) 14(23), 2022. e-Pub 2022. PMID: 36497224.
- Hao D, Han G, Sinjab A, Gomez-Bolanos LI, Lazcano R, Serrano A, Hernandez SD, Dai E, Cao X, Hu J, Dang M, Wang R, Chu Y, Song X, Zhang J, Parra ER, Wargo JA, Swisher SG, Cascone T, Sepesi B, Futreal AP, Li M, Dubinett SM, Fujimoto J, Solis Soto LM, Wistuba II, Stevenson CS, Spira A, Shalapour S, Kadara H, Wang L. The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma. Cancer Discov 12(11):2626-2645, 2022. e-Pub 2022. PMID: 36098652.
- Pataer A, Weissferdt A, Correa AM, Vaporciyan AA, Sepesi B, Heymach JV, Berezowska S, Cascone T, Swisher SG. Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy. JTO Clin Res Rep 3(11):100420, 2022. e-Pub 2022. PMID: 36389133.
- Sepesi B, Zhou N, William WN Jr, Lin HY, Leung CH, Weissferdt A, Mitchell KG, Pataer A, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Negrao MV, Tsao AS, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone T. Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 164(5):1327-1337, 2022. e-Pub 2022. PMID: 35190177.
- Akhave, NS, Zhang, J, Bayley, EM, Frank, ML, Chiou, SH, Behrens, MC, Chen, R, Hu, X, Parra Cuentas, ER, Lee, WC, Swisher, SG, Solis Soto, LM, Weissferdt, A, Moran, C, Kalhor, N, Zhang, J, Scheet, PA, Vaporciyan, AA, Sepesi, B, Gibbons, DL, Heymach, JV, Lee, JJ, Wistuba, II, Futreal, A, Zhang, J, Fujimoto, J, Reuben, A. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment. Lung Cancer 172:19-28, 2022. e-Pub 2022. PMID: 35973335.
- Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SL. Clinical Significance of [(18)F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients. Ann Thorac Surg 114(4):1183-1188, 2022. e-Pub 2022. PMID: 34634240.
- Deboever N, Feldman HA, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era. J Surg Res 277:125-130, 2022. e-Pub 2022. PMID: 35489217.
- Zorrilla-Vaca A, Feldman H, Antonoff M, Sepesi B, Hofstetter W, Rajaram R, Swisher S, Mena G, Vaporciya A, Mehran R, Rice D. Single Chest Drain Practice Reduces Discharge Opioid Prescriptions in Thoracic Surgery. Thorac Cardiovasc Surg, 2022. e-Pub 2021. PMID: 34894636.
- Sepesi B, Swisher SG. Role of neoadjuvant chemoimmunotherapy for resectable NSCLC. Nat Rev Clin Oncol 19(8):497-498, 2022. e-Pub 2022. PMID: 35585121.
- Bayley EM, Zhou N, Mitchell KG, Antonoff MB, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Cinciripini PM, Karam-Hage M, Roth JA, Hofstetter WL. Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients. Ann Thorac Surg 114(1):286-292, 2022. e-Pub 2022. PMID: 34358522.
- Liu, Y, Zhang, Z, Rinsurongkawong, W, Gay, CM, Le, X, Ning, M, Lewis, J, Rinsurongkawong, V, Lee, JJ, Roth, JA, Swisher, SG, Gandhi, S, Lee, PP, Gibbons, DL, Vaporciyan, AA, Heymach, JV, Zhang, J, Lin, SH. Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab. JAMA Network Open 5(6), 2022. e-Pub 2022. PMID: 35666500.
- Rocha P, Zhang J, Laza-Briviesca R, Cruz-Bermudez A, Bota-Rabassedas N, Sanchez-Espiridon B, Yoshimura K, Behrens C, Lu W, Tang X, Pataer A, Parra ER, Haymaker C, Fujimoto J, Swisher SG, Heymach JV, Gibbons DL, Lee JJ, Sepesi B, Cascone T, Solis LM, Provencio M, Wistuba II, Kadara H. Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC. Clin Cancer Res 28(11):2461-2473, 2022. e-Pub 2022. PMID: 35394499.
- Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Strange CD, Antonoff MB. Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer. Ann Thorac Surg 113(6):1835-1844, 2022. e-Pub 2022. PMID: 34252403.
- Ahmed, T, Mouhayar, E, Song, J, Koutroumpakis, E, Palaskas, NL, Yusuf, SW, Lopez-Mattei, J, Hassan, SA, Kim, P, Cilingiroglu, M, Marmagkiolis, K, Vaporciyan, AA, Swisher, SG, Deswal, A, Iliescu, C. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Frontiers in Cardiovascular Medicine 9, 2022. e-Pub 2022. PMID: 35711368.
- Bostock IC, Zhou N, Antonoff MB, Murphy MB, Lin S, Maru D, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Prolonged neutrophilia is associated with worse outcomes after Esophagectomy. Dis Esophagus, 2022. e-Pub 2021. PMID: 34897440.
- Zhao H, Misariu AM, Ramirez-GarciaLuna JL, Nobel T, Mueller C, Cools-Lartigue J, Spicer J, Molena D, Bains M, Swisher S, Hofstetter W, Ferri L. Synchronous Esophageal and Lung Cancers - Is Combined Anatomic Resection Appropriate?. Ann Thorac Surg, 2022. e-Pub 2021. PMID: 33905733.
- Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg 113(3):975-983, 2022. e-Pub 2022. PMID: 33838123.
- Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer. Ann Thorac Surg 113(3):1008-1014, 2022. e-Pub 2022. PMID: 33774003.
- Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AA. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep 3(3):100288, 2022. e-Pub 2022. PMID: 35252897.
- Zhang X, Zhang R, Ren C, Xu Y, Wu S, Meng C, Pataer A, Song X, Zhang J, Yao Y, He H, Chen H, Ma W, Wang J, Meric-Bernstam F, Champlin RE, Heymach JV, Rooney CM, Swisher SG, Vaporciyan AA, Roth JA, You MJ, Wang M, Fang B. Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo. Blood Adv 6(3):891-901, 2022. e-Pub 2022. PMID: 34861697.
- Zorrilla-Vaca A, Rice D, Brown JK, Antonoff M, Sepesi B, Hofstetter W, Swisher S, Walsh G, Vaporciyan A, Mehran R, Hagberg C, Mena GE. Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model. Surgery, 2022. e-Pub 2021. PMID: 34740455.
- Deboever N, McGrail DJ, Lee Y, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Bernatchez C, Vailati Negrao M, Zhang J, Wistuba II, Heymach JV, Cascone T, Gibbons DL, Haymaker CL, Sepesi B. Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection. Lung Cancer 164:69-75, 2022. e-Pub 2022. PMID: 35038676.
- Federico, L, McGrail, DJ, Bentebibel, SE, Haymaker, CL, Ravelli, A, Forget, MA, Karpinets, T, Jiang, P, Reuben, A, Vailati Negrao, M, Li, J, Khairullah, R, Zhang, J, Weissferdt, A, Vaporciyan, AA, Antonoff, MB, Walsh, GL, Lin, S, Futreal, A, Wistuba, II, Roth, JA, Byers, LA, Gaudreau, PO, Uraoka, N, Francisco-Cruz, A, Dejima, H, Segura Lazcano, R, Solis Soto, LM, Parra Cuentas, ER, Lee, JJ, Swisher, SG, Cascone, T, Heymach, JV, Sepesi, B, Gibbons, DL, Bernatchez, C. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer. Annals of Oncology 33(1):42-56, 2022. e-Pub 2022. PMID: 34653632.
- Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi B. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg 113(1):200-208, 2022. e-Pub 2022. PMID: 33971174.
- Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, Li J, Chow CW, Mao X, Song X, Lee WC, Wu J, Little L, Gumbs C, Behrens C, Moran C, Weissferdt A, Lee JJ, Sepesi B, Swisher S, Cheng C, Kurie J, Gibbons D, Heymach JV, Wistuba II, Futreal PA, Kalhor N, Zhang J. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nat Commun 12(1):7081, 2021. e-Pub 2021. PMID: 34873156.
- Bostock, I, Hofstetter, WL, Mehran, RJ, Rajaram, R, Rice, DC, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL, Antonoff, MB. Barriers to surveillance imaging adherence in early-staged lung cancer. Journal of Thoracic Disease 13(12):6848-6854, 2021. e-Pub 2021. PMID: 35070369.
- Rice D, Rodriguez-Restrepo A, Mena G, Cata J, Thall P, Milton D, Correa A, Woodard T, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Mehran R. Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg 274(6):1099-1106, 2021. e-Pub 2021. PMID: 32229762.
- Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg 162(5):1404-1412.e2, 2021. e-Pub 2021. PMID: 33010880.
- Blumenthaler AN, Zhou N, Parikh K, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients. Innovations (Phila) 16(6):529-535, 2021. e-Pub 2021. PMID: 34494925.
- Zhou N, Mitchell KG, Corsini EM, Truong VTT, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WL. Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma. Br J Surg 108(10):1207-1215, 2021. e-Pub 2021. PMID: 34095952.
- Chang, JY, Mehran, RJ, Feng, L, Verma, V, Liao, Z, Welsh, J, Lin, SH, O'Reilly, M, Jeter, M, Balter, PA, McRae, SE, Berry, D, Heymach, JV, Roth, JA, Antonoff, MB, Hofstetter, WL, Rajaram, R, Rice, DC, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL, DeGraaf, C, Correa, AM, Chen, A, Gandhi, S, Komaki, R, Lee, PP, Nguyen, Q, Ning, M, Gao, S, Pollard-Larkin, JM, Nitsch, PL, Sadagopan, R, Wang, X. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS). The lancet oncology 22(10):1448-1457, 2021. e-Pub 2021. PMID: 34529930.
- Corsini EM, Mitchell KG, Zhou N, Bernatchez C, Forget MA, Haymaker CL, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Amaria RN, Jazaeri AA, Antonoff MB. Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility. J Surg Oncol 124(4):699-703, 2021. e-Pub 2021. PMID: 34057733.
- Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy. J Gastrointest Surg 25(9):2185-2191, 2021. e-Pub 2021. PMID: 33555525.
- Cascone T, Weissferdt A, Godoy MCB, William WN Jr, Leung CH, Lin HY, Basu S, Yadav SS, Pataer A, Mitchell KG, Khan MAW, Shi Y, Haymaker C, Solis LM, Parra ER, Kadara H, Wistuba II, Sharma P, Allison JP, Ajami NJ, Wargo JA, Jenq RR, Gibbons DL, Lee JJ, Swisher SG, Vaporciyan AA, Heymach JV, Sepesi B. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer. Nat Commun 12(1):5045, 2021. e-Pub 2021. PMID: 34413300.
- Pataer A, Weissferdt A, Vaporciyan AA, Correa AM, Sepesi B, Wistuba II, Heymach JV, Cascone T, Swisher SG. Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy. J Thorac Oncol 16(8):1289-1297, 2021. e-Pub 2021. PMID: 33857666.
- Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Mena GE, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Hofstetter WL. Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications. Ann Thorac Surg 112(2):423-429, 2021. e-Pub 2021. PMID: 33129774.
- Negrao MV, Skoulidis F, Montesion M, Schulze K, Bara I, Shen V, Xu H, Hu S, Sui D, Elamin YY, Le X, Goldberg ME, Murugesan K, Wu CJ, Zhang J, Barreto DS, Robichaux JP, Reuben A, Cascone T, Gay CM, Mitchell KG, Hong L, Rinsurongkawong W, Roth JA, Swisher SG, Lee J, Tsao A, Papadimitrakopoulou V, Gibbons DL, Glisson BS, Singal G, Miller VA, Alexander B, Frampton G, Albacker LA, Shames D, Zhang J, Heymach JV. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer. J Immunother Cancer 9(8), 2021. e-Pub 2021. PMID: 34376553.
- Corsini, EM, Mitchell, KG, Correa, AM, Morris, VK, Antonoff, MB, Zhou, N, Hofstetter, WL, Mehran, RJ, Rice, DC, Roth, JA, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL. Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy. Journal of Thoracic and Cardiovascular Surgery 162(1):296-305, 2021. e-Pub 2021. PMID: 32713636.
- Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg 273(4):751-757, 2021. e-Pub 2021. PMID: 31188215.
- Mitchell, KG, Farooqi, AS, Ludmir, EB, Corsini, EM, Sepesi, B, Gomez, D, Antonoff, MB, Vaporciyan, AA, Swisher, SG, Heymach, JV, Zhang, J, Gandhi, S. Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer. Journal of Thoracic and Cardiovascular Surgery 161(4):1497-1504.e2, 2021. e-Pub 2021. PMID: 32331820.
- Le X, Negrao MV, Reuben A, Federico L, Diao L, McGrail D, Nilsson M, Robichaux J, Munoz IG, Patel S, Elamin Y, Fan YH, Lee WC, Parra E, Solis Soto LM, Chen R, Li J, Karpinets T, Khairullah R, Kadara H, Behrens C, Sepesi B, Wang R, Zhu M, Wang L, Vaporciyan A, Roth J, Swisher S, Haymaker C, Zhang J, Wang J, Wong KK, Byers LA, Bernatchez C, Zhang J, Wistuba II, Gibbons DL, Akbay EA, Heymach JV. Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target. J Thorac Oncol 16(4):583-600, 2021. e-Pub 2021. PMID: 33388477.
- Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Lin SH, Ajani JA, Hofstetter WL. Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation. Ann Thorac Surg 111(4):1133-1140, 2021. e-Pub 2021. PMID: 32857997.
- Corsini EM, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac. Ann Thorac Surg 111(4):1111-1117, 2021. e-Pub 2021. PMID: 32980327.
- Lam VK, Zhang J, Wu CC, Tran HT, Li L, Diao L, Wang J, Rinsurongkawong W, Raymond VM, Lanman RB, Lewis J, Roarty EB, Roth J, Swisher S, Lee JJ, Gibbons DL, Papadimitrakopoulou VA, Heymach JV. Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC. J Thorac Oncol 16(4):601-609, 2021. e-Pub 2021. PMID: 33388476.
- Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, Nabet BY, Fujimoto J, Solis LM, Lu W, Xi Y, Cardnell RJ, Wang Q, Fabbri G, Cargill KR, Vokes NI, Ramkumar K, Zhang B, Della Corte CM, Robson P, Swisher SG, Roth JA, Glisson BS, Shames DS, Wistuba II, Wang J, Quaranta V, Minna J, Heymach JV, Byers LA. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39(3):346-360.e7, 2021. e-Pub 2021. PMID: 33482121.
- Zhou, N, Bott, M, Park, B, Vallieres, E, Wilshire, CL, Yasufuku, K, Spicer, JD, Jones, DR, Sepesi, B, Mitchell, KG, Corsini, EM, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Huynh, C, Fiset, PO, Chun, SG, Gay, CM. Predictors of survival following surgical resection of limited-stage small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 161(3):760-771.e2, 2021. e-Pub 2021. PMID: 33349449.
- Cascone T, William WN Jr, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G Jr, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med 27(3):504-514, 2021. e-Pub 2021. PMID: 33603241.
- Sitthideatphaiboon P, Galan-Cobo A, Negrao MV, Qu X, Poteete A, Zhang F, Liu DD, Lewis WE, Kemp HN, Lewis J, Rinsurongkawong W, Giri U, Lee JJ, Zhang J, Roth JA, Swisher S, Heymach JV. LKB1 mutations in NSCLC are associated with KEAP1/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition. Clin Cancer Res 27(6):1720-1733, 2021. e-Pub 2021. PMID: 33323404.
- Schwalk AJ, Ost DE, Saltijeral SN, De La Garza H, Casal RF, Jimenez CA, Eapen GA, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Elamin Y, Zhang J, Roth JA, Swisher S, Heymach JV, Grosu HB. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients with Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations. Chest 159(3):1256-1264, 2021. e-Pub 2021. PMID: 33217413.
- Corsini, EM, Hofstetter, WL, Mitchell, KG, Zhou, N, Antonoff, MB, Mehran, RJ, Mena, GE, Rice, DC, Roth, JA, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL. Ketorolac use and anastomotic leak in patients with esophageal cancer. Journal of Thoracic and Cardiovascular Surgery 161(2):448-454, 2021. e-Pub 2021. PMID: 32340809.
- Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy. Eur J Cardiothorac Surg 59(1):100-108, 2021. e-Pub 2021. PMID: 32864702.
- Gaudreau PO, Negrao MV, Mitchell KG, Reuben A, Corsini EM, Li J, Karpinets TV, Wang Q, Diao L, Wang J, Federico L, Parra-Cuentas ER, Khairullah R, Behrens C, Correa AM, Gomez D, Little L, Gumbs C, Kadara HN, Fujimoto J, McGrail DJ, Vaporciyan AA, Swisher SG, Walsh G, Antonoff MB, Weissferdt A, Tran H, Roarty E, Haymaker C, Bernatchez C, Zhang J, Futreal PA, Wistuba II, Cascone T, Heymach JV, Sepesi B, Zhang J, Gibbons DL. Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC. J Thorac Oncol 16(1):127-139, 2021. e-Pub 2021. PMID: 33096269.
- Liu X, Hong L, Nilsson M, Hubert SM, Wu S, Rinsurongkawong W, Lewis J, Spelman A, Roth J, Swisher S, He Y, Jack Lee J, Fang B, Heymach JV, Zhang J, Le X. Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer. Lung Cancer 149:33-40, 2020. e-Pub 2020. PMID: 32956986.
- Lee WC, Reuben A, Hu X, McGranahan N, Chen R, Jalali A, Negrao MV, Hubert SM, Tang C, Wu CC, Lucas AS, Roh W, Suda K, Kim J, Tan AC, Peng DH, Lu W, Tang X, Chow CW, Fujimoto J, Behrens C, Kalhor N, Fukumura K, Coyle M, Thornton R, Gumbs C, Li J, Wu CJ, Little L, Roarty E, Song X, Lee JJ, Sulman EP, Rao G, Swisher S, Diao L, Wang J, Heymach JV, Huse JT, Scheet P, Wistuba II, Gibbons DL, Futreal PA, Zhang J, Gomez D, Zhang J. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity. Genome Biol 21(1):271, 2020. e-Pub 2020. PMID: 33148332.
- Chen R, Lee WC, Fujimoto J, Li J, Hu X, Mehran R, Rice D, Swisher SG, Sepesi B, Tran HT, Chow CW, Little LD, Gumbs C, Haymaker C, Heymach JV, Wistuba II, Lee JJ, Futreal PA, Zhang J, Reuben A, Tsao AS, Zhang J. Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment. Clin Cancer Res 26(20):5477-5486, 2020. e-Pub 2020. PMID: 32816946.
- Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer 23(5):904-912, 2020. e-Pub 2020. PMID: 32347396.
- Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi B. Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J Surg Oncol 122(3):495-505, 2020. e-Pub 2020. PMID: 32356321.
- Hong L, Negrao MV, Dibaj SS, Chen R, Reuben A, Bohac JM, Liu X, Skoulidis F, Gay CM, Cascone T, Mitchell KG, Tran HT, Le X, Byers LA, Sepesi B, Altan M, Elamin YY, Fossella FV, Kurie JM, Lu C, Mott FE, Tsao AS, Rinsurongkawong W, Lewis J, Gibbons DL, Glisson BS, Blumenschein GR Jr, Roarty EB, Futreal PA, Wistuba II, Roth JA, Swisher SG, Papadimitrakopoulou VA, Heymach JV, Lee JJ, Simon GR, Zhang J. Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC. J Thorac Oncol 15(9):1449-1459, 2020. e-Pub 2020. PMID: 32389639.
- Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rice DC. Importance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms. J Surg Oncol 122(3):515-522, 2020. e-Pub 2020. PMID: 32468580.
- Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN Jr, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone T. (18)F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother 69(8):1519-1534, 2020. e-Pub 2020. PMID: 32300858.
- Corsini EM, Wang Q, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Reuben A, Vasquez ME, Bernatchez C, Wang J, Cascone T, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi B. Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively. Lung Cancer 146:303-309, 2020. e-Pub 2020. PMID: 32619781.
- Schwalk AJ, Marcoux M, Swisher SG, Casal RF. Development of Miniature Y Stent for Treatment of Postoperative Bronchial Stenosis. Ann Thorac Surg 110(2):e99-e101, 2020. e-Pub 2020. PMID: 32006477.
- Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
- Cascone T, Sepesi B, Lin HY, Kalhor N, Parra ER, Jiang M, Godoy MCB, Zhang J, Fossella FV, Tsao AS, Lam VK, Lu C, Mott FE, Simon GR, Antonoff MB, Mehran RJ, Rice DC, Behrens C, Weissferdt A, Moran C, Vaporciyan AA, Lee JJ, Swisher SG, Gibbons DL, Wistuba II, William WN Jr, Heymach JV. A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clin Cancer Res 26(14):3525-3536, 2020. e-Pub 2020. PMID: 32193228.
- Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SG. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer 21(4):341-348, 2020. e-Pub 2020. PMID: 32279936.
- Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. Clin Lung Cancer 21(4):e294-e301, 2020. e-Pub 2020. PMID: 32089476.
- Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol 38(14):1569-1579, 2020. e-Pub 2020. PMID: 32160096.
- Corsini EM, Datar SS, Mitchell KG, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Blackmon SH, Loree JM, Morris VK, Antonoff MB. High mutational concordance between primary colorectal tumors and associated pulmonary metastases. J Surg Oncol 121(6):984-989, 2020. e-Pub 2020. PMID: 32077113.
- Corsini EM, Wang J, Wu CC, Fujimoto J, Negrao MV, Chen R, Quek K, Mitchell KG, Chow CB, Little L, Gumbs C, Song X, Behrens C, Correa AM, Antonoff MB, Swisher SG, Heymach JV, Zhang J, Wistuba II, Futreal PA, Sepesi B, Zhang J. Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers. J Thorac Dis 12(5):1952-1959, 2020. e-Pub 2020. PMID: 32642098.
- Stewart CA, Gay CM, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J, Bolisetty M, Hartsfield PM, Balasubramaniyan V, Chalishazar MD, Moran C, Kalhor N, Stewart J, Tran H, Swisher SG, Roth JA, Zhang J, de Groot J, Glisson B, Oliver TG, Heymach JV, Wistuba I, Robson P, Wang J, Byers LA. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer 1:423-436, 2020. e-Pub 2020. PMID: 33521652.
- Mitchell KG, Diao L, Karpinets T, Negrao MV, Tran HT, Parra ER, Corsini EM, Reuben A, Federico L, Bernatchez C, Dejima H, Francisco-Cruz A, Wang J, Antonoff MB, Vaporciyan AA, Swisher SG, Cascone T, Wistuba II, Heymach JV, Gibbons DL, Zhang J, Haymaker CL, Sepesi B. Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort. J Immunother Cancer 8(1), 2020. e-Pub 2020. PMID: 32350118.
- Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus 33(3), 2020. e-Pub 2020. PMID: 31313820.
- Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MB. Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. J Thorac Dis 12(3):184-190, 2020. e-Pub 2020. PMID: 32274083.
- Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis 12(3):329-337, 2020. e-Pub 2020. PMID: 32274099.
- Zhuo M, Guan Y, Yang X, Hong L, Wang Y, Li Z, Chen R, Abbas HA, Chang L, Gong Y, Wu N, Zhong J, Chen W, Chen H, Dong Z, Zhu X, Li J, Wang Y, An T, Wu M, Wang Z, Wang J, Roarty EB, Rinsurongkawong W, Lewis J, Roth JA, Swisher SG, Lee JJ, Heymach JV, Wistuba II, Kalhor N, Yang L, Yi X, Futreal PA, Glisson BS, Xia X, Zhang J, Zhao J. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. Clin Cancer Res 26(4):892-901, 2020. e-Pub 2020. PMID: 31694833.
- Tang C, Lee WC, Reuben A, Chang L, Tran H, Little L, Gumbs C, Wargo J, Futreal A, Liao Z, Xia X, Yi X, Swisher SG, Heymach JV, Gomez D, Zhang J. Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial. Int J Radiat Oncol Biol Phys 106(2):349-357, 2020. e-Pub 2020. PMID: 31678224.
- Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B. Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients. Ann Thorac Surg 109(2):404-411, 2020. e-Pub 2020. PMID: 31539514.
- Mitchell KG, Negrao MV, Parra ER, Li J, Zhang J, Dejima H, Vaporciyan AA, Swisher SG, Weissferdt A, Antonoff MB, Cascone T, Roarty E, Wistuba II, Heymach JV, Gibbons DL, Zhang J, Sepesi B. Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer. Ann Thorac Surg 109(2):358-366, 2020. e-Pub 2020. PMID: 31550464.
- Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB. Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations (Phila) 15(1):57-65, 2020. e-Pub 2020. PMID: 31875755.
- Reuben A, Zhang J, Chiou SH, Gittelman RM, Li J, Lee WC, Fujimoto J, Behrens C, Liu X, Wang F, Quek K, Wang C, Kheradmand F, Chen R, Chow CW, Lin H, Bernatchez C, Jalali A, Hu X, Wu CJ, Eterovic AK, Parra ER, Yusko E, Emerson R, Benzeno S, Vignali M, Wu X, Ye Y, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Cascone T, Snyder A, Wargo JA, Herbst R, Swisher S, Kadara H, Moran C, Kalhor N, Zhang J, Scheet P, Vaporciyan AA, Sepesi B, Gibbons DL, Robins H, Hwu P, Heymach JV, Sharma P, Allison JP, Baladandayuthapani V, Lee JJ, Davis MM, Wistuba II, Futreal PA, Zhang J. Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nat Commun 11(1):603, 2020. e-Pub 2020. PMID: 32001676.
- Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer. Clin Lung Cancer 21(1):37-46.e7, 2020. e-Pub 2020. PMID: 31447303.
- Pataer A, Ozpolat B, Shao R, Cashman NR, Plotkin SS, Samuel CE, Lin SH, Kabil NN, Wang J, Majidi M, Fang B, Roth JA, Vaporciyan AA, Wistuba II, Hung MC, Swisher SG. Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells. Oncogene 39(4):801-813, 2020. e-Pub 2020. PMID: 31554935.
- Zhang X, Zhang R, Chen H, Wang L, Ren C, Pataer A, Wu S, Meng QH, Ha MJ, Morris J, Xi Y, Wang J, Zhang J, Gibbons DL, Heymach JV, Meric-Bernstam F, Minna J, Swisher SG, Roth JA, Fang B. KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. Am J Cancer Res 10(12):4464-4475, 2020. e-Pub 2020. PMID: 33415011.
- Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. Semin Thorac Cardiovasc Surg 32(2):337-343, 2020. e-Pub 2020. PMID: 31857153.
- Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL. Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?. Dis Esophagus 32(10):1-6, 2019. e-Pub 2019. PMID: 30888418.
- Marcus RK, Lillemoe HA, Caudle AS, Weinberg JS, Gidley PW, Skibber JM, Levenback CF, Swisher SG, Aloia TA. Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety?. Ann Surg 270(6):937-941, 2019. e-Pub 2019. PMID: 30946086.
- Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA. Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf 45(10):686-693, 2019. e-Pub 2019. PMID: 31371099.
- Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Colorectal Cancer Mutations are Associated with Survival and Recurrence After Pulmonary Metastasectomy. J Surg Oncol 120(4):729-735, 2019. e-Pub 2019. PMID: 31290159.
- Kim MP, Swisher SG. Heterogeneity of stage IIIA leads to difficulty in determining optimal treatment. J Thorac Dis 11(Suppl 15):S2043-S2045, 2019. e-Pub 2019. PMID: 31632824.
- Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation For Siewert II/III Adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
- Kadara H, Sivakumar S, Jakubek Y, San Lucas FA, Lang W, McDowell T, Weber Z, Behrens C, Davies GE, Kalhor N, Moran C, El-Zein R, Mehran R, Swisher SG, Wang J, Zhang J, Fujimoto J, Fowler J, Heymach JV, Dubinett S, Spira AE, Ehli EA, Wistuba II, Scheet P. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer. Am J Respir Crit Care Med 200(6):742-750, 2019. e-Pub 2019. PMID: 30896962.
- Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol. e-Pub 2019. PMID: 31529018.
- Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg 108(2):370-376, 2019. e-Pub 2019. PMID: 31004583.
- Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaprociyan AA, Hofstetter WL, Antonoff MB. Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component. J Thorac Dis 11(8):3391-3398, 2019. e-Pub 2019. PMID: 31559043.
- Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG, Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 10(1):1-10, 2019. e-Pub 2019. PMID: 31278276.
- Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer. e-Pub 2019. PMID: 31287557.
- Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol 37(18):1558-1565, 2019. e-Pub 2019. PMID: 31067138.
- Negrao MV, Lam VK, Reuben A, Rubin ML, Landry LL, Roarty EB, Rinsurongkawong W, Lewis J, Roth JA, Swisher SG, Gibbons DL, Wistuba II, Papadimitrakopoulou V, Glisson BS, Blumenschein GR, Lee JJ, Heymach JV, Zhang J. PD-L1 expression, tumor mutational burden and cancer gene mutations are stronger predictors of benefit from immune checkpoint blockade than HLA class I genotype in non-small cell lung cancer. J Thorac Oncol 14(6):1021-1031, 2019. e-Pub 2019. PMID: 30780001.
- Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B. Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database. J Thorac Dis 11(4):1269-1278, 2019. e-Pub 2019. PMID: 31179069.
- Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg 157(4):1648-1655, 2019. e-Pub 2019. PMID: 30635188.
- Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB. Ground Glass Lesions on Imaging: Evaluation of Reported Incidence Using Natural Language Processing. Ann Thorac Surg 107(3):936-940, 2019. e-Pub 2019. PMID: 30612991.
- Yan X, Zhang X, Wang L, Zhang R, Pu X, Wu S, Li L, Tong P, Wang J, Meng QH, Jensen VB, Girard L, Minna JD, Roth JA, Swisher SG, Heymach JV, Fang B. Inhibition of thioredoxin/thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis. Cancer Res 79(1):125-132, 2019. e-Pub 2019. PMID: 30401714.
- Spicer JD, Shewale JB, Nelson DB, Mitchell KG, Bott MJ, Vallières E, Wilshire CL, Vaporciyan AA, Swisher SG, Jones DR, Darling GE, Sepesi B. Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm. Ann Thorac Surg 107(1):277-284, 2019. e-Pub 2019. PMID: 30227129.
- Xie Y, Lu W, Wang S, Tang X, Tang H, Zhou Y, Moran C, Behrens C, Roth JA, Zhou Q, Johnson DH, Swisher SG, Heymach JV, Papadimitrakopoulou VA, Xiao G, Minna JD, Wistuba II. Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer. Clin Cancer Res 25(1):150-157, 2019. e-Pub 2019. PMID: 30287547.
- Elamin YY, Gomez DR, Antonoff MB, Robichaux JP, Tran H, Shorter MK, Bohac JM, Negrao MV, Le X, Rinsurogkawong W, Lewis J, Lacerda L, Roarty EB, Swisher SG, Roth JA, Zhang J, Papadimitrakopoulou V, Heymach JV. Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC). Clin Lung Cancer 20(1):43-47, 2019. e-Pub 2019. PMID: 30343004.
- Lam VK, Tran HT, Banks KC, Lanman RB, Rinsurongkawong W, Peled N, Lewis J, Lee JJ, Roth J, Roarty EB, Swisher SG, Talasaz A, Futreal PA, Papadimitrakopoulou V, Heymach JV, Zhang J. Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations. Clin Lung Cancer 20(1):30-36.e3, 2019. e-Pub 2019. PMID: 30279110.
- Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res 9(6):1201-1211, 2019. e-Pub 2019. PMID: 31285952.
- Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Occult stage IIIA-N2 patients have excellent overall survival with initial surgery. J Thorac Dis 10(12):6670-6676, 2018. e-Pub 2018. PMID: 30746212.
- Le X, Puri S, Negrao MV, Nilsson MB, Robichaux J, Boyle T, Hicks JK, Lovinger KL, Roarty E, Rinsurongkawong W, Tang M, Sun H, Elamin Y, Lacerda LC, Lewis J, Roth JA, Swisher SG, Lee JJ, William WN, Glisson BS, Zhang J, Papadimitrakopoulou VA, Gray JE, Heymach JV. Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC. Clin Cancer Res 24(24):6195-6203, 2018. e-Pub 2018. PMID: 30228210.
- Pu X, Zhang R, Wang L, Chen Y, Xu Y, Pataer A, Meraz IM, Zhang X, Wu S, Wu L, Su D, Mao W, Heymach JV, Roth JA, Swisher SG, Fang B. Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer. J Transl Med 16(1):328, 2018. e-Pub 2018. PMID: 30477533.
- Simon G, DiNardo CD, Takahashi K, Cascone T, Powers C, Stevens R, Allen J, Antonoff MB, Gomez D, Keane P, Suarez Saiz F, Nguyen Q, Roarty E, Pierce S, Zhang J, Hardeman Barnhill E, Lakhani K, Shaw K, Smith B, Swisher SG, High R, Futreal PA, Heymach J, Chin L. Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care. Oncologist. e-Pub 2018. PMID: 30446581.
- Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. Ann Thorac Surg 106(5):1499-1503, 2018. e-Pub 2018. PMID: 30118712.
- Williams LA, Dibaj S, Chandwani S, Vaghani VB, Shi Q, Hirschmann M, Andry LL, Roarty E, Zhang J, Rinsumogkawong W, Lewis J, Burke T, Cleeland C, Lee J, Roth JA, Swisher SG, Heymach JV, Simon GR, Cancer Center TUOTMA, of America HS, &Co M, Rahway I, of America NS. Real-Wrold Patient-Reported Outcome Assessment of Patients with Metastic Non-Small Cell Lung Cancer, 2018. e-Pub 2018.
- Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi B. Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series. J Surg Oncol 118(3):518-524, 2018. e-Pub 2018. PMID: 30109699.
- Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components. Ann Thorac Surg 106(1):235-241, 2018. e-Pub 2018. PMID: 29534957.
- Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer. Ann Thorac Surg 106(1):272-279, 2018. e-Pub 2018. PMID: 29530770.
- Sepesi B, Nelson DB, Mitchell KG, Gibbons DL, Heymach JV, Vaporciyan AA, Swisher SG, Roszik J. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer. Ann Thorac Surg 105(6):1621-1626, 2018. e-Pub 2018. PMID: 29510096.
- Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MB. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Ann Thorac Surg 105(6):1671-1677, 2018. e-Pub 2018. PMID: 29432718.
- Parra ER, Villalobos P, Behrens C, Jiang M, Pataer A, Swisher SG, William WN, Zhang J, Lee J, Cascone T, Heymach JV, Forget MA, Haymaker C, Bernatchez C, Kalhor N, Weissferdt A, Moran C, Zhang J, Vaporciyan A, Gibbons DL, Sepesi B, Wistuba II. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 6(1):48, 2018. e-Pub 2018. PMID: 29871672.
- Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS, Mohan R. A Bayesian Adaptive-Randomization Trial of Passive-Scattering Proton Therpay and Intensity-Modulated Photon Radiotherapy for Locally Advance Non-Small Cell Lung Cancer. J Clin Oncol 36(18):1813-1822, 2018. e-Pub 2018. PMID: 29293386.
- Lee WC, Diao L, Wang J, Zhang J, Roarty EB, Varghese S, Chow CW, Fujimoto J, Behrens C, Cascone T, Peng W, Kalhor N, Moran CA, Weissferdt A, Johnson FM, William WN, Swisher SG, Lee JJ, Hong WK, Heymach JV, Wistuba II, Futreal PA, Zhang J. Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer. Mod Pathol 31(6):947-955, 2018. e-Pub 2018. PMID: 29410488.
- Pataer A, Shao R, Correa AM, Behrens C, Roth JA, Vaporciyan AA, Wistuba II, Swisher SG. Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy. Cancer Med 7(6):2405-2414, 2018. e-Pub 2018. PMID: 29673125.
- Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. J Thorac Cardiovasc Surg 155(6):2635-2645.e15, 2018. e-Pub 2018. PMID: 29548588.
- Parra ER, Villalobos P, Zhang J, Behrens C, Mino B, Swisher SG, Sepesi B, Weissferdt A, Kalhor N, Heymach JV, Moran C, Zhang J, Lee J, Rodriguez-Canales J, Gibbons D, Wistuba II. Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors. J Thorac Oncol 13(6):779-791, 2018. e-Pub 2018. PMID: 29526824.
- Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 53(5):960-966, 2018. e-Pub 2018. PMID: 29211849.
- Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher SG, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Ann Oncol 29(4):1072, 2018. e-Pub 2018. PMID: 29688333.
- Quek K, Li J, Estecio M, Zhang J, Fujimoto J, Roarty E, Little L, Chow CW, Song X, Behrens C, Chen T, William WN, Swisher S, Heymach J, Wistuba I, Zhang J, Futreal A, Zhang J. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas. Oncotarget 8(13):21994-22002, 2018. e-Pub 2018. PMID: 28423542.
- Gomez DR, Byers LA, Nilsson M, Diao L, Wang J, Li L, Tong P, Hofstad M, Saigal B, Wistuba I, Kalhor N, Swisher SG, Fan Y, Hong WK, Suraokar M, Behrens C, Moran C, Heymach JV. Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer. Oncotarget 9(18):14268-14284, 2018. e-Pub 2018. PMID: 29581842.
- Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang B. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer 124(5):1061-1069, 2018. e-Pub 2018. PMID: 29178133.
- Tsao AS, Lin H, Carter BW, Lee JJ, Rice D, Vaporcyan A, Swisher SG, Mehran R, Heymach J, Nilsson M, Fan Y, Nunez M, Diao L, Wang J, Fujimoto J, Wistuba II, Hong WK. Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma. J Thorac Oncol 13(2):246-257, 2018. e-Pub 2018. PMID: 29313814.
- Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WN. Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer. Ann Thorac Surg 105(2):418-424, 2018. e-Pub 2018. PMID: 29217088.
- Goltsov AA, Fang B, Pandita TK, Maru DM, Swisher SG, Hofstetter WL. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells. Ann Thorac Surg 105(2):363-370, 2018. e-Pub 2018. PMID: 29223420.
- Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial. Br J Cancer 118(3):331-337, 2018. e-Pub 2018. PMID: 29235564.
- Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: Secondary analysis of a Randomized Trial. Target Oncol 13(1):99-106, 2018. e-Pub 2018. PMID: 29218623.
- Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer. Clin Cancer Res 24(2):341-350, 2018. e-Pub 2018. PMID: 29030353.
- Elimova E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee JH, Weston BR, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Rogers JE, Skinner HD, Maru DM, Hofstetter WL, Ajani JA. Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort. Oncology 94(6):345-353, 2018. e-Pub 2018. PMID: 29705797.
- Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg 104(6):1821-1828, 2017. e-Pub 2017. PMID: 28987393.
- Huang X, Cao M, Wu S, Wang L, Hu J, Mehran RJ, Roth JA, Swisher SG, Wang RY, Kantarjian HM, Andreeff M, Sun X, Fang B. Anti-leukemia activbity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities. Oncotarget 8(60):102150-102160, 2017. e-Pub 2017. PMID: 29254232.
- Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017. PMID: 28885712.
- Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi B. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol 35(29):3354-3362, 2017. e-Pub 2017. PMID: 28817374.
- Schvartsman G, Peng SA, Bis G, Lee JJ, Benveniste MFK, Zhang J, Roarty EB, Lacerda L, Swisher S, Heymach JV, Fossella FV, William WN. Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer 112:90-95, 2017. e-Pub 2017. PMID: 29191606.
- Reuben A Gittelman R, Gao J, Zhang J, Yusko E, Wu CJ, Emerson R, Chen R, Zhang J, Tipton C, Vence L, Cascone T, Vignali M, Fujimoto J, Rodriguez-Canales J, e P, Forget MA, Federico L, Haymaker C, Behren C, Benzeno S, Bernatchez C, Sepesi B, Gibbons D, Wargo J, Swisher SG, Heymach J, Robins H, Lee JJ, Sharma P, Allison J, Futreal PA, Wistuba I, Zhang J. TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence". Cancer Discov 7(10):1088-1097, 2017. e-Pub 2017. PMID: 28133428.
- Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA. Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. Oncotarget 8(45):79356-79365, 2017. e-Pub 2017. PMID: 29108314.
- Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.
- Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JA. Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. Br J Cancer 117(5):648-655, 2017. e-Pub 2017. PMID: 28728163.
- Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?. Ann Thorac Surg 103(6):1710-1714, 2017. e-Pub 2017. PMID: 28366460.
- Dalvi MP, Wang L, Zhong R, Kollipara RK, Park H, Bayo J, Yenerall P, Zhou Y, Timmons BC, Rodriguez-Canales J, Behrens C, Mino B, Villalobos P, Parra ER, Suraokar M, Pataer A, Swisher SG, Kalhor N, Bhanu NV, Garcia BA, Heymach JV, Coombes K, Xie Y, Girard L, Gazdar AF, Kittler R, Wistuba II, Minna JD, Martinez ED. Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors. Cell Rep 19(8):1669-1684, 2017. e-Pub 2017. PMID: 28538184.
- Roife D, Kang Y, Wang L, Fang B, Swisher SG, Gershenwald JE, Pretzsch S, Dinney CP, Katz MH, Fleming JB. Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy. Surgery 161(5):1246-1254, 2017. e-Pub 2017. PMID: 28081955.
- Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, Heymach JV, Swisher SG, Bernatchez C, Alatrash G, Hanash S, Molldrem JJ. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. Cancer Immunol Res 5(4):319-329, 2017. e-Pub 2017. PMID: 28254787.
- Shi A, Liao Z, Allen PK, Ho L, Murphy MB, Maru DM, Swisher SG, Hofstetter WL, Mehran RJ, Cox JD, Komaki R, Lin SH. Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study. Adv Radiat Oncol 2(3):316-324, 2017. e-Pub 2017. PMID: 29114598.
- Swisher SG, Marks J, Rice D. Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation. Ann Cardiothorac Surg 6(2):144-151, 2017. e-Pub 2017. PMID: 28447003.
- Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG, Welxh JW, Zhang J, Lin SH, Gomez DR. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials. Int J Radiat Oncol Biol Phys 97(4):770-777, 2017. e-Pub 2017. PMID: 28244413.
- Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. J Thorac Oncol S1556-0864(16):31141-8, 2017. e-Pub 2017. PMID: 27729298.
- Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol 12(2):375-382, 2017. e-Pub 2017. PMID: 27794500.
- Chang JY, Zhang W, Komaki R, Choi NC, Chan S, Gomez D, O'Reilly M, Jeter M, Gillin M, Zhu X, Zhang X, Mohan R, Swisher S, Hahn S, Cox JD. Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol 122(2):274-280, 2017. e-Pub 2017. PMID: 28139305.
- Sepesi B, Cuentas EP, Canales JR, Behrens C, Correa AM, Vaporciyan A, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer. Semin Thorac Cardiovasc Surg 29(3):408-415, 2017. e-Pub 2017. PMID: 29195578.
- Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17(12):1672-1682, 2016. e-Pub 2016. PMID: 27789196.
- Parra ER, Behrens C, Rodriguez-Canales J, Lin H, Mino B, Blando J, Zhang J, Gibbons DL, Heymach JV, Sepesi B, Swisher SG, Weissferdt A, Kalhor N, Izzo J, Kadara H, Moran C, Lee JJ, Wistuba II. Image Analysis-Based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-Small Cell Lung Carcinoma Patients. Clin Cancer Res 22(24):6278-6289, 2016. e-Pub 2016. PMID: 27252415.
- Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter WB, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Ann Thorac Surg 102(5):1653-1659, 2016. e-Pub 2016. PMID: 27526650.
- Liu Y, Zhang J, Li L, Yin G, Zhang J, Zheng S, Cheung H, Wu N, Lu N, Mao X, Yang L, Zhang J, Zhang L, Seth S, Chen H, Song X, Liu K, Xie Y, Zhou L, Zhao C, Han N, Chen W, Zhang S, Chen L, Cai W, Li L, Shen M, Xu N, Cheng S, Yang H, Lee JJ, Correa A, Fujimoto J, Behrens C, Chow CW, William WN, Heymach JV, Hong WK, Swisher S, Wistuba II, Wang J, Lin D, Liu X, Futreal PA, Gao Y. Genomic heterogeneity of multiple synchronous lung cancer. Nat Commun 21(7):13200, 2016. e-Pub 2016. PMID: 27767028.
- Sepesi B, Rice DC, Heymach JV, Vaporciyan AA, Swisher SG. Stage I lung cancer-to operate or to radiate? that is the question. J Thorac Dis 8(9):2324-2327, 2016. e-Pub 2016. PMID: 27746966.
- Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Ann Oncol. e-Pub 2016. PMID: 27687306.
- Choi M, Kadara H, Zhang J, Cuentas EP, Canales JR, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Kim K, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee JJ, Lifton RP, Herbst RS, Wistuba II. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function. Ann Oncol. e-Pub 2016. PMID: 27687303.
- Jakubek Y, Lang W, Vattathil S, Garcia M, Xu L, Huang L, Yoo SY, Shen L, Lu W, Chow CW, Weber Z, Davies G, Huang J, Behrens C, Kalhor N, Moran C, Fujimoto J, Mehran R, El-Zein R, Swisher SG, Wang J, Fowler J, Spira AE, Ehli EA, Wistuba II, Scheet P, Kadara H. Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway. Cancer Res 76(13):3676-83, 2016. e-Pub 2016. PMID: 27216194.
- Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Post-Discharge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg 102(1):276-81, 2016. e-Pub 2016. PMID: 27083250.
- Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Wl H, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg 102(1):276-81, 2016. e-Pub 2016. PMID: 27083250.
- Hao C, Shao R, Raju U, Fang B, Swisher SG, Pataer A. Accumulation of RNA-dependent protein kinase (PKR) in the nuclei of lung cancer cells mediates radiation resistance. Oncotarget 7(25):38235-38242, 2016. e-Pub 2016. PMID: 27203671.
- Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Survival in Patients with Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg 101(3):1075-80; Discussion 1080-1, 2016. e-Pub 2016. PMID: 26680311.
- Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, Swisher SG, Mehran RJ, Buchholz TA, Elting LS, Giordano SH. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer 122(6):917-28, 2016. e-Pub 2016. PMID: 26716915.
- Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer. J Natl Compr Canc Netw 14(2):173-9, 2016. e-Pub 2016. PMID: 26850487.
- Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer. Ann Thorac Surg 101(1):211-7, 2016. e-Pub 2016. PMID: 26279367.
- Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Rj M, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer. Ann Thorac Surg 101(1):211-17, 2016. e-Pub 2016. PMID: 26279367.
- Li H, Hu J, Wu S, Wang L, Cao X, Zhang X, Dai B, Cao M, Shao R, Zhang R, Majidi M, Ji L, Heymach JV, Wang M, Pan S, Minna J, Mehran RJ, Swisher SG, Roth JA, Fang B. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Oncotarget 7(3):3548-58, 2016. e-Pub 2016. PMID: 26657290.
- Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, Betancourt SL, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection. Ann Thorac Surg 100(5):1812-6, 2015. e-Pub 2015. PMID: 26233274.
- Rice D, Sepesi B, Heymach J, Swisher S, Vaporciyan A. SABR vs surgery for NSCLC in the media. Lancet Oncol 16(9):e422, 2015. e-Pub 2015. PMID: 26370343.
- Smith BD, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, Swisher SG, Shirvani SM. Cost-Effectiveness of Stereotactic Radiation, Sublobar Resection, and Lobectomy for Early Non-Small Cell Lung Cancers in Older Adults. J Geriatr Oncol 6(4):324-31, 2015. e-Pub 2015. PMID: 26094172.
- Shewale JB, Correa AM, Baker CM, Villafane-Ferriol N, Hofstetter WL, Jordan VS, Kehlet H, Lewis KM, Mehran RJ, Summers BL, Schaub D, Wilks SA, Swisher SG, Collaborative Group UOTMAEC. Impact of a Fast-Track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges. Ann Surg 261(6):1114-23, 2015. e-Pub 2015. PMID: 25243545.
- Guo C, Hao C, Shao R, Fang B, Correa AM, Hofstetter WL, Roth JA, Behrens C, Kalhor N, Wistuba II, Swisher SG, Pataer A. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget 6(13):11114-24, 2015. e-Pub 2015. PMID: 25798539.
- Gomez DR, Liao KP, Swisher SG, Blumenschein GR, Erasmus JJ, Buchholz TA, Giordano SH, Smith BD. Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol 115(2):257-63, 2015. e-Pub 2015. PMID: 26013292.
- Zhang J, Gold KA, Lin HY, Swisher SG, Xing Y, Lee JJ, Kim ES, William WN. Relationship between tumor size and survival in non-small cell lung cancer (NSCLC): an analysis of the Surveillance, Epidemiology, and End Results (SEER) registry. J Thorac Oncol 10(4):682-90, 2015. e-Pub 2015. PMID: 25590605.
- Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang B. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett 357(1):179-85, 2015. e-Pub 2015. PMID: 25444907.
- Lin SH, Wang J, Allen PK, Correa AM, Maru DM, Swisher SG, Hofstetter WL, Liao Z, Ajani JA. A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer. J Gastrointest Oncol 6(1):45-52, 2015. e-Pub 2015. PMID: 25642337.
- Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management. Ann Thorac Surg 99(2):414-20, 2015. e-Pub 2015. PMID: 25497068.
- Huang X, Cao M, Wang L, Wu S, Liu X, Li H, Zhang H, Wang RY, Sun X, Wei C, Baggerly KA, Roth JA, Wang M, Swisher SG, Fang B. Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380. Oncotarget 6(1):345-54, 2015. e-Pub 2015. PMID: 25514600.
- Fang B, Mehran RJ, Heymach JV, Swisher SG. Predictive Biomarkers in Precision Medicine and Drug Development against Lung Cancer. Chin J Cancer 34(1):26, 2015. e-Pub 2015. PMID: 26134262.
- Neishaboori N, Wadhwa R, Nogueras-González GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients After Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 2015. e-Pub 2015. PMID: 25765719.
- Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Sci Rep 5:12068, 2015. e-Pub 2015. PMID: 26165383.
- Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, Swisher SG, Smith BD. Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancers in the Elderly. JAMA Surg 149(12):1244-53, 2014. e-Pub 2014. PMID: 25321323.
- Dhupar R, Correa AM, Ajani J, Betancourt S, Mehran RJ, Swisher SG, Hofstetter WL. Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770-6, 2014. e-Pub 2014. PMID: 24152134.
- Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA, Gomez DR. Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy. Int J Radiat Oncol Biol Phys 90(4):850-7, 2014. e-Pub 2014. PMID: 25216859.
- Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 2014. e-Pub 2014. PMID: 25225435.
- Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran C, Protopopov A, Sun H, Tang J, Wu X, Ye Y, William WN, Lee JJ, Heymach JV, Hong WK, Swisher S, Wistuba II, Futreal PA. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346(6206):256-9, 2014. e-Pub 2014. PMID: 25301631.
- Wu S, Wang L, Huang X, Cao M, Hu J, Li H, Zhang H, Sun X, Meng QH, Hofstetter WL, Roth JA, Swisher SG, Fang B. Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380. Bioorg Med Chem 22(19):5234-40, 2014. e-Pub 2014. PMID: 25182964.
- Patel VR, Hofstetter WL, Correa AM, Agarwal A, Rashid A, Bhutani MS, Lin SH, Ajani JA, Swisher SG, Maru DM. Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation. Ann Thorac Surg 98(3):1064-71, 2014. e-Pub 2014. PMID: 25038008.
- William WN, Swisher SG. Optimizing Surrogate End Points for Preoperative Systemic Therapies in Non-Small Cell Lung Cancers. Ann Surg Oncol 21(9):2813-4, 2014. e-Pub 2014. PMID: 24833104.
- Gao W, Wang M, Wang L, Lu H, Wu S, Dai B, Ou Z, Zhang L, Heymach JV, Gold KA, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang B. Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells. J Natl Cancer Inst 106(9), 2014. e-Pub 2014. PMID: 25214559.
- Subbiah IM, Blackmon SH, Correa AM, Kee B, Vaporciyan AA, Swisher SG, Eng C. Preoperative Chemotherapy Prior to Pulmonary Metastasectomy in Surgically Resected Primary Colorectal Carcinoma. Oncotarget 5(16):6584-93, 2014. e-Pub 2014. PMID: 25051371.
- Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-6, 2014. e-Pub 2014. PMID: 25157774.
- Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post Chemoradiation Surgical Pathology Stage can Customize the Surveillance Strategy in Patients with Esophageal Adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 2014. e-Pub 2014. PMID: 25099446.
- Takeuchi S, Khiewvan B, Fox PS, Swisher SG, Rohren EM, Bassett RL, Macapinlac HA. Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 41(5):906-14, 2014. e-Pub 2014. PMID: 24442598.
- Chang JY, Li QQ, Xu QY, Allen PK, Rebueno N, Gomez DR, Balter P, Komaki R, Mehran R, Swisher SG, Roth JA. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". Int J Radiat Oncol Biol Phys 88(5):1120-8, 2014. e-Pub 2014. PMID: 24661665.
- Ajani JA, Swisher SG. Three Angels are Dancing on the Head of the Esophageal Cancer Pin, but Shouldn't We Not Topple One or Two?. Ann Surg Oncol. e-Pub 2014. PMID: 24756809.
- Kim ES, Tang X, Peterson DR, Kilari D, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Stewart DJ, Wistuba II, Sidedick ZH. Copper transporter CTR1 expression and tissue concentration in non-small cell lung cancer. Lung Cancer, 2014. e-Pub 2014. PMID: 24792335.
- Ste3wart DJ, Nunez MI, Behrens C, Liu D, Lin YH, Lee JJ, Roth J, Heymach J, Swish4er SG, Hong WK, Wistuba II. Membrane Carbonic Anhydrase IX Expression and Relapse Risk in Resected Stage I-II Non-Small-Cell Lung Cancer. J Thorac Oncol. e-Pub 2014. PMID: 24662455.
- Stephens N, Rice D, Correa A, Hofstetter W, Mehran R, Roth J, Walsh G, Vaporciyan A, Swisher S. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases. Eur J Cardiothorac Surg. e-Pub 2014. PMID: 24603446.
- Avritscher EB, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS. Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume. Support Care Cancer 22(2):527-35, 2014. e-Pub 2014. PMID: 24141699.
- Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani JA, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SH. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Dis Esophagus 27(2):168-75, 2014. e-Pub 2014. PMID: 23621168.
- Hellmann MD, Chaft JE, William WN, Rusch V, Pisters KM, Kalhor N, Pataer A, Travis WD, Swisher SG, Kris MG, Collaborative Group UOTMALC. Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. Lancet Oncol 15(1):e42-50, 2014. e-Pub 2014. PMID: 24384493.
- Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors Associated with Local-Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer. Ann Surg Oncol 21(1):306-14, 2014. e-Pub 2014. PMID: 24197760.
- Behrens C, Solis LM, Lin H, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran CA, Kalhor N, Swisher SG, Simon GR, Stewart DJ, Lee JJ, Wistuba II. EZH2 Protein Expression Associates With the Early Pathogenesis, Tumor Progression and Prognosis of Non-small Cell Lung Carcinoma. Clin Cancer Res 19(23):6556-65, 2013. e-Pub 2013. PMID: 24097870.
- Gold KA, Kim ES, Liu D, Yuan P, Behrens C, Solis Soto LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WK. Prediction of survival in resected non-small cell lung cancer using a protein-expression based risk model: Implications for personalized chemoprevention and therapy. Clin Cancer Res. e-Pub 2013. PMID: 24366692.
- Lu H, Wang L, Gao W, Meng J, Dai B, Wu S, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang B. IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non-Small Cell Lung Cancer Cells. Mol Cancer Ther 12(12):2864-73, 2013. e-Pub 2013. PMID: 24130049.
- Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies. J Clin Oncol 31(34):4306-10, 2013. e-Pub 2013. PMID: 24145339.
- Sudo K, Taketa T, Correa AM, Campagna M, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Local-regional failure Rate Following Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies. J Clin Onc 31(34):4306-4310, 2013. e-Pub 2013. PMID: 24145339.
- Marks J, Rice DC, Swisher SG. Salvage esophagectomy in the management of recurrent or persistent esophageal carcinoma. Thorac Surg Clin 23(4):559-67, 2013. e-Pub 2013. PMID: 24199705.
- Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 2013. e-Pub 2013. PMID: 23994746.
- Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MS, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SG. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24(11):2844-9, 2013. e-Pub 2013. PMID: 23975663.
- Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E, Reid J, Sangale Z, Swisher SG, Kalhor N, Moran CA, Gutin A, Lanchbury JS, Barberis M, Kim ES. Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res 19(22):6261-71, 2013. e-Pub 2013. PMID: 24048333.
- Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic Hernia After Esophagectomy in 440 Patients With Long-Term Follow-Up. Ann Thorac Surg 96(4):1138-45, 2013. e-Pub 2013. PMID: 23810174.
- Murphy CC, Hofstetter WL, Correa AM, Ajani JA, Komaki RU, Swisher SG. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Dis Esophagus 26(7):708-15, 2013. e-Pub 2013. PMID: 23350713.
- Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, Cancer Group UOTMAE. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-507, 2013. e-Pub 2013. PMID: 24022442.
- Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WL. Pretreatment Patient Comorbidity and Tobacco Use Increase Cost and Risk of Postoperative Complications After Esophagectomy at a High-Volume Cancer Center. J Oncol Pract 9(5):233-9, 2013. e-Pub 2013. PMID: 23943906.
- Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez DR, Komaki R, Roth JA, Swisher SG. Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer. Cancer 119(18):3402-10, 2013. e-Pub 2013. PMID: 23798353.
- Weissferdt A, Kalhor N, Marom EM, Benveniste MF, Godoy MC, Correa AM, Swisher SG, Moran CA. Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Experience. Mod Pathol 10(8):1065-75, 2013. e-Pub 2013. PMID: 23542459.
- Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of Postoperative Complications After Trimodality Therapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys 86(5):885-891, 2013. e-Pub 2013. PMID: 23845841.
- Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM. Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome. AJR Am J Roentgenol 201(1):W57-63, 2013. e-Pub 2013. PMID: 23789697.
- Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation. Oncology 85(2):95-99. e-Pub 2013. PMID: 23860252.
- Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery. Ann Surg Oncol 20(6):1934-40, 2013. e-Pub 2013. PMID: 23263700.
- Wheler J, Hong D, Swisher SG, Falchook G, Tsimberidou AM, Helgason T, Naing A, Stephen B, Janku F, Stephens PJ, Yelensky R, Kurzrock R. Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses. Oncotarget 4(6):890-8, 2013. e-Pub 2013. PMID: 23765114.
- David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg 95(6):1872-7, 2013. e-Pub 2013. PMID: 23643547.
- Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol 24(5):1262-6, 2013. e-Pub 2013. PMID: 23247658.
- Murphy CC, Correa AM, Ajani JA, Komaki RU, Welsh JW, Swisher SG, Hofstetter WL. Surgery Is an Essential Component of Multimodality Therapy for Patients with Locally Advanced Esophageal Adenocarcinoma. J Gastrointest Surg. e-Pub 2013. PMID: 23715646.
- Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, Marom EM. FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies. J Thorac Oncol 8(4):502-10, 2013. e-Pub 2013. PMID: 23446204.
- Guo C, Shao R, Correa AM, Behrens C, Johnson FM, Raso MG, Prudkin L, Solis LM, Nunez MI, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC. J Thorac Oncol 8(3):301-8, 2013. e-Pub 2013. PMID: 23370317.
- William WN, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, Research Group UOTMALCC. Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small Cell Lung Cancer after Neoadjuvant Chemotherapy. J Thorac Oncol 8(2):222-8, 2013. e-Pub 2013. PMID: 23287849.
- Georgiadou SP, Sampsonas FL, Rice D, Granger JM, Swisher S, Kontoyiannis DP. Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses. Eur J Clin Microbiol Infect Dis 32(1):101-5, 2013. e-Pub 2013. PMID: 22895891.
- Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol 24(1):67-74, 2013. e-Pub 2013. PMID: 23002278.
- Donington J, Vaillères E, Bains M, Swisher S, Pass H. Management of the Apical Tumor: May 4, 2013, Minneapolis, MN. Semin Thorac Cardiovasc Surg 25(3):256-71, 2013. e-Pub 2013. PMID: 24331149.
- Guo C, Lu H, Gao W, Wang L, Lu K, Wu S, Pataer A, Huang M, El-Zein R, Lin T, Roth JA, Mehran R, Hofstetter W, Swisher SG, Wu X, Fang B. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLoS One 8(9):e74973, 2013. e-Pub 2013. PMID: 24069370.
- Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology 85(4):204-7, 2013. e-Pub 2013. PMID: 24051869.
- Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer. Ann Thorac Surg S0003-4975(12):01626-8, 2012. e-Pub 2012. PMID: 23063195.
- Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, Buchholz TA, Smith BD. Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly. Int J Radiat Oncol Biol Phys 84(5):1060-70, 2012. e-Pub 2012. PMID: 22975611.
- Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys 84(5):1078-85, 2012. e-Pub 2012. PMID: 22867894.
- Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY. Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys 84(4):1017-23, 2012. e-Pub 2012. PMID: 22543216.
- Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-51, 2012. e-Pub 2012. PMID: 22939861.
- Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 2012. e-Pub 2012. PMID: 22831985.
- Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged Pedicled Jejunal Interposition for Esophageal Replacement: A 10-Year Experience. Ann Thorac Surg 94(4):1104-11; discussion 1111-3, 2012. e-Pub 2012. PMID: 22939245.
- Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 2012. e-Pub 2012. PMID: 22921233.
- Kim ES, Lee JJ, He G, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Wistuba II, Stewart DJ, Siddik ZH. Tissue platinum concentration and tumor response in non-small-cell lung cancer. J Clin Oncol 30(27):3345-52, 2012. e-Pub 2012. PMID: 22891266.
- Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients With High Body Mass Index Tend To Have Lower Stage Of Esophageal Carcinoma At Diagnosis. Dis Esophagus 25(7):614-22, 2012. e-Pub 2012. PMID: 22150920.
- Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy. Ann Thorac Surg 94(3):914-20, 2012. e-Pub 2012. PMID: 22819472.
- Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis. Int J Radiat Oncol Biol Phys 84(1):e61-7, 2012. e-Pub 2012. PMID: 22503522.
- Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys 83(3):e345-51, 2012. e-Pub 2012. PMID: 22417808.
- Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer. e-Pub 2012. PMID: 22853875.
- Chang KJ, Reid T, Senzer N, Swisher S, Pinto H, Hanna N, Chak A, Soetikno R. Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer. Gastrointest Endosc 75(6):1139-46.e2, 2012. e-Pub 2012. PMID: 22520270.
- Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, Research Group UOTMDALCC. Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy. J Thorac Oncol 7(5):825-32, 2012. e-Pub 2012. PMID: 22481232.
- Liu X, Guo W, Wu S, Wang L, Wang J, Dai B, Kim ES, Heymach JV, Wang M, Girard L, Minna J, Roth JA, Swisher SG, Fang B. Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells. Biochem Pharmacol 83(10):1456-64, 2012. e-Pub 2012. PMID: 22387047.
- Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A Phase II Study of a Paclitaxel-Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. Int J Radiat Oncol Biol Phys 82(5):1967-72, 2012. e-Pub 2012. PMID: 21507583.
- Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2012. e-Pub 2012. PMID: 22172216.
- Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. J Clin Oncol 30(4_Suppl):6. e-Pub 2012. PMID: 27983438.
- Lin SH, Myles BH, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher SG, Lee JH, Bhutani MS, Maru D, Ajani JA, Cox JD, Komaki R, Liao ZX. Propensity score-based comparison of outcomes with 3D conformal radiotherapy (3D-CRT) versus intensity-modulated radiation therapy (IMRT) in treatment of esophageal cancer. J Clin Oncol 30(4):66. e-Pub 2012. PMID: 27982879.
- Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc 75(2):242-53, 2012. e-Pub 2012. PMID: 22115605.
- Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Maru D, Rice DC, Hofstetter WL, Erasmus JJ, Swisher SG, Ajani JA. Nomograms for prognostication of patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. J Clin Oncol 30(4):82. e-Pub 2012. PMID: 27982800.
- Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, Swisher SG, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH. Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer. J Clin Oncol 30(4):10. e-Pub 2012. PMID: 27983086.
- Ajani JA, Swisher SG. Preoperative Chemotherapy for Localized Squamous Cell Carcinoma of the Esophagus? We Should Go Back to the Drawing Board!. Ann Surg Oncol 19(1):3-4, 2012. e-Pub 2012. PMID: 21989665.
- Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal Cancer Dose Escalation using a Simultaneous Integrated Boost Technique. Int J Radiat Oncol Biol Phys 82(1):468-74, 2012. e-Pub 2012. PMID: 21123005.
- Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 118(2):444-51, 2012. e-Pub 2012. PMID: 21713767.
- Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?. Ann Thorac Surg 93(1):207-12; discussion 212-3, 2012. e-Pub 2012. PMID: 21962263.
- Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation. Oncology 83(5):300-304, 2012. e-Pub 2012. PMID: 22964903.
- Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Mehran RJ, Roth JA, Swisher SG. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 7(1):152, 2012. e-Pub 2012. PMID: 22963661.
- Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-13, 2012. e-Pub 2012. PMID: 22328056.
- He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One 7(2):e31087, 2012. e-Pub 2012. PMID: 22348039.
- Benveniste MF, Rosado-de-Christenson ML, Sabloff BS, Moran CA, Swisher SG, Marom EM. Role of imaging in the diagnosis, staging, and treatment of thymoma. Radiographics 31(7):1847-61, 2011. e-Pub 2011. PMID: 22084174.
- Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 117(21):4823-33, 2011. e-Pub 2011. PMID: 21456015.
- Hemmati SH, Correa AM, Walsh GL, Swisher SG, Roth JA, Rice DC, Mehran RJ, Vaporciyan AA. The prognostic factors of chest wall metastasis resection. Eur J Cardiothorac Surg 40(2):328-33, 2011. e-Pub 2011. PMID: 21466960.
- Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and Patterns of Failure of Adaptive/Ablative Proton Therapy for Early-Stage, Medically Inoperable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 80(5):1350-7, 2011. e-Pub 2011. PMID: 21251767.
- Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Duplicated Muscularis Mucosae Invasion has Similar Risk of Lymph Node Metastasis and Recurrence-Free Survival as Intramucosal Esophageal Adenocarcinoma. Am J Surg Pathol 35(7):1045-53, 2011. e-Pub 2011. PMID: 21602659.
- Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, Curley SA, Mehran RJ, Abdalla EK. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg 213(1):62-9; discussion 69-71, 2011. e-Pub 2011. PMID: 21700179.
- Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-81, 2011. e-Pub 2011. PMID: 21623235.
- Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after Chemotherapy Is a Novel Predictor of Poor Outcomes after Pulmonary Metastasectomy in Sarcoma Patients. J Am Coll Surg 212(5):821-6, 2011. e-Pub 2011. PMID: 21435923.
- Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus 24(3):147-52, 2011. e-Pub 2011. PMID: 21040152.
- Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(5):925-30, 2011. e-Pub 2011. PMID: 20960497.
- Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128(1):132-43, 2011. e-Pub 2011. PMID: 20309880.
- Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, M D Anderson Esophageal Cancer Group M, Foregut Group UORSOMAD. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer 117(1):63-9, 2011. e-Pub 2011. PMID: 20803613.
- He Y, Correa AM, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer A. The Role of PKR/eIF2a Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer. PLoS One 6(11):e24855, 2011. e-Pub 2011. PMID: 22102852.
- Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-5627, 2010. e-Pub 2010. PMID: 21136578.
- Zhou Y, Hofstetter WL, He Y, Hu W, Pataer A, Wang L, Wang J, Zhou Y, Yu L, Fang B, Swisher SG. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther 9(7):507-13, 2010. e-Pub 2010. PMID: 20215880.
- Pataer A, Raso MG, Correa AM, Behrens C, Tsuta K, Solis L, Fang B, Roth JA, Wistuba II, Swisher SG. Prognostic Significance of RNA-Dependent Protein Kinase (PKR) on Non-Small Cell Lung Cancer Patients. Clin Cancer Res 16(22):5522-5528, 2010. e-Pub 2010. PMID: 20930042.
- Vallböhmer D, Hölscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schröder W, Bollschweiler E, Hofstetter W. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 252(5):744-9, 2010. e-Pub 2010. PMID: 21037429.
- Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Foregut Group MOTMAECGATUORSOMAD. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 2010. e-Pub 2010. PMID: 20881767.
- Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer 116(19):4487-94, 2010. e-Pub 2010. PMID: 20629031.
- Rodney AJ, Tannir NM, Siefker-Radtke AO, Liu P, Walsh GL, Millikan RE, Swisher SG, Tu SM, Pagliaro LC. Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience. Urol Oncol, 2010. e-Pub 2010. PMID: 20933444.
- Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg 90(3):884-90; discussion 890-1, 2010. e-Pub 2010. PMID: 20732513.
- Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Chromosomal Aberrations Predict Malignant Progression of Esophageal Adenocarcinoma: a Genome-wide High-Density SNP Array Analysis. Cancer Prev Res (Phila) 3(9):1176-86, 2010. e-Pub 2010. PMID: 20651033.
- Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 2010. e-Pub 2010. PMID: 20732514.
- Katz RL, He W, Khanna A, Fernandez RL, Zaidi TM, Krebs M, Caraway NP, Zhang HZ, Jiang F, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, Swisher SG, Roth JA, Morris JS, Etzel CJ, El-Zein R. Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization-Based Case-Control Study. Clin Cancer Res 16(15):3976-87, 2010. e-Pub 2010. PMID: 20651054.
- Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba II. Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clin Cancer Res 16(14):3743-53, 2010. e-Pub 2010. PMID: 20534738.
- Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-Small Cell Lung Cancer Resection in Lymphoma Patients. Ann Thorac Surg 90(1):210-216, 2010. e-Pub 2010. PMID: 20609777.
- Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg 89(6):1797-1803, 1804.e1-3; discussion 1803-4, 2010. e-Pub 2010. PMID: 20494031.
- Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D. Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patients. Ann Thorac Surg 89(5):1563-70, 2010. e-Pub 2010. PMID: 20417778.
- Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Tri-Modality Therapy Without a Platinum Compound for Localized Carcinoma of the Esophagus and Gastroesophageal junction. Cancer 116(7):1656-63, 2010. e-Pub 2010. PMID: 20143431.
- Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KK. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle 9(6):1122-30, 2010. e-Pub 2010. PMID: 20237430.
- Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma. Oncology 78(5-6):316-22, 2010. e-Pub 2010. PMID: 20699623.
- Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One 5(11):e15074, 2010. e-Pub 2010. PMID: 21152079.
- Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol 22(12):1612-21, 2009. e-Pub 2009. PMID: 19734842.
- DeLappe EM, Truong MT, Bruzzi JF, Swisher SG, Rohren EM. Hepatic radiation injury mimicking a metastasis on positron-emission tomography/computed tomography in a patient with esophageal carcinoma. J Thorac Oncol 4(11):1442-4, 2009. e-Pub 2009. PMID: 19861910.
- Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, Ajani JA. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer 115(22):5184-92, 2009. e-Pub 2009. PMID: 19685531.
- Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of Age and Survival in Patients with Gastroesophageal Cancer Undergoing Surgery With or Without Preoperative Therapy. Cancer 115(19):4450-8, 2009. e-Pub 2009. PMID: 19562780.
- Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of Tumor Length on Long-Term Survival of pT1 Esophageal Adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 2009. e-Pub 2009. PMID: 19660349.
- Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, Wang L, Xie K, Swisher SG, Fang B. Putative tumor-suppressive function of kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res 15(18):5688-95, 2009. e-Pub 2009. PMID: 19737957.
- Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-8; discussion 868-9, 2009. e-Pub 2009. PMID: 19699913.
- Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 2009. e-Pub 2009. PMID: 19699915.
- Daliani DD, Tannir NM, Papandreou CN, Wang X, Swisher S, Wood CG, Swanson DA, Logothetis CJ, Jonasch E. Prospective Assessment of Systemic Therapy Followed by Surgical Removal of Metastases in Selected Patients with Renal Cell Carcinoma. BJU Int 104(4):456-60, 2009. e-Pub 2009. PMID: 19338544.
- Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 2009. e-Pub 2009. PMID: 19619787.
- Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with non-small cell lung cancer. Am Surg 75(7):598-603, 2009. e-Pub 2009. PMID: 19655604.
- Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, Liao ZX. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 4(7):880-8, 2009. e-Pub 2009. PMID: 19458557.
- Bakaeen FG, Jaroszewski DE, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Benjamin R, Blackmon S, Reardon MJ. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era. J Thorac Cardiovasc Surg 137(6):1454-60, 2009. e-Pub 2009. PMID: 19464464.
- Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74(2):482-9, 2009. e-Pub 2009. PMID: 19289262.
- Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: A multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-1387, 2009. e-Pub 2009. PMID: 19464452.
- Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a is a Potential Marker of Progression During Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus. Am J Pathol 174(5):1940-1948, 2009. e-Pub 2009. PMID: 19342367.
- Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 2009. e-Pub 2009. PMID: 19156915.
- Brücher BL, Swisher SG, Königsrainer A, Zieker D, Hartmann J, Stein H, Kitagawa Y, Law S, Ajani JA. Response to preoperative therapy in upper gastrointestinal cancers. Ann Surg Oncol 16(4):878-86, 2009. e-Pub 2009. PMID: 19194759.
- Hu W, Hofstetter W, Wei X, Guo W, Zhou Y, Pataer A, Li H, Fang B, Swisher SG. Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound. J Pharmacol Exp Ther 328(3):866-72, 2009. e-Pub 2009. PMID: 19066342.
- Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-30, 2009. e-Pub 2009. PMID: 19130466.
- Pataer A, Swisher SG, Roth JA, Logothetis CJ, Corn PG. Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity. Cancer Biol Ther 8(3):245-252, 2009. e-Pub 2009. PMID: 19106640.
- Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal Tumor Length is Independently Associated with Long-Term Survival. Cancer 115(3):508-516, 2009. e-Pub 2009. PMID: 19117343.
- Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 2009. PMID: 19021684.
- Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ, Blackstone EH. Worldwide esophageal cancer collaboration. Dis Esophagus 22(1):1-8, 2009. e-Pub 2009. PMID: 19196264.
- Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G, Yang G. Esophageal cancer. J Natl Compr Canc Netw 6(9):818-49, 2008. e-Pub 2008. PMID: 18926093.
- Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, Lin A, Swisher SG, Fang B. JNK-Deficiency Enhanced Oncolytic Vaccinia Virus Replication and Blocked Activation of Double-Stranded RNA-Dependent Protein Kinase. Cancer Gene Ther 15(9):616-24, 2008. e-Pub 2008. PMID: 18535619.
- Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 2008. e-Pub 2008. PMID: 18670347.
- Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979-84, 2008. e-Pub 2008. PMID: 18758299.
- Deus HF, Stanislaus R, Veiga DF, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Chang A, Vogel LH, Almeida JS. A semantic web management model for integrative biomedical informatics. PLoS ONE 3(8):e2946, 2008. e-Pub 2008. PMID: 18698353.
- Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer, 2008. e-Pub 2008. PMID: 18623381.
- Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 3(3):277-82, 2008. e-Pub 2008. PMID: 18317071.
- Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. Cancer 112(5):1020-7, 2008. e-Pub 2008. PMID: 18205187.
- Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 112(3):503-10, 2008. e-Pub 2008. PMID: 18072264.
- Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. Development of Ad-mda7/IL-24-resistant Lung Cancer Cell Lines. Cancer Biol Ther 7(1):103-108, 2008. e-Pub 2008. PMID: 18059175.
- Deus HF, Stanislaus R, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Almeida JS. Data driven semantic integration of translational lung cancer research at MDAnderson Cancer Center. AMIA Annu Symp Proc:927, 2008. e-Pub 2008. PMID: 18999102.
- Pataer A, Hu W, Xiaolin L, Chada S, Roth JA, Hunt KK, Swisher SG. Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing. Mol Cancer Ther 7(8):2528-2535, 2008. e-Pub 2008. PMID: 18723497.
- Tetzlaff ED, Correa AM, Komaki R, Swisher SG, Maru D, Ross WA, Ajani JA. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction. Dis Esophagus 21(7):575-81, 2008. e-Pub 2008. PMID: 18459989.
- Erasmus JJ, Macapinlac HA, Swisher SG. Positron emission tomography imaging in nonsmall-cell lung cancer. Cancer 110(10):2155-68, 2007. e-Pub 2007. PMID: 17896784.
- Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. "Seedling" Mesenchymal Tumors (Gastrointestinal stromal tumors and leiomyomas) are Common Incidental Tumors of the Esophagogastric Junction. Am J Surg Pathol 31(11):1629-35, 2007. e-Pub 2007. PMID: 18059218.
- Hu W, Davis JJ, Zhu H, Dong F, Guo W, Ang J, Peng H, Guo ZS, Bartlett DL, Swisher SG, Fang B. Redirecting Adaptive Immunity Against Foreign Antigens to Tumors for Cancer Therapy. Cancer Biol Ther 6(11):1773-9, 2007. e-Pub 2007. PMID: 17986853.
- Abraham SC, Krasinskas AM, Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TT. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 31(11):1719-25, 2007. e-Pub 2007. PMID: 18059229.
- Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-8, 2007. e-Pub 2007. PMID: 17975494.
- Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-92; discussion 1692-3, 2007. e-Pub 2007. PMID: 17954086.
- von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y, Lu X, Roth JA, Aggarwal BB, Barber GN, Keyomarsi K, Hunt KK, Swisher SG. The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res 13(20):6032-9, 2007. e-Pub 2007. PMID: 17947465.
- Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg 84(3):982-6, 2007. e-Pub 2007. PMID: 17720413.
- Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis. Ann Thorac Surg 84(3):973-80, 2007. e-Pub 2007. PMID: 17720411.
- Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System. Ann Thorac Surg 84(2):365-73; discussion 374-5, 2007. e-Pub 2007. PMID: 17643602.
- Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JA. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev 16(6):1200-5, 2007. e-Pub 2007. PMID: 17548685.
- Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-Matched Analysis of Three Techniques for Intrathoracic Esophagogastric Anastomosis. Ann Thorac Surg 83(5):1805-1813, 2007. e-Pub 2007. PMID: 17462404.
- Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 14(4):1305-11, 2007. e-Pub 2007. PMID: 17253104.
- Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN, Ajani JA. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 25(6):698-707, 2007. e-Pub 2007. PMID: 17308274.
- Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Oncogene 26(8):1201-1212, 2007. e-Pub 2007. PMID: 16924232.
- Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue. Cancer Gene Ther 14(1):12-18, 2007. e-Pub 2007. PMID: 17024233.
- Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31(1):58-64, 2007. e-Pub 2007. PMID: 17197919.
- Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109(1):125-134, 2007. e-Pub 2007. PMID: 17146785.
- Wang KL, Wu TT, Choi IS, Wang H, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-667, 2007. e-Pub 2007. PMID: 17211865.
- Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg 82(6):1982-1987; discussion 1987-1988, 2006. e-Pub 2006. PMID: 17126095.
- Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-974, 2006. e-Pub 2006. PMID: 16874819.
- Wang SL, Liao Z, Liu H, Ajani J, Swisher S, Cox JD, Komaki R. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12(34):5501-5508, 2006. e-Pub 2006. PMID: 17006988.
- Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107(7):1467-1474, 2006. e-Pub 2006. PMID: 16955509.
- Wu X, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Etzel CJ, Amos CI, Huang M, Chiang SS, Milas L, Hittelman WN, Ajani JA. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 24(23):3789-3798, 2006. e-Pub 2006. PMID: 16785472.
- Pataer A, Fanale MA, Roth JA, Swisher SG, Hunt KK. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther 13(8):806-814, 2006. e-Pub 2006. PMID: 16628227.
- Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12(15):4598-4604, 2006. e-Pub 2006. PMID: 16899607.
- Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1(5):478-86, 2006. e-Pub 2006. PMID: 17409902.
- Chada S, Mhashilkar AM, Liu Y, Nishikawa T, Bocangel D, Zheng M, Vorburger SA, Pataer A, Swisher SG, Ramesh R, Kawase K, Meyn RE, Hunt KK. mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members. Cancer Gene Ther 13:490-502, 2006. e-Pub 2006. PMID: 16282987.
- Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-1025, 2006. e-Pub 2006. PMID: 16456809.
- Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, Ajani J, Phan A, Swisher S, Allen P, Cox JD, Komaki R. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol 1(3):252-9, 2006. e-Pub 2006. PMID: 17409865.
- Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 64(3):700-708, 2006. e-Pub 2006. PMID: 16242255.
- Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-699, 2006. e-Pub 2006. PMID: 16242257.
- Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, Aggarwal BB, Ajani JA. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 24(5):748-754, 2006. e-Pub 2006. PMID: 16401681.
- Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-558, 2006. e-Pub 2006. PMID: 16353210.
- Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. e-Pub 2006. PMID: 16399296.
- Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24(2):259-267, 2006. e-Pub 2006. PMID: 16344314.
- Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19(3):152-157, 2006. e-Pub 2006. PMID: 16722991.
- Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104(11):2365-2372, 2005. e-Pub 2005. PMID: 16245310.
- Izzo JG, Malhotra U, Wu TT, Ensor J, Babenko IM, Swisher SG, Correa A, Bresalier RS, Hittelman WN, Ajani JA. Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis. Semin Oncol 32:S11-5, 2005. e-Pub 2005. PMID: 16399423.
- Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80(6):1988-1992; discussion 1992-1993, 2005. e-Pub 2005. PMID: 16305830.
- Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-1610, 2005. e-Pub 2005. PMID: 16308005.
- Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391-1398, 2005. e-Pub 2005. PMID: 16256794.
- Vorburger SA, Hetrakul N, Xia W, Wilson-Heiner M, Mirza N, Pollock RE, Feig B, Swisher SG, Hunt KK. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol Cancer Ther 4(11):1710-1716, 2005. e-Pub 2005. PMID: 16275992.
- Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104(8):1620-1626, 2005. e-Pub 2005. PMID: 16118804.
- Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-1355, 2005. e-Pub 2005. PMID: 16130133.
- Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Surgery 138(3):422-430, 2005. e-Pub 2005. PMID: 16213894.
- Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242(3):392-402; discussion 399-402, 2005. e-Pub 2005. PMID: 16135925.
- Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29(8):1079-1085, 2005. e-Pub 2005. PMID: 16006804.
- von Holzen U, Bocangel D, Pataer A, Vorburger SA, Liu Y, Lu X, Hunt KK, Swisher SG. Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer. Surgery 138(2):261-268, 2005. e-Pub 2005. PMID: 16153435.
- Lu C, Perez-Soler R, Piperdi B, Walsh GL, Swisher SG, Smythe WR, Shin HJ, Ro JY, Feng L, Truong M, Yalamanchili A, Lopez-Berestein G, Hong WK, Khokhar AR, Shin DM. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. J Clin Oncol 23(15):3495-3501, 2005. e-Pub 2005. PMID: 15908659.
- Pataer A, Vorburger SA, Chada S, Balachandran S, Barber GN, Roth JA, Hunt KK, Swisher SG. Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol Ther 11(5):717-723, 2005. e-Pub 2005. PMID: 15851010.
- Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-817; discussion 817-20, 2005. e-Pub 2005. PMID: 15849517.
- Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux. Ann Thorac Surg 79(5):1716-1723, 2005. e-Pub 2005. PMID: 15854962.
- Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: A potential target for prevention. Carcinogenesis 26(4):785-791, 2005. e-Pub 2005. PMID: 15661803.
- Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103(7):1347-1355, 2005. e-Pub 2005. PMID: 15719440.
- Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61(3):656-664, 2005. e-Pub 2005. PMID: 15708243.
- Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki RR, Rashid A, Hamilton SR, Wu TT. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11(6):2229-2236, 2005. e-Pub 2005. PMID: 15788671.
- Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-397, 2005. e-Pub 2005. PMID: 15680801.
- Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Walsh GL, Vaporciyan AA, Rice DC, Fukami N, Roth JA, Ajani JA. Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus. Int J Gastrointest Cancer 36(2):69-76, 2005. e-Pub 2005. PMID: 16648656.
- Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484-1493, 2004. e-Pub 2004. PMID: 15590179.
- Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-436, 2004. e-Pub 2004. PMID: 15380576.
- Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-1785, 2004. e-Pub 2004. PMID: 15386332.
- McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/NEU-overexpressing breast cancer cells. Surgery 136(2):437-442, 2004. e-Pub 2004. PMID: 15300212.
- Wu TT, Chirieac LR, Swisher SG, Komaki RU, Correa AM, Roth J, Rashid A, Hamilton SR, Ajani JA. Post-Chemoradiation surgicalpathologic stage accurately predicts outcome of patients with esophageal or gastroesophageal junciton carcinoma. J Clin Oncol 22(14_suppl):4028, 2004. e-Pub 2004. PMID: 28016401.
- Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-1266, 2004. e-Pub 2004. PMID: 15233663.
- Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44:369-379, 2004. e-Pub 2004. PMID: 15140551.
- Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100(11):2347-2354, 2004. e-Pub 2004. PMID: 15160337.
- Sieger KA, Mhashilkar AM, Stewart A, Sutton RB, Strube RW, Chen SY, Pataer A, Swisher SG, Grimm EA, Ramesh R, Chada S. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Mol Ther 9(3):355-367, 2004. e-Pub 2004. PMID: 15006602.
- Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127(3):779-786, 2004. e-Pub 2004. PMID: 15001907.
- Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis. Oncogene 23(6):1300-1307, 2004. e-Pub 2004. PMID: 14676844.
- Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 17:38-43, 2004. e-Pub 2004. PMID: 15209739.
- Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-1322, 2003. e-Pub 2003. PMID: 14630268.
- Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg 76(4):1001-1007; discussion 1007-1008, 2003. e-Pub 2003. PMID: 14529975.
- Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-127, 2003. e-Pub 2003. PMID: 12909224.
- Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):20-22, 2003. e-Pub 2003. PMID: 14569843.
- Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol 21(5):327-333, 2003. e-Pub 2003. PMID: 14670538.
- Pataer A, Chada S, Hunt KK, Roth JA, Swisher SG. Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. J Thorac Cardiovasc Surg 125(6):1328-1335, 2003. e-Pub 2003. PMID: 12830052.
- Vorburger SA, Pataer A, Yoshida K, Liu Y, Lu X, Swisher SG, Hunt KK. The mitochondrial apoptosis-inducing factor plays a role in E2F-1-induced apoptosis in human colon cancer cells. Ann Surg Oncol 10(3):314-322, 2003. e-Pub 2003. PMID: 12679318.
- Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. e-Pub 2003. PMID: 12538456.
- Munden RG, Truong MT, Swisher SG, Gupta S, Hicks ME, Merritt JA, Roth JA. CT evaluation of non-small cell lung cancer undergoing gene therapy with adenoviral p53. Internet J. Radiol 3:52-59, 2003. e-Pub 2003.
- Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia W, Chiao P, Ellis LM, Hung MC, Swisher SG, Hunt KK. Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene 21(41):6278-6288, 2002. e-Pub 2002. PMID: 12214268.
- Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-384; discussion 384-385, 2002. e-Pub 2002. PMID: 12192324.
- Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, Smythe R, Roth J. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg 22(1):47-52, 2002. e-Pub 2002. PMID: 12103372.
- Nutt LK, Chandra J, Pataer A, Fang B, Roth JA, Swisher SG, O'Neil RG, McConkey DJ. Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis. J Biol Chem 277(23):20301-20308, 2002. e-Pub 2002. PMID: 11909872.
- Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, Zou-Yang H, Stewart AL, Balachandran S, Roth JA, Hunt KK, Swisher SG. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res 62(8):2239-2243, 2002. e-Pub 2002. PMID: 11956076.
- Nutt LK, Pataer A, Pahler J, Fang B, Roth J, McConkey DJ, Swisher SG. Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J Biol Chem 277(11):9219-9225, 2002. e-Pub 2002. PMID: 11741880.
- Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher SG, Walsh GL, Nesbitt JC, Putnam JB. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg 73(2):420-425; discussion 425-426, 2002. e-Pub 2002. PMID: 11845853.
- Kuerer HM, Beahm EK, Swisher SG, Ross MI. Surgery for inoperable breast cancer. Am J Surg 183(2):160-161, 2002. e-Pub 2002. PMID: 11918881.
- Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175-183, 2002. e-Pub 2002. PMID: 11782772.
- Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 92:279-286, 2001. e-Pub 2001. PMID: 11466680.
- Kagawa S, Gu J, Honda T, McDonnell TJ, Swisher SG, Roth JA, Fang B. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin Cancer Res 7:1474-1480, 2001. e-Pub 2001. PMID: 11350920.
- Siegenthaler MP, Pisters KM, Merriman KW, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Smythe WR, Putnam JB, Jr. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 71:1105-11; discussion 1111-2, 2001. e-Pub 2001. PMID: 11308144.
- Smythe WR, Estrera AL, Swisher SG, Merriman KW, Walsh GL, Putnam JB, Jr, Vaporciyan AA, Roth JA. Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Ann Thorac Surg 71:962-966, 2001. e-Pub 2001. PMID: 11269481.
- Schnirer, II, Komaki R, Yao JC, Swisher S, Putnam J, Pisters PW, Roth JA, Ajani JA. Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction. Am J Clin Oncol 24:91-95, 2001. e-Pub 2001. PMID: 11232959.
- Pataer A, Smythe WR, Yu R, Fang B, McDonnell T, Roth JA, Swisher SG. Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines. J Thorac Cardiovasc Surg 121:61-67, 2001. e-Pub 2001. PMID: 11135160.
- Walsh GL, Davis BM, Swisher SG, Vaporciyan AA, Smythe WR, Willis-Merriman K, Roth JA, Putnam JB, Jr. A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg 121:48-60, 2001. e-Pub 2001. PMID: 11135159.
- Weill D, Mack M, Roth J, Swisher S, Proksch S, Merritt J, Nemunaitis J. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection. Chest 118:966-970, 2000. e-Pub 2000. PMID: 11035664.
- Swisher SG, Deford L, Merriman KW, Walsh GL, Smythe R, Vaporicyan A, Ajani JA, Brown T, Komaki R, Roth JA, Putnam JB. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 119:1126-1132, 2000. e-Pub 2000. PMID: 10838528.
- Yen N, Ioannides CG, Xu K, Swisher SG, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano RJ, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Mukhopadhyay T, Nesbitt JC, Nguyen D, Perez-Soler R, Pisters KM, Putnam JB, Schrump DS, Shin DM, Walsh GL, Roth JA. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther 7(4):530-536, 2000. e-Pub 2000. PMID: 10811470.
- Kagawa S, Gu J, Swisher SG, Ji L, Roth JA, Lai D, Stephens LC, Fang B. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res 60:1157-1161, 2000. e-Pub 2000. PMID: 10728665.
- Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Cristiano RJ, Roth JA. Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res 6:887-890, 2000. e-Pub 2000. PMID: 10741712.
- Putnam JB, Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord LL. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69:369-375, 2000. e-Pub 2000. PMID: 10735665.
- Pataer A, Fang B, Yu R, Kagawa S, Hunt KK, McDonnell TJ, Roth JA, Swisher SG. Adenoviral Bak overexpression mediates caspase-dependent tumor killing. Cancer Res 60:788-792, 2000. e-Pub 2000. PMID: 10706081.
- Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Weill D, Wait J, Lawrence DD, Kemp BL, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Richli WR, Shin DM, Walsh GL, Merritt J, Roth J. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 18:609-622, 2000. e-Pub 2000. PMID: 10653876.
- Kagawa S, Pearson SA, Ji L, Xu K, McDonnell TJ, Swisher SG, Roth JA, Fang B. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Ther 7(1):75-79, 2000. e-Pub 2000. PMID: 10680019.
- Gandhi S, Walsh GL, Komaki R, Gokaslan ZL, Nesbitt JC, Putnam JB, Jr, Roth JA, Merriman KW, McCutcheon IE, Munden RF, Swisher SG. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 68:1778-1784; discussion 1784-1785, 1999. e-Pub 1999. PMID: 10585058.
- York JE, Walsh GL, Lang FF, Putnam JB, McCutcheon IE, Swisher SG, Komaki R, Gokaslan ZL. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 91:74-80, 1999. e-Pub 1999. PMID: 10419372.
- Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Jr, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D, Waugh MK. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 91:763-771, 1999. e-Pub 1999. PMID: 10328106.
- Gokaslan ZL, York JE, Walsh GL, McCutcheon IE, Lang FF, Putnam JB, Jr, Wildrick DM, Swisher SG, Abi-Said D, Sawaya R. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 89:599-609, 1998. e-Pub 1998. PMID: 9761054.
- Roth JA, Swisher SG, Merritt JA, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khurl FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol 25:33-37, 1998. e-Pub 1998. PMID: 9704675.
- Walsh GL, Gokaslan ZL, McCutcheon IE, Mineo MT, Yasko AW, Swisher SG, Schrump DS, Nesbitt JC, Putnam JB, Jr, Roth JA. Anterior approaches to the thoracic spine in patients with cancer: indications and results. Ann Thorac Surg 64:1611-1618, 1997. e-Pub 1997. PMID: 9436544.
- Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res 57:4722-4726, 1997. e-Pub 1997. PMID: 9354430.
- Toloza EM, Hunt K, Miller AR, McBride W, Lau R, Swisher S, Rhoades K, Arthur J, Choi J, Chen L, Chang P, Chen A, Glaspy J, Economou JS. Transduction of murine and human tumors using recombinant adenovirus vectors. Ann Surg Oncol 4(1):70-79, 1997. e-Pub 1997. PMID: 8985520.
- Swisher SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DW. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 112(2):341-8, 1996. e-Pub 1996. PMID: 8751501.
- Swisher SG, Holmes EC, Hunt KK, Doty JE, Zinner MJ, McFadden DW. The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 131(8):819-24; discussion 824-5, 1996. e-Pub 1996. PMID: 8712904.
- Toloza EM, Hunt K, Swisher S, McBride W, Lau R, Pang S, Rhoades K, Drake T, Belldegrun A, Glaspy J, Economou JS. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther 3:11-17, 1996. e-Pub 1996. PMID: 8785705.
- Swisher SG, Hunt KK, Holmes EC, Zinner MJ, McFadden DW. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg 169(6):609-14, 1995. e-Pub 1995. PMID: 7771626.
- Schmit PJ, Hiyama DT, Swisher SG, Bennion RS, Thompson JE, Jr. Analysis of risk factors of postappendectomy intra-abdominal abscess. J Am Coll Surg 179:721-6, 1994. e-Pub 1994. PMID: 7952484.
- Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Am J Surg 168(6):576-9; discussion 580-1, 1994. e-Pub 1994. PMID: 7977999.
- Swisher SG, Hunt KK, Schmit PJ, Hiyama DT, Bennion RS, Thompson JE. Management of pancreatitis complicating pregnancy. Am Surg 60:759-62, 1994. e-Pub 1994. PMID: 7944038.
- Swisher SG, Cates JA, Hunt KK, Robert ME, Bennion RS, Thompson JE, Roslyn JJ, Reber HA. Pancreatitis associated with adult choledochal cysts. Pancreas 9:633-7, 1994. e-Pub 1994. PMID: 7809018.
- Swisher SG, Kiertscher SM, Golub SH, Holmes EC, Roth MD. Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes. Am J Respir Cell Mol Biol 8:486-92, 1993. e-Pub 1993. PMID: 8481233.
- Swisher SG, Anderson TM, Wen DR, Stene MA, Cochran AJ, Golub SH, Holmes EC. Immunopathological features of human pulmonary tumors following low-dose interleukin-2. Cancer Immunol Immunother 33:327-32, 1991. e-Pub 1991. PMID: 1868491.
- Economou JS, Hoban M, Lee JD, Essner R, Swisher S, McBride W, Hoon DB, Morton DL. Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity. Cancer Immunol Immunother 34:49-52, 1991. e-Pub 1991. PMID: 1760811.
- Swisher SG, Economou JS, Holmes EC, Golub SH. TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function. Cell Immunol 128:450-61, 1990. e-Pub 1990. PMID: 2113430.
- Wong JH, Cagle LA, Kopald KH, Swisher SG, Morton DL. Natural history and selective management of in transit melanoma. J Surg Oncol 44:146-50, 1990. e-Pub 1990. PMID: 2370798.
- Lee JD, Swisher SG, Minehart EH, McBride WH, Economou JS. Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells. J Leukoc Biol 47:475-9, 1990. e-Pub 1990. PMID: 2335755.
- Economou JS, Essner R, Rhoades K, Yamada T, Swisher SG, Holmes EC, Golub S, Morton DL. Genetic analysis of tumor necrosis factor promoter function in human tumor-infiltrating lymphocytes and other cell lines. Surg Forum 40:448-452, 1989. e-Pub 1989.
- Hansbrough JF, Soderberg C, Field TO, Swisher S, Brahme J, Zapata-Sirvent RL, Tonks M, Gadd MA. Analysis of murine splenic lymphocyte subpopulations by dual-color flow cytometry: technical considerations and specificities of monoclonal antibodies directed against surface markers. J Surg Res 44(2):121-36, 1988. e-Pub 1988. PMID: 2892969.
- Burton R, Swisher SG. Population structure of the intertidal copepod tigriopus californicus as revealed by field manipulation of allele frequencies. Oecologica 65:108-111, 1984. e-Pub 1984.
- Burton RS, Feldman MW, Swisher SG. Linkage relationships among five enzyme-coding gene loci in the copepod Tigriopus californicus: a genetic confirmation of achiasmiatic meiosis. Biochem Genet 19:1237-45, 1981. e-Pub 1981. PMID: 6461328.
- Yan X, Zhang X, Wang L, Zhang R, Pu X, Wu S, Li L, Tong P, Wang J, Meng Z, Jensen V, Girard L, Minna J, Roth J, Swisher SG, Heymach J, Fang B. Synthetic lethality therapy for lung cancers with compromised glutathione homeostasis. Cancer Research.
- x L, Puri S, Negrao M, Nilsson M, Robichaux J, Boyle T, Hicks J, Lovinger K, Roarty E, Rinsurongkawong W, Tang M, Elamin Y, Lacerda L, Lewis J, Lee J, Roth J, Swisher SG, Zhang J, William W, Glisson B, Papadimitrakopoulou V, Gray J, Heymach J. Landscape of EGFR -dependent and -independent resistance mechanisms to osimertinib and continuation therapy post-progression in EGFR-mutant NSCLC. Clin Cancer Research.
- Fang B, Chen Y, Zhang R, Wang L, Correa A, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng Q, Fujimoto J, Jensen V, Antonoff M, Hofseter W, Huynh T, Mehran R, Pisimissis G, Rice D, Sepesi B, Vaporciyan AA, Walsh G, Roth J, Swisher SG, Heymach J. Tumor characteristics associated wit engraftment of patient-derived non-small cell lung cancer xenografts in immunocomromised mice. Clin Cancer Res.
- Tsao A, Lin H, Carter B, Lee JJ, Rice D, Vaporciyan AA, Swisher SG, Mehran R, Heymach J, Nilsson M, Youhong F, Nunez M, Diao L, Wang J, Fujimoto J, Wistuba I, Hong W. Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma. Clin Cancer Res.
- Fossella F, Blumenschein G, Swisher SG, Choi NC, Delaney TF, Hahn S, Cox J. A Bayesian Adaptive-Randomization Trial of Passive-Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer. JCO 740720.
- Sepesi B, Cuentas EP, Canales JR, Behrens C, Correa AM, Vaporciyan A, Weissferdt A, Kalhor N, Moran C, Swisher SG, Wistuba I. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non–Small Cell Lung Cancer. Thoracic.
- Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MD, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SG. A Randomized Trial of Induction Chemotherapy or No Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Esophageal Cancer. JCO.
- Lu H, Wang L, Gao W, Meng J, Dai B, Wu S, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang B. IGFBP2/FAK pathway is causally associated with dasatinib resistance in non–small cell lung cancer cells. Clin Can Res.
- Zhang X, Zhang R, Chen H, Wang L, Ren C, Pataer A, Wu S, Meng Q, Ha MJ, Morris J, Xi Y, Wang J, Zhang J, Gibbons D, Heymach J, Meric-Bernstam F, Minna J, Swisher S, Roth J, Fang B. KRT-232 and navitoclax enhance trametinib's anti-Cancer activity of in non-small cell lung cancer patient-derived xenografts with KRAS mutations. Clin Cancer Res.
- Negaro M, Skoulidis F, Montesion M, Schulze K, Bara I, Shen V, Hu S, Sui D, Elamin Y, Le X, Michael G, Murugesan K, Wu C, Zhang J, Barreto D, Robichaux J, Reuben A, Cascone T, Gay C, Mitchell K, Hong L, Rinsurongkawong W, Roarty E, Simon G, Roth J, Swisher S, Lee J, Tsao A, Papadimitrakopoulou V, Gibbons D, Glisson B, Singal G, Mille V, Alexander B, Frampton G, Albacker L, Shames D, Zhang J, Heymach J. Oncogene-driven non-small cell lung cancers have distinct outcomes from PD-1/PD-L1 inhibitors with higher efficacy in BRAF-mutant tumors. Clin Cancer Res.
- Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Merza IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, roszik J, Gibbons DL, Heymach JV, Swisher SG, Bernantchez C, Alatrash G, Hanash S, Molldrem JJ. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
- Reuben A, Gittelman R, Gao J, Zhang J, Yusko E, Wu CJ, Emerson R, chen R, Zhang J, Tiption C, Vence L, Cascone T, vignali M, Fujimoto J, Rodriguez-Canales J, Parra E, Ma F, Federico L, Haymaker C, Behren C, Benzeno S Bernatchez C, Sepesi B, Givvons D, Wargo J, Swisher SG, Heymach J, Robins H, Lee JJ, Sharma P, Allison J, Futreal PA, Wistuba I, Zhang J. "T cell receptor repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with neoantigen heterogeneity and postsurgical recurrence".
- Guo C, Shao R, Correa AM, Behrens C, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A. Prognostic Significance of Combinations of RNA-Dependent Protein Kinase and EphA2 Biomarkers for NSCLC. Clin Cancer Res.
- Kalhor N, Swisher SG. An Update on Clinicopathological, Immunohistochemical and Molecular Profile of Colloid Carcinoma of the Lung. J Thor Onc.
- Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, William WN, Zhang J, |Swisher SG, Heymach JV. Local Consolidative Therapy Prolongs Progression-Free Survival and Time to New Metastases in Patients with Oligometastatic Non-Small Cell Lung Cancer That Does Not Progress after Front Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study. The Lancet.
- Mehran RJ, Walsh FL, Roth JA, Hofstetter WL, Vaporciyan, AA, Swisher SG, Rice DC. VATS lobectomy is associated with improved short-term and equivalent oncologic outcomes compared to open lobectomy for c-Stage I NSCLC: a propensity-matched analysis of 963 cases. Eur J Cardiothoracic Surg.
- Gomez D, Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA. The Role of Site Specificity and Comprehensive Aggressive Local Therapy in Disease Outcomes for Oligometastatic NSCLC. Intl J Rad Onc Bio Phys.
- Cascone T, William Jr WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy M, Carter BW, Federico L, Reuben A, Khan AW, Dejima H, Cruz AF, Parra ER, Solis LM, Fujimoto J, Tran H, Moran C, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein Jr G, Le X, Zhang J, Skoulidis F, Kurie J, Altan M, Lu C, Glisson B, Byers LA, Elamin Y, Mehran RJ, Rice DC, Walsh G, Hofstetter WL, Roth JA, Antonoff M, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison J, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Clinical and immune responses in patients with resectable non-small cell lung cancer treated with neoadjuvant nivolumab or nivolumab plus ipilimumab (NEOSTAR study). Nat Med.
- Schwalk A, Ost D, Saltijeral S, De La Garza H, Casal R, Jimenez C, Eapen G, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee JJ, Elamin Y, Zhang J, Roth J, Swisher S, Heymach J, Grosu H. Risk Factgors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients with Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations. Chest.
- Chen R, Lee WC, Fujimoto J, Li J, Hu X, Mehran R, Rice D, Swisher S, Sepesi B, Tran H, Chow CW, Little L, Gumbs C, Haymaker C Heymach J, Wituba I, Lee J, Futreal A, Zhang J, Reuben A Tsao A, Zhang J. Genomic and T cell repertoire intratumor heterogeneity of mailignant pleural mesothelioma and its evolution under dasatinib treatment. Clin Cancer Res.
- Swisher S, Futreal A. Genomic profiling of multiple synchronous lung adenocarcinoma. Journal of Clinical Oncology.
- Zhang N, Godby J, Wang J, marsh G, Liao Z, Komaki R, Ho L, Hofstetter W, Swisher S, Mehran R, Buchholz T, Elting L, Giordano S. Radiation Modality Utilization and Cardiopulmonary Mortality Risk in the Elderly with Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics.
- Sitthideatphaiboon P, Galan-Cobo A, Negrao M, Qu X, Poteete A, Zhang F, Liu D, Lewis W, Kemp H, Lewis J, Rinsurongkawong W, Giri U, Lee JJ, Zhang J, Roth J, Swisher S, Heymach. LKB1 mutations im NSCLC are associated with KEAP1/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition. Clin Cancer Res.
- Elimova, E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee J, Weston B, Bhutani M, Komaki R, Rice D, Swisher S, Blum M, Rogers J, Skinner H, Maru D, Hofstetter W. Actionable Local-regional Relapses After Therapy of Localized Esophageal Carcinoma: Insights from a Large Cohort. The Oncologist Journal.
- Gomez D, Byers L, Diao L, Nilsson M, Wang J, Saigal B, Wistuba I, Suraokar M, Moran C, Kalhor N, |BSwisher S, Fan Y, Hong W, Behrens C, Heymach J. Integrative proteomic and transcriptomic analysis identifies TrkB (NTRK2) as a therapeutic target and a potential driver of EGFR inhibitor resistance in lung squamous cell cancer. Cancer Discovery.
- Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. PKR (RNA-dependent protein kinase) indirectly regulates AKT survival signaling. Cancer Biol Ther.
- Lin S, Shi A, Liao Z, Allen PK, Ho L, Blum MM, Maru DM, Swisher SG, Hofstetter WL, Mehran RJ, Cox JD, Komaki R. Long Term Survival and Toxicity Outcomes of Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer: A Large Single-Institutional Cohort Study. AdvancesRadOnc.
- Quek K, Li J, Estecio M, Zhang J, Fujimoto J, Little L, Chow C, Song X, Behrens C, Chen T, William WN, Swisher SG, Heymach J, Wistuba I, Zhang J, Futreal A. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas. Oncogene.
- Zhang W, Komaki R, Nc C, Chan S, Gomez D, O;Reilly M, Jeer M, Gillin M, Zhu X, Zhang X, Mohan R, Swisher SG, Hahn S, Cox J. Long-term outcome of phase I/II prospective study of dose-escalated/accelerated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol.
- Pataer A, Ozpolat B, Shao R, Cashman N, Plotkin S, Samuel C, Lin S, Kabil N, Wang J, Majidi M, Fang B, roth J, Vaporciyan AA, Wistuba I, Hung MC, Swisher SG. Therapeutic Targeting of the PKR/PI4K2A Lysosome Network is Critical for Misfolded Protein Clearance and Survival in Cancer Cells. Cancer Discovery.
- Reuben A, Zhang J, Chiou SH, Gittelman R, Li J, Lee WC, Quek K, Fujimoto J, Wang C, Behrens C, Kheradmand F, Chen R, Chow CW, Bernatchez C, Jalali A, Xin H, Wu CJ, Eerovic A, Parra E, Yusko E, Emerson R, Benzeno S, Vignali M, Wu X, Ye Y, Little L, Gumbs C, Mao X, Song X, Tippen S, Thornton R, Cascone T, Snyder A, Wargo J, Herbst R, Swisher SG, Kadara H, Moran C, Kalhor N, Zhang J, Scheet P, Vaporciyan AA, Sepesi B, Gibbons D, Robbins H, Hwu P, Heymach J, Sharma P, Allison J, Baladandayuthapani V, Lee J, Davis M, Wistuba I, Futreal PA, Zhang J. Comprehensive T cell repertoire characterization of localized non-small cell lung cancer. Cancer Discovery.
- Gomez D, Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG, Welsh JW, Zhang J, Lin SH. A Prospective Analysis of Factors Affecting Successful Clinical TrialEnrollment in the Context of Three Ramdomized Control Trials. ROB.
- Gold KA, Kim ES, Liu7 DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Lee JJ, Hong WK. Biologic risk model for recurrence in surgically resected non-small cell lung carcinoma. Clin Cancer Res.
- Mitchell KG, Parra ER, Zhang J, Nelson DB, Corsini EM, Lee JJ, Vaporciyan AA, Hofstetter WL, Mehran RJ, Swisher SG, Dc R, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran CA, Skoulidis F, Wistuba II, Fujimoto J, Roth JA, Antonoff MB. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations with Patterns of Recurrence,. Ann Thorac Surg.
Invited Articles
- Rice D, Swisher S Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 134(6), 2008. e-Pub 2008. PMID: 19059972.
- Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, Swisher SG, Wood DE, Yen Y. Gastric Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 4(4):350-366, 2006. e-Pub 2006. PMID: 16569388.
- Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, Swisher SG, Wood DE, Yen Y. Esophageal Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 4(4):328-47, 2006. e-Pub 2006. PMID: 16569387.
- Martin LW, Hofstetter W, Swisher SG, Roth JA. Management of intrathoracic leaks following esophagectomy. Adv Surg 40:173-190, 2006. e-Pub 2006. PMID: 17163101.
- Swisher SG, Roth JA. Clinical update of Ad-p53 gene therapy for lung cancer. Surg Oncol Clin N Am 11(3):521-35, 2002. e-Pub 2002. PMID: 12487055.
- Swisher SG, Roth JA. p53 Gene therapy for lung cancer. Curr Oncol Rep 4(4):334-40, 2002. e-Pub 2002. PMID: 12044243.
- Swisher SG, Roth JA, Carbone DP. Genetic and immunologic therapies for lung cancer. Semin Oncol 29(1 Suppl 4):95-101, 2002. e-Pub 2002. PMID: 11894019.
- Roth JA, Grammer SF, Swisher SG, Komaki R, Nemunaitis J, Merritt J, Fujiwara T, Meyn RE, Jr. Gene therapy approaches for the management of non-small cell lung cancer. Semin Oncol 28:50-56, 2001. e-Pub 2001. PMID: 11605184.
- Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Savin M, Weill D, Shulkin A, Wait J, Ognoskie N, Lawrence DD, Kemp BL, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters DMW, Putnam JB, Jr, Richli WR, Shin DM, Walsh GL, Merritt J, Roth JA. Update "Best of the JCO-2000", Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer. J. Clin. Oncol. Classic Papers Curr. Comm 6:123-138, 2001. e-Pub 2001.
- Swisher SG, Pisters PW, Komaki R, Lahoti S, Ajani JA. Gastroesophageal junction adenocarcinoma. Curr Treat Options Oncol 1(5):387-98, 2000. e-Pub 2000. PMID: 12057146.
- Roth JA, Grammer SF, Swisher SG, Nemunaitis J, Merritt J, Meyn RE. Gene replacement strategies for treating non-small cell lung cancer. Semin Radiat Oncol 10(4):333-342, 2000. e-Pub 2000. PMID: 11040334.
- Fine A, Janssen-Heininger Y, Soultanakis RP, Swisher SG, Uhal BD. Apoptosis in lung pathophysiology. Am J Physiol Lung Cell Mol Physiol 279(3):L423-7, 2000. e-Pub 2000. PMID: 10956615.
- Toloza EM, Roth JA, Swisher SG. Molecular events in bronchogenic carcinoma and their implications for therapy. Semin Surg Oncol 18:91-99, 2000. e-Pub 2000. PMID: 10657910.
- Swisher SG, Roth JA. Gene therapy in lung cancer. Curr Oncol Rep 2(1):64-70, 2000. e-Pub 2000. PMID: 11122826.
- Pataer A, Fang B, Roth JA, Swisher SG. Adenoviral bak overexpression mediates caspase-dependent tumor killing. Cancer Res. Alert 2:17-19, 2000. e-Pub 2000.
- Roth JA, Swisher SG, Meyn RE. p53 tumor suppressor gene therapy for cancer. Oncology (Williston Park) 13(10 Suppl 5):148-54, 1999. e-Pub 1999. PMID: 10550840.
- Swisher SG, Roth JA. Gene therapy for human lung cancers. Surg Oncol Clin N Am 7:603-16, 1998. e-Pub 1998. PMID: 9624220.
- Swisher SG, Roth JA, Putnam JB, Jr. Diagnosis and management of benign esophageal tumors. Cancer Bull 47:396-401, 1995. e-Pub 1995.
- Roth JA, Swisher SG, Bouvet M, Merritt JA. p53 gene replacement therapy in lung cancer. Adv. Oncol 14:2-7, 1995. e-Pub 1995.
- Golub SH, Iho S, Gallardo D, Ebina N, Swisher SG, Economou JS, Shau H. Cytokine regulation of induction of cytotoxic effector cells by IL-2. 6th International NK Workshop, R.E. Schmidt (Ed) 47:63-67, 1989. e-Pub 1989.
Review Articles
- Weissferdt A, Pataer A, Swisher SG, Heymach JV, Gibbons DL, Cascone T, Sepesi B. Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatment. Lung Cancer 154:76-83, 2021. e-Pub 2021. PMID: 33631448.
- Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lopez-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy. J Thorac Oncol 15(5):709-740, 2020. e-Pub 2020. PMID: 32004713.
- Ning MS, Gomez DR, Heymach JV, Swisher SG. Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease. Transl Lung Cancer Res 8(1):97-106, 2019. e-Pub 2019. PMID: 30788239.
- Blumenthal GM, Bunn PA, Chaft JE, McCoach CE, Perez EA, Scagliotti GV, Carbone DP, HJWL A, Aisner DL, Bergh J, Berry DA, Jarkowski A, Botwood N, Cross DAE, Diehn M, Drezner NL, Doebele RC, Blakely CM, Eberhardt WEE, Felip E, Gianni L, Keller SP, Leavey PJ, Malik S, Pignatti F, Prowell TM, Redman MW, Rizvi NA, Rosell R, Rusch V, de Ruysscher D, Schwartz LH, Sridhara R, Stahel RA, Swisher SG, Taube JM, Travis WD, Keegan P, Wiens JR, Wistuba II, Wynes MW, Hirsch FR, Kris MG. Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. J Thorac Oncol 13(12):1818-1831, 2018. e-Pub 2018. PMID: 30268698.
- Erasmus JJ, Rohren E, Swisher SG. Prognosis and reevaluation of lung cancer by positron emission tomography imaging. Proc Am Thorac Soc 6(2):171-9, 2009. e-Pub 2009. PMID: 19349485.
- Munden RF, Swisher SG, Stevens CW, Stewart DJ. Imaging of the patient with non-small cell lung cancer. Radiology 237(3):803-818, 2005. e-Pub 2005. PMID: 16251391.
- Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-1160, 2004. e-Pub 2004. PMID: 15464463.
- Vorburger SA, Pataer A, Swisher SG, Hunt KK. Genetically targeted cancer therapy: tumor destruction by PKR activation. Am J Pharmacogenomics 4(3):189-198, 2004. e-Pub 2004. PMID: 15174900.
- Roth JA, Grammer SF, Swisher SG, Komaki R, Nemunaitis J, Merritt J, Meyn RE. P53 gene replacement for cancer--interactions with DNA damaging agents. Acta Oncol 40:739-744, 2001. e-Pub 2001. PMID: 11765069.
Professional Educational Materials
- Swisher SG. Intrathoracic Leaks Not Deadly in Esophagectomy. Physician's Weekly Surgery Edition, 2005.
- Swisher SG. Faculty Health Panel Discussion, Balancing Careers and Relationships, M. D. Anderson Cancer Center, Houston, TX, 2005.
- Swisher SG. Ad-p53 Gene Therapy in Lung Cancer. Association of Physician Assistants Oncology Meeting, Austin, TX, 2003.
- Swisher SG. Do I Really Need the Gastroenterologist/Endoscopist for Esophageal and Pulmonary Surgery? A Surgeon's Perspective, 2003.
- Swisher SG. Integration of Systemic Therapy with Surgery, Current Trends in Lung Cancer, Houston, TX, 2003.
- Swisher SG. Lung Cancer: Progress, Biology, and Clinical Implications (Virtual CME course), Annual American Society of Clinical Oncology Meeting, San Francisco, CA, 2001.
- Swisher SG. Ad-p53 Gene Therapy for Lung Cancer, Best of ASCO, CD Rom, 2001.
- Swisher SG. Proposal of Phase II Study of Esophageal Cancer, GI in Lung Cancer Study Group, Bethesda, Washington DC, 2001.
- Swisher SG. Ad-p53 Gene Transfer Strategies for Non-Small Cell Lung Cancer, 9th Annual Radiation Workshop. Round Top, TX, 2001.
- Swisher SG. Proposal of Randomized Phase III Esophageal Cancer Trial, Radiation Therapy Oncology Group (RTOG), Tampa, FL, 2001.
- Swisher SG. Adenoviral p53 Gene Therapy in Lung Cancer, MDACC Donors Symposium, Chicago, IL, 2000.
- Swisher SG. Status of Neoadjuvant/Adjuvant Therapy for Resectable NSCLC, Webcast for Academy of Medicine of New Jersey (AMNJ), Princeton Junction, NJ, 1999.
- Swisher SG. Gene Therapy - P.I.K.N.I.C, The University of Texas MD Anderson Cancer Center, Houston, T, 1999.
- Swisher SG. Panel Discussion, Advances in Clinical Research, Cancer in the 21st Century, Albert and Margaret Alkek Hospital, Houston, TX, 1998.
- Swisher SG. Potentially Resectable Non-Small Cell Lung Cancer: Is Surgery Enough? Oncology Teleconference, 1998.
- Swisher SG. Multimodality Conference on Thoracic Malignancies, Orlando Telemed Conference, Houston, TX, 1997.
- Swisher SG. Integration of Ad5CMV-p53 with Radiation Therapy in Multiple Tumor Tissue Types, Expert Panel Meeting, Philadelphia, PA, 1997.
- Swisher SG. Induction of Apoptosis with Adenoviral Bax Recombinant, Introgen Therapeutics, Inc., Houston, TX, 1997.
Other Articles
- Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG, Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 12(1):2888, 2021. PMID: 33980839.
Editorials
Abstracts
- Kris MG, Faivre-Finn C, Kordbacheh T, Chaft J, Luo J, Tsao A, Swisher S. Making Checkpoint Inhibitors Part of Treatment of Patients With Locally Advanced Lung Cancers: The Time Is Now. Am Soc Clin Oncol Educ Book 40:1-12, 2020. e-Pub 2020. PMID: 32298162.
- Spicer JD, Shewale JB, Nelson DB, Mitchell KG, Bott MJ, Vallieres E, Wilshire CL, Vaporciyan AA, Swisher SG, Dr J, Darling GE, Sepesi B. Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm. Ann Cardiothorac Surg. e-Pub 2018. PMID: 30227129.
- Cascone T, William Jr WN, Weissferdt A, Leung CH, Federico L, Haymaker C, Bernatchez C, Fossella FV, Mott FE, Papadimitrakopoulou VA, Byers LA, Lam VK, Godoy MC, Lee JJ, Vaporciyan A, Givvons DL, Swisher SG, Heymach JV, Sepesi B. Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC). Clin Cancer Res. e-Pub 2018. PMID: 30287547.
- Negrao MV, Reuben A, Robichaux JP, LE X, Nilsson M, Elamin YY, Wu CJ, Zhang J, Landry LL, Roarty E, Rinsurongkawong W, Swisher SG, Simon G, Glisson BS, Futreal A, Zhang J, Heymach JV. EGFR and HER-2 exon 20 mutations are associated with distinct patterns of response to immune checkpoint blockade in non-small cell lung cancer. ASCO, 2018. e-Pub 2018.
- Adame L, Behrens C, Bernatchez C, Bhatta A, Bogatenkova E, Bristow CA, Bers, LA, Carter B, Carugo A, Cascone T, Celestino M, Cupian AM, Ce D, Fang B, Fayle S, Feerico L, Forget MA, Fujimoto J, Garcia-Prieto C, Gaudreau PO, Giana M, Gibbons DL, Haymaker C, Heymach JV, Hofstetter WL, Karpinets TV, Kim YU, Kovacs JJ, Landry LCA, Lawson PM, Lizee G, Majidi M, Marszalek J, Mendoza G, Meraz IM, Moghaddam S, Morgan MB, Para cuentas ER, Prado EA, Pritchard LK, Ravelli A, Reuben A, Roarty EB, Roszik J, Roth JA, Sanchez Espiridion B, Sepesi B, Sing Heir J, Swisher SG, Talukder A, Toniatti C, Tran HT, Aa V, Vasquez ME, Wagner HE, Wang L, Weissferdt A, William Jr WN, Wistuba II, Yee C, Zhang J, Zhang R, Zhang X. The T cell receptor landscape is associated with survival in non-small cell lung cancer. ASCO, 2018. e-Pub 2018.
- Nelson DB, Godoy M, Shewale J, Correa A, Spicer J, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff M. Clinicoradiographic Predictors of Aggressive Behavior in Resected Malignant Ground Glass Opacity Lesions. WTSA 2017, 2017. e-Pub 2017.
- Elamin Y, Gomez D, Papadimitrakopoulou V, Tran H, Rinsurogkawong W, Lewis J, Landry L, Roarty E, Lee J, Roth J, Swisher S, Zhang J, Heymach J. Local consolidation therapy (LCT) after first line tyrosine kinase inhibitor (TKI) for patients with EGFR mutant metastatic non-small cell lung cancer (NSCLC). ASCO 2017, 2017. e-Pub 2017.
- Schvartsman G, Peng SA, Bis G, Lee JJ, Benveniste MFK, Zhang J, Rinsurongkawong W, Lewis J, Roarty EB, Swisher SG, Heymach JV, Fossella FV, William Jr WN. Response to single-agent chemotherapy (CTx) after immunotherapy exposure in non-small cell lung cancer (NSCLC). ASCO 2017, 2017. e-Pub 2017.
- Hofstetter WL, SG &, Correa A, Lerut T, Blackmon S, Vallboehmer D, Low D. Predictors of Staging Accuracy and Pathologic Nodal Involvement for cT2N0 Carcinoma of the Esophagus: A Review of the Esophageal Cancer Study Group (ECSG, 2017. e-Pub 2017.
- Sepesi B, Ye Y, Zhang L, Gu J, Ji L, Antonoff M, Hofstette W, Rice D, Mehran R, Walsh G, Vaporciyan A, Swisher SG, Roth JA, Wu X. GENETIC VARIANTS IN CYTOKINE SIGNALING PATHWAY AND CLINICAL OUTCOMES IN EARLY STAGE LUNG CANCER PATIENTS, 2017. e-Pub 2017.
- Sivakumar S, Jakubek Y, McDowell T, Lang W, Garcia MM, Chow C, Weber Z, behrens C, Kalhor N, Moran C, El-zein R, Davies G, Fujimoto J, Mehran R, Swisher SG, Wang J, Spira AE, Fowler J, San Lucas FA, Wistuba II, Ehli E, Scheet P, Kadara H. Mutational landscape in the normal-appearing airway cancerization field of early-stage non-small cell lung cancer. AACR 2017, 2017. e-Pub 2017.
- Lin S, Mansfield J, Rao X, Jiang W, Fang P, Roman K, Wang C, Komaki R, Hahn S, Swisher SG, Fujimoto J, Wistuba I, Wang J, Hoyt C. Multiplex in situ Immunoprofiling and Survival Outcomes in Non-Small Cell Lung Cancer. AACR 2016, 2017. e-Pub 2017.
- Pataer A, Shao R, Ozpolat B, Fang B, Swisher SG. PKR promotes EphA2 and other proteins degradation and is predictor of survival in lung cancer. AACR 2017, 2017. e-Pub 2017.
- Cuentas ER, Behrens C, Rodriguez-Canales J, Jiang M, Pataer A, Correa A, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Zhang J, Lee J, Heymach J, Moran C, Zhang J, Gibbons D, Wistuba I. Neoadjuvant chemotherapy influence changes of the immune response in non-small cell lung carcinomas immune response in non-small cell lung carcinomas. AACR 2017, 2017. e-Pub 2017.
- Nelson DB, Correa A, Dhupar R, Goltsov A, Maru D, Sepesi B, Antonoff M, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Davila R, Betancourt S, Skinner H, Blum M, Hofstetter WL. Endoscopic Mucosal Resection for Submucosal Esophageal Cancer. AATS 2017, 2017. e-Pub 2017.
- Tang C, Heymach J, Reuben A, Tran H, Welsh J, Liao Z, Tsao A, Swisher SG, Zhang J, Gomez D. Correlative analysis of systemic markers from a randomized trial assessing local consolidative therapy for non-small cell lung cancer (NSCLC) patients with oligometastatic disease. AACR 2017, 2017. e-Pub 2017.
- Sepesi B, Parra Cuentes E, Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. Tumor Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. 2017 Multidisciplinary Thoracic Cancers Symposium, 2017. e-Pub 2017.
- Antonoff M, Ragalie W, Sepesi B, Roth J, Walsh G, Hofstetter W, Swisher S, Rice D, Vaporciyan A, Mehran R. Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection. 2017 Multidisciplinary Thoracic Cancers Symposium, 2017. e-Pub 2017.
- Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh FL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Wl H, Roth JA, Mehran RJ. Polytetrafluoroethylene or collagen matrix for diaphragmatic reconstruction?. STS 2017, 2017. e-Pub 2017.
- Goltsov A, Fang B, Pandita TK, Maru D, Swisher SG, Hofstetter WL. HER2 Amplification Confers Resistance to Targeted Therapy in Esophageal Adenocarcinoma Cells With Concomitant Amplification of MET. STS 2017, 2017. e-Pub 2017.
- Van Haren R, SG &. : Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer, 2017. e-Pub 2017.
- Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?. Ann Cardiothorac Surg 103:1710-4, 2017. e-Pub 2017.
- Atay SM, Niu J, Giordano SH, Antonoff M, Heymach J, Hofstetter WL, Mehran R, Rice D, Roth JA, Vaporciyan A, Walsh G, William W, Swisher SG, Sepesi B. Perioperative Outcomes and Downstaging Following Neoadjuvant Therapy For Lung Cancer - Analysis of the National Cancer Database. IASLC 2016, 2016. e-Pub 2016.
- Parra ER, Villalobos P, Zhang J, Behrens C, Mino B, Moran C, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Heymach J, Lee JJ, Zhang J, Gibbons DL, Rodrigues-Canales J, Wistuba I. Image Analysis-Based Expression of Nine Immune Checkpoints Identifies Distinct Immunoprofiling Patterns in Non-Small Cell Lung Carcinomas. IASLC 2016, 2016. e-Pub 2016.
- Parra ER, Rodriguez-Canales J, Behrens C, Jiang M, Pataer A, Correa AM, Swisher S, Sepesi B, Weissferdt A, Kalhor N, William Jr WN, Lee JJ, Heymach J, Moran C, Zhang J, Gibbons DL, Wistuba I. The Influence of Neoadjuvant Chemotherapy, on Immune Response Profile in Non-Small Cell Lung Carcinomas. World Conference on Lung Cancer, 2016. e-Pub 2016.
- Haymaker C, Federico L, Forget MA, Vence LM, Sharma P, Allison JP, Fang B, Zhang J, Wagner H, Bogatenkova E, Wistuba I, Sepesi B, Heymach J, Gibbons D, Bernatchez C, Weissferdt A, Vaporciyan AA, Futreal A, Karpinets T, Yee C, Lizee G, Talukder A, Roszik J, Tran H, Vasquez M, Prado E, Behrens C, Parra E, Rodriguez-Canales J, Fujimoto J, Roth J, Meraz I, Roarty E, Landry L, Byers L, Kalhor N, Swisher SG, William Jr W. Phenotypic and functional profiling of tumor-infiltrating lymphocytes (TIL) in early stage non-small cell lung cancer (NSCLC). IASLC WCLC, 2016. e-Pub 2016.
- Sepesi B, Weissferdt A, Vaporciyan AA, Futreal A, Karpinets T, Yee C, Haymaker C, Federico L, Forget MA, Lizee G, Talukder A, Roszik J, Tran H, Vasquez M, Prado E, Gehrens C, Parra E, Rodriguez-Canales J, Fujimoto J, Vence L, Roth J, Meraz I, Roarty E, Landry L, Byers L, Swisher SG, William Jr W, Allison S, Fang B, Zhang J, Wagner H, Bogatenkova E, Wistuba II, Heymach JV, Bernatches C, Gibbons D. Prospective Immunogenomic Profiling of Non-small cell lung cancer - the ICON Project. IASLC WCLC 2016, 2016. e-Pub 2016.
- Roszik J, Gibbonons DL, Heymach J, Vaporciyan AA, Swisher S, Sepesi B. Lung Cancer PD-L1 mRNA Expression Profile and Clinical Outcomes - An Analysis From The Cancer Genome Atlas and Cancer Cell Line Encyclopedia. IASLC 2016, 2016. e-Pub 2016.
- Atay S, Correa A, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidorgrel. STSA, 2016. e-Pub 2016.
- Sceusi E, Atay S, Correa A, Swisher SG, Vaporciyan AA, Roth J, Walsh G, Hofstetter W, Mehran R, Rice D, Sepesi B, Antonoff M. Outcomes for Patients with Surgically Resected Thymic Neuroendocrine Tumors. NANETS symposium: Exploring Novel Mechanisms and Therapies for Neuroendocrine Cancers, 2016. e-Pub 2016.
- Shimodaira Y, Slack R, Chen H, Bhutani M, Lee J, Weston B, Elimova E, Lin Q, Harada K, Amlashi F, Mizrak D, Blum M, Roth J, |BSwisher S, Skinner H, Hofstetter W, Komaki R, Walsh G, Ajani J. Influence of Induction chemotherapy (IC) in Trimodality-Eligible Esophageal Cancer Patients: Secondary Analysis of a Randomized trial. ASCO 2016, 2016. e-Pub 2016.
- Sepesi B, Cuentas E, Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. The Expression Of Programmed Death 1 Ligand (PD-L1) In The Tumor and Tumor Infiltrating Macrophages Predicts Overall and Disease Free Survival in Surgically Resected Pathologic Stage I Non-Small Cell Lung Cancer. WTSA 2016, 2016. e-Pub 2016.
- Sceusi E, Miguel L, Mehran R, Kalhor N, Shaw K, Futreal A, Correa A, Moran C, Wistuba I, Junya F, Rao X, |BSwisher S, Vaporciyan A, Wang J, Antonoff M, Hofstetter W, Rice D, Sepesi B, Walsh G, Roth J. Well Differentiated Neuroendocrine Carcinoma (Typical Carcinoid) with Mediastinal Lymph Node Metastases: Surgical Outcomes and Whole Exome Sequencing (WES). AATS 2016, 2016. e-Pub 2016.
- Antonoff M, Correa A, Sepesi B, Nguyen Q, Walsh G, Swisher S, Vaporciyan A, Mehran R, Hofstetter W, Rice D. Salvage pulmonary resection following SBRT: A feasible and safe option for local failure. AATS 96th Annual Meeting, 2016. e-Pub 2016.
- Pataer A, Chengcheng H, Correa AM, Fang B, Roth JA, Wistuba II, Swisher SG. PKR and Jagged1 associated with lymph node metastasis in lung cancer. Proc Am Assoc Cancer Res, 2016. e-Pub 2016.
- Choi, M, Kadara H, Zhang J, Parra Cuentas E, Rodriguez Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Kalhor N, Moran C, Rimm D, Swisher SG, Gibbons DL, Heymach JV, Kaftan E, Townsend J, Lynch TJ, Schlessinger J, Lee JJ, Lifton R, Herbst RS, Wistuba II. Mutation and immune profiles in early-stage lung squamous cell carcinoma. AACR 2016, 2016. e-Pub 2016.
- Kadara H, Choi M, Zhang J, Cuentas E, Canales R, Gaffney S, Zhao Z, Behrens C, Fujimoto J, Chow C, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons D, Heymach J, Kaftan E, Townsend D, Lynch T, Schlessinger J, Lee, J, Lifton R, Wistuba I, Herbst R. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma. AACR 2016, 2016. e-Pub 2016.
- Zhang J, Wu C, Zhang J, Jujimoto J, Song XM, Mao X, Sun H, Seth S, Thornton R, Coyle M, Little L, Gumbs C, Behrens C, Chow C, Sulman E, Rao G, Swisher S, Wistuba I, Heymach J, Futreal A, Gomez D. Integrated exome and transcriptome sequencing of primary lung cancers and paired distant metastases. AACR 2016, 2016. e-Pub 2016.
- Pataer A, Wistuba II, Swisher SG. Biomarker associated with lymph node metastasis in lung cancer. Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research: From Biology to Therapeutics, Maui, Hawaii, USA, 2016. e-Pub 2016.
- Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Shiozaki H, Minsky B, Das P, Hofstetter W, Swisher S, Skinner H, Maru D, Matamoros A, Blum M, Lee J, Weston B, Bhutani M, Mansfield P, Badgwell B, Ajani J. Outcomes in older patients with localized gastric adenocarcinoma treated preoperatively. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
- Elimova E, Kim SM, Wang X, Shimodaira Y, Sohn BH, Skinner HD, Lee JH, Weston BR, Bhutani MS, Minsky B, Rice DC, Hwang JE, Swisher SG, Hofstetter W, Blum MA, Maru D, Ajani JA, Lee JS. Correlation of pretreatment p63-positive subtype of gastroesophageal adenocarcinoma (GEAC) with pathologic complete response (pathCR) in patients receiving preoperative chemoradiation. GI ASCO 2016, 2016. e-Pub 2016.
- Zhang J, Fujimoto J, Yusko E, Zhang J, Vignali M, Song X, Rodriguez J, Cuentas E, Behrens C, Nenzeno S, Robins H, Gibbons D, Swisher S, heymach J, Futreal A, Wistuba I. Intra-tumor heterogeneity of T cell receptor repertoire in lung adenocarcinomas and its association with tumor genomic profile. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
- Gomez D, Blumenschein G, Lee J, Hernandez M, Camidge R, Doebele R, Gaspar L, Karam J, Kavanagh B, Louie A, Palma D, William W, Zhang J, Swisher S, Heymach J. Local Consolidative Therapy (LCT) Improves Progression-Free Survival (PFS) in Patients with Oligometastatic Non-Small Cell Lung Cancer (NSCLC) who do not Progress after Induction Chemotherapy: Results of a Multi-Institutional Phase II Randomized Study. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
- Sanchez N, Shewela J, Baker C, Wilks S, Correa A, Sepesi B, Mehran R, Rice D, Roth J, Walsh G, Swisher S, Vaporciyan A, Hofstetter W. Implications of Early Foley Removal in Thoracic Surgical Oncology Patients Utilizing Epidural Analgesia. STSA 2015, 2015. e-Pub 2015.
- Spicer J, Shewale J, Antonoff M, Correa A, Hofstetter W, Rice D, Vaporciyan A, Mehran R, Walsh G, Roth J, Swisher S, Sepesi B. The Influence of Reconstructive Technique on Perioperative Outcomes Following Chest Wall Resection. STSA 2015, 2015. e-Pub 2015.
- Welsh JW, Seyedin SN, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Swisher SG, Blum MA, Nguyen Q, Minsky BD, Erasmus J, Lee JH, Bhutani MS, Komaki RU. Prospective Phase I/II Clinical Trial: Evaluating Dose Escalation for Esophageal Cancer. ASTRO 57th Annual meeting, 2015. e-Pub 2015.
- Spicer JD, Shewale J, Correa AM, Heymach JV, Antonoff MB, Hofstetter W, Mehran R, Roth J, Rice D, Sepesi B, Vaporciyan AA, William W, Walsh G, Swisher S. Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience. IASLC 2015, 2015. e-Pub 2015.
- Antonoff MB, Simon GR, Gold KA, Patel S, Gomez D, Ferrarotto R, Allen J, Stevens R, Suarez Saiz FJ, Berger M, Walsh G, Mynhier M, High R, Futreal A, Hahn S, Swisher S, Heymach J, Chin L. MD Anderson Oncology Expert Advisor™: A Cognitive Clinical Decision Support Tool for Evidence-Based Multi-Disciplinary Lung Cancer Care. IASLC 2015, 2015. e-Pub 2015.
- Spicer J, Shewale J, Sepesi B, Antonoff M, Correa A, Hofstetter W, Rice D, Vaporciyan A, Mehran R, Walsh G, Roth J, Swisher S. The Role of Pneumonectomy After Neoadjuvant Chemotherapy for N2 Non-Small Cell Lung Cancer. Canadian Surgery Forum 2015, 2015. e-Pub 2015.
- Zhang J, Liu Y, Zhang J, Gomez D, Fujimoto J, Behrens C, Zhang, J, Correa A, Gumbs C, Mao X, Seth S, Song X, Heymach J, Lee JJ, Swisher S, William W, Hong W, Gao Y, Wistuba I, Futreal A. Genomic heterogeneity of lung cancers and its potential clinical implications. American Society of Clinical Oncology, 2015. e-Pub 2015.
- Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, WlL H, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Indications For Counseling And Intervention After Pulmonary Resection: Results Of Post-discharge Nursing Telephone Assessments. Western Thoracic Surgical Association Annual Meeting 2015, 2015. e-Pub 2015.
- Gomez D, Diao L, Wang J, Wistuba I, Moran C, Kalhor N, Suraokar M, Swisher SG, Behrens C, Fan Y, Heymach J, Byers L. Neoadjuvant chemotherapy is associated with increased expression of DNA repair proteins and epithelial to mesenchymal transition (EMT) in patients with non-small cell lung cancer (NSCLC). AACR, 2015. e-Pub 2015.
- Pataer A, Shao R, Correa AM, Behrens C, Roth JA, Wistuba II, Swisher SG. Evaulate biomarkers in NSCLC tumors receiving neoadjuvant chemotherapy. AACR 2015, 2015. e-Pub 2015.
- Antonoff MB, Hofstetter WL, Correa A, Bell J, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer: Is There a Role for Selective Surgery?. Society of Thoracic Surgeons, 2015. e-Pub 2015.
- Dhupar R, Correa A, Rice R, Bhutani M, Weston B, DaSilva A, Maru D, Betancourt S, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Less Accurate for Early Mid-Stage Patients: Implications for the Liberal Use of Endoscopic Resection. 51st Annual Meeting of The Society of Thoracic Surgeons:56, 2015. e-Pub 2015.
- Elimova E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Planjery V, Nkis C, Skinner HD, Lee JH, Weston B, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Maru DM, Hofstetter WL, Ajani JA. Actionable Locoregional Failures (LRFs) after Therapy of Localized Esophageal Carcinoma (LEC): Surveillance Strategies and their Benefits. 2015 Gastrointestinal Cancers Symposium, 2015. e-Pub 2015.
- Blum M, Xiao L, Correa A, Wadhwa R, Elimova E, Skinner H, Komaki R, Lee J, Bhutani M Liao X, Rice D, Swisher S, Hofstetter, Ajani J. Analysis of Patients with Esophageal Cancer Following Trimodality Therapy: Pathological Complete Remission (PathCR) versus Non-PathCR. ASCO 2015, 2015. e-Pub 2015.
- Spicer J, Rice R, Shewale J, Sepesi B, Anotnoff M, Walsh G, Swisher S, Estrera T, Safi H, Khalil K. Comparative Outcomes Following Tracheal Resection for Benign Versus Malignant Conditions. CATS Meeting- 07, 2015. e-Pub 2015.
- Sepesi B, Schmidt HE, Lada M, Correa A, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Surgical Therapy Is An Important Multimodality Component in Patient with Distal Esophageal Adenocarcinoma Independent of Regional Lymph Node Location. STSA 2014, 2014. e-Pub 2014.
- Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki RU, Ho L, Hofstetter WL, Swisher SG, Elting LS, Giordano SH. Population-Based Analysis of Cause-Specific Mortality in Older Esophageal Cancer Patients Treated With Conformal Radiation Therapy or Intensity Modulated Radiation Therapy. 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, 2014. e-Pub 2014.
- Chang JY, Roth JA, Swisher SG, Komaki R, Mehran RJ, Gomez D, Balter PA, Rebueno N, Li Q, Xu Q, Zhu Z, Welsh J. Stereotactic ablative radiotherapy (SABR) for centrally located early-stage or isolated parenchymal recurrences of non-small cell lung cancer (NSCLC): How to fly in a “no fly zone. IASLC 2014, 2014. e-Pub 2014.
- Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Walsh GL, Swisher SG, Hofstetter WL. Trends and Improving Outcomes of 882 Surgical Patients With Gastro-Esophageal Junction Adenocarcinoma – A Single Institution Experience. The International Society for Diseases of the Esophagus 2014, 2014. e-Pub 2014.
- Pataer A, Guo C, Shao R, Correa AM, Behrens C, Fang B, Roth JA, Wistuba II, Swisher SG. Nutrient depletion caused by PKR induces phosphorylation of AMPK in lung cancer. American Association for Cancer Research 2014, 2014. e-Pub 2014.
- Hofstetter W, Smithers M, Rizk N, Lerut T, Nason K, Luketich J, Orringer M, Chang A, Low D, Darling G, Altorki N, Ferri L, DeMeester S, DeMeester T, Vallboehmer F, Crabtree T, Little A, Van Lanschot JJ, Rice T, Blacksonte E, Miller D, Yang S, Salo J, Peters J, Blackmon S, Krasna M, D'Amico T, Varghese T, Ajani J, Correa A, Swisher S. Surgery alone or preoperative therapy in cT2N0 Esophageal Cancer?. AATS, 2014. e-Pub 2014.
- Sepesi B, Swisher SG Hofstetter WL, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA. Experience with Primary and Metastatic Adenoid Cystic Carcinoma. SSO 2014, 2014. e-Pub 2014.
- Francis AM, Correa AM, Betancourt-Cuellar SL, Kim JY, Sepesi B, Ajani JA, Komaki R, Erasmus J, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG. Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation. AASC 186(2):680, 2014. e-Pub 2014.
- Pataer A, Chengcheng G, Ruping S, Correa AM, Fang B, Roth JA, Wistuba II, Swisher SG. RNA-Dependent Protein Kinase (PKR) Depletes Nutrients, Inducing Phosphorylation of AMP-Activated Kinase in Lung Cancer. Proc Am Assoc Cancer Res, 2014. e-Pub 2014.
- Betancourt-Cuellar SL, Carter B, Macapinlac HA, Ajani JJ, Komaki R, Swisher SG, Erasmus J, Hofstetter WL. Clinical Staging of Patients with Early Esophageal Cancer: Does FDG-PET/CT have a role?. IASLC 2014, 2014. e-Pub 2014.
- Chang JY, Zhang Y, Zhu A, Welsh J, Gomez DR, Komaki R, Roth JA, Swisher SG. Stereotactic Ablative Radiotherapy: A Potentially Curable Approach to Multiple Primary Lung Cancer. IASLC 2013, 2013. e-Pub 2013.
- Kim MP, Correa AM, Blackmon SH, Erasmus J, Hofstetter W, Macapinlac H, Mehran R, Rice D, Roth J, Vaporciyan AA, Walsh GL, Swisher SG. Preoperative Flourodeoxyglucose-Positron Emission Tomography Scan with Positive N1 Disease Does Not Predict Worse Survival in Pathologic Stage II Patients. IASLC 2013, 2013. e-Pub 2013.
- Gomez D, Liao KP, Swisher SG, Blumenschein G, Erasmus J, Buchholz TA, Giordano SH, Smith B. The influence of positron emission tomography scanning on treatment delay for non-small cell lung cancer. ASTRO 2013, 2013. e-Pub 2013.
- Wang J, Lin SH, Allen PK, Juloori A, Lee JK, Komaki R, Liao Z, Swisher SG, Hofstetter WL, Ajani JA. Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival Outcomes in Esophageal Cancer Patients Treated with Definitive Chemoradiation. ASTRO 2013, 2013. e-Pub 2013.
- Kilari D, Tang X, Chow CW, Fujimoto J, Kalhor N, Swisher S, Wistuba II, Stewart DJ, Siddik ZH, Kim ES. Copper trasporter CTR1 expression and tissue platinum concentration in NSCLC. ASCO 2013, 2013. e-Pub 2013.
- Stephens A, Rice D, Swisher S, Vaporciyan A, Hofstetter W, Walsh G, Mehran R, Roth J. VATS lobectomy is Associated with Improved Short-Term and Long-Term Outcomes Compared to Open Lobectomy for C-Stage I NSCLC: A Propensity-Matched Analysis of 963 Cases. 21st European Conference on General Thoracic Surgery, 2013. e-Pub 2013.
- Singh A, Bhattacharya A, Ladha HS, Kwak NH, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Erasmus JJ, Hofstetter WL, Swisher SG, Lee JH. Comparison of Lymph Node Detection on PET and EUS in Patients With Esophageal Cancer. Digestive Disease Week 2013, 2013. e-Pub 2013.
- Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Skinner HD, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher SG, Hofstetter WL, Ajani AJ. Customizing surveillance of patients with esophageal or esophagogastric junction adenocarcinoma (E-EGA) after trimodality theraphy (TMT). ASCO 2013, 2013. e-Pub 2013.
- Francis AM, Sepesi B, Correa AM, Ajani JA, Blum M, Komaki R, Erasmus J, Lee JH, Maru D, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh FL, Welsh J, Swisher SG, Hofstetter WL. Long Term Survival and Recurrence Rates Following Trimodality Therapy of Esophageal Adenocarcinoma - The Influence of Histologic Tumor Viability. ASA 2013 Annual Meeting, 2013. e-Pub 2013.
- Garvey PB, Clemens MW, Doolittle JP, Baumann D, Swisher SG, Butler CE. Complex Composite Oncologic Chest Wall Defects Reconstructed With Synthetic Or Bioprosthetic Mesh Experience Similar Surgical Outcomes When Combined Wtih Soft Tissue Flap Coverage. Academic Surgical Congress 2013, 2013. e-Pub 2013.
- Suzuki A, Xiao L, Taketa T, Sudo K, Blum MA, Komaki R, Liao ZX, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S; Ajani JA. Various clinical outcomes in patients with esophageal or gastroesophageal junction (E-GEJ) adenocarcinoma undergoing trimodality therapy: Prognostic implications. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele BN, Erasmus JJ, Hofstetter WL, Kim E, Komaki R, Mehran RJ, Moran CA, Papadimitrakopoulou, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, William WN, Wistuba II, Swisher SG. The Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC Seventh) Following Neoadjuvant Chemotherapy. STS 2013 Annual Meeting, 2013. e-Pub 2013.
- Swisher S, Moughan J, Komaki R, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett C. Final results of RTOG 0246: A phase II study of selective surgical resection for locoregionally advanced esophageal cancer treated with a paclitaxel-based chemoradiation regimen. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- Subbiah IM, Blackmon SH, Correa AM, Kee BK, Vaporciyan AA, Swisher SG, Eng C. Preoperative chemotherapy prior to pulmonary metastatecomy in patients with prior surgically resected primary colorectal carcinoma. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy. 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- Kim JY, Nelson R, Chen SL, Hofstetter, Kim J, Swisher SG, Raz DJ. Does the Seventh Edition AJCC Staging System for Esophageal Adenocarcinoma Predict Survival after Neoadjuvant Therapy?. STS 2013 Annual Meeting, 2013. e-Pub 2013.
- Wadhwa R, Taketa T, Correa AM, Sudo K, Blum MA, Campagna MC, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases following trimodality therapy (TMT) in patients with esophageal and gastroesophageal (E-EGCJ) cancer. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- Campagna MC, Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of relapse in patients with esophageal and esophagogastric junction (E-EGJ) cancer with surgical stage after trimodality therapy (TMT): Implications for customized surveillance. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- Taketa T, Xiao L, Suzuki A, Blum MA, Sudo K, Lee JH, Weston B, Bhutani MS, Lin SH, Wadhwa R, Swisher S, Hofstetter WL, Ajani JA. 16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
- David EA, Wai C, Correa AM, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Thall P, Mehran RJ. Visceral pleural invasion is not predictive of survial in NSCLC patients with small tumors in a North American patient population. STS 2012 Annual Meeting, 2013. e-Pub 2013.
- Sudo K, Xiao L, Wadhwa R, Taketa T, Blum MA, Skinner HD, Lee JH, Bhutani MS, Weston B, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Pattern of local-regional relapse and survival after bimodality therapy for esophageal cancer: Implications for the surveillance strategy. ASCO 2013, 2013. e-Pub 2013.
- Takeuchi S, Khiewvan B, Swisher SG, Rohren E, Macapinlac HA. The clinical impact and prognostic value of 18F-Fluorodeoxyglucose PET/CT in the initial staging non-small cell lung cancer at MD Anderson Cancer Center. 2013 ASCO Annual Meeting, 2013. e-Pub 2013.
- Wadhwa R, Xiao L, Sudo K, Taketa T, Blum MA, Skinner HD, Lee JH, Bhutani MS, Weston B, Komaki R, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Frequency of relapse over time based on baseline stage in esophageal cancer patients treated with definitive chemoradiation (DCRT). ASCO GI 2013, 2013. e-Pub 2013.
- Chang JY, Komaki R, Welsh J, Gomez D, Roth JA, Swisher SG. Clinical Outcome and Toxicity in Central Located State I or Isolated Recurrent Non-Small Cell Lung Cancer Treated with Stereotatic Ablative Radiotherapy. ASTRO 2013, 2013. e-Pub 2013.
- Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice DC, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic Hernia After Esophagectomy in 440 Patients with Long-term Follow-up. STSA 2012 Annual meeting, 2012. e-Pub 2012.
- Gomez DR, Liao K, Chang JY, Liao Z, Shirvani SM, Komaki R, Welsh JW, Heymach JY, Swisher SG, Smith BD. Treatment Modality and Other Prognostic Factors for Overall Survival in Stage III Non-small Cell Lung Cancer (NSCLC): A Population-based Analysis. 2012 ASTRO Meeting, 2012. e-Pub 2012.
- Liu Y, Balter P, Komaki R, Xu Q, Swisher S, Chang J. Stereotactic Ablative Radiation Therapy for Multiple Primary Lung Cancer. 2012 ASTRO Meeting, 2012. e-Pub 2012.
- Gomez DR, Liao K, Chang JY, Liao Z, Shirvani SM, Komaki R, Welsh JW, Swisher SG, Heymach JV, Smith BD. Patient Selection for Treatment Modality in Stage III Non-small Cell Lung Cancer: A Population-based Analysis. 2012 ASTRO Meeting, 2012. e-Pub 2012.
- Zhang J, Gold KA, Lin HY, Swisher SG, Lippman SM, Lee JJ, Kim ES, William WN. Relationship between tumor size and survival in non small cell lung cancer (NSCLC): an analysis of the Surveillance, Epidemiology, and End Results (SEER) registry. 2012 ASCO Meeting, 2012. e-Pub 2012.
- Cheedella NKS, Suzuki A, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Maru DM, Vaporciyan AA, Mariel Taketa T, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Walsh GL, Swisher SG, Ajani JA. Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT). 2012 ASCO Meeting, 2012. e-Pub 2012.
- Lin SH, Myles B, Wei C, Swisher SG, Hofstetter WL, Ajani JA, Ho L, Cox, JD, Komaki R, Liao Z. Radiation Modality is a Strong Predictor for Postoperative Pulmonary Complications after Trimodality Therapy for Esophageal Cancer. ASCO 2012 Meeting, 2012. e-Pub 2012.
- Lin SH, Amini A, Lou F, Correa A, Roth JA, Swisher SG, Huang J, Rimner A, Vaporciyan AA. Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery. Proc Am Soc Clin Oncol, 2012. e-Pub 2012.
- Sepesi B, Swisher SG, Walsh GL, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Hofstetter WL. Omental Reinforcement of the Thoracic Esophagogastric Anastomosis - An Analysis of Leak and Reintervention Rates in Planned and Salvage Esophagectomy Patients. American Association of Thoracic Surgeons, 2012. e-Pub 2012.
- Shirvani SM, Jiang J, Chang JY, Gomez D, Welsh J, Swisher SGBuchholz TA, Smith BD. Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly. 2012 ASCO Meeting, 2012. e-Pub 2012.
- Behrens C, Lombardi Fujimoto J, Raso MG, Hughes E, Reid J, Gutin A, Lanchbury J, Wagner S, Swisher SG, Kalhor N, Moran C, Kim E, Barberis M, Wistuba II. Use of a proliferation-based mRNA signature to predict outcome in early-stage non-small cell lung adenocarcinoma. 2012 ASCO Meeting, 2012. e-Pub 2012.
- Suzuki A, Xiao L, Taketa T, Blum MA, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Rice DC, Mehran RJ, Maru DM, Erasmus JJ, Hofstetter WL, Swisher S, Ajani JA. Customization of treatment for patients with esophageal adenocarcinoma (EAC) who achieve clinical complete response (cCR) after chemoradiation using initial standardized uptake value (iSUV) of 18f-fluorodeoxyglucose PET. ASCO 2012 Meeting, 2012. e-Pub 2012.
- Taketa T, Correa AM, Suzuki A, Blum MA, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Outcome of 58 trimodality-eligible esophagogastric cancer (EC) patients who achieved clinical complete response (cCR) after preoperative chemoradiation but then declined surgery. ASCO 2012 Meeting, 2012. e-Pub 2012.
- Blum MA, Hayashi Y, Xiao L, Suzuki A, Sabloff B, Maru DM, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer (EC). ASCO 2012 Meeting, 2012. e-Pub 2012.
- Shirvani SM, Jiang J, Chang JY, Gomez, DR, Welsh JW, Swisher SG, Buchholz TA, Smith BD. Comparative Eff ectiveness of Five Treatment Strategies for Early-Stage Non–Small-Cell Lung Cancer in the Elderly. ARS 2012 Annual Meeting, 2012. e-Pub 2012.
- Guo C, Shao R, Correa AM, Behrens C, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC. AACR 2012:(#1734), 2012. e-Pub 2012.
- Agarwal A, Appleberry T, Guha S, Ajani J, Hofstetter W, Swisher S, Lennon P, Rashid A, Maru D. Novel Chromosomal Abnormalites in Barrett's Esophagus and Esophageal Adenocarcinoma Identified by Array Comparative Genomic Hybridization (CGH). United States and Canada Academy of Pathology Meeting 2012, 2012. e-Pub 2012.
- Lin SH, Myles BH, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher SG, Lee JH, Bhutani MS, Maru D, Ajani JA, Cox JD, Komaki R, Liao ZX. Propensity score-based comparison of outcomes with 3D conformal radiotherapy (3D-CRT) versus intensity-modulated radiation therapy (IMRT) in treatment of esophageal cancer. J Clin Oncol, 2012. e-Pub 2012. PMID: 27982879.
- Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, SG &, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH. Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer, 2012. e-Pub 2012. PMID: 27983086.
- Blackmon SH, Stephenes E, Correa AM, Hofstetter WL, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrence in the Lung and Survival in Pulmonary Metastasectomy for Colorectal Carcinoma Patients. Society of Thoracic Surgeons 2012 Meeting, 2012. e-Pub 2012.
- Blackmon SH, Correa AM, Chevray PM, Mehran RJ, Rice DC, Skoracki R, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter WL. Super-Charged Jejunal Interposition for Esophageal Replacement: A 10 Year Experience. Society of Thoracic Surgeons 2012 Meeting, 2012. e-Pub 2012.
- Lin SH, Myles BH, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher S, Lee JH, Bhutani MS, Maru D, Ajani JA, Cox JD, Komaki R, Liao ZX. Propensity score–based comparison of outcomes with 3D conformal radiotherapy (3D-CRT) versus intensity-modulated radiation therapy (IMRT) in treatment of esophageal cancer. ASCO 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
- Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, Swisher S, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH. Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer. ASCO 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
- Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. ASCO 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
- Suzuki A, Xiao L, Hayashi H, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Maru D, Rice DC, Hofstetter WL, Erasmus JJ, Swisher S, Ajani JA. Nomograms for prognostication of patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. ASCO 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
- Marom EM, Moran CA, Piu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, SGb S. Computed Tomography Findings Predicting Invasiveness of Thymoma. 40th Congress of the International Society of Oncology and Biomarkers, October 13-17, 2012; Jerusalem, Israel, 2012. e-Pub 2012.
- Marks JL, Hofstetter WL, Correa AM, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA, Erasmus JJ, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. STSA 58th Annual Meeting, 2011. e-Pub 2011.
- Amini A, Lin SH, Correa AM, Swisher SG, Komaki R, Pisters KM, Tsao A, Roth JA, Vaporciyan. Locoregional Recurrence Rate in Resected Stage III-N2 Non-Small Cell Lung Cancers (NSCLC) with Nodal Downstaging Following Induction Chemotherapy. Intl J Radiation Oncol/Biol/Physics 81(2):S134(#270), 2011. e-Pub 2011.
- Myles B, Lin SH, tucker SL, Ajani JA, Hofstetter WL, Swisher SG, Ho L, Komaki R, Cox JD, Liao Z. Long Term Outcomes Comparing Three-Dimensional Conformal Radiation Therapy to Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancer: The MD Anderson Experience. 2011 ASTRO Meeting, 2011. e-Pub 2011.
- Chang JY, Liu H, Zhang X, Balter P, Liao Z, Jeter M, Swisher SG, Mehran RJ, Roth JA, Komaki R. Four-dimensional CT and on-board volumetric image-guided stereotactic ablative radiotherapy (SABR) for Stage I non-small cell lung cancer. Intl J Radiat Oncol/Biol/Physics - Proceedings of the 53rd Annual ASTRO Meeting 81(2):S623 (#2859), 2011. e-Pub 2011.
- Benveniste M, Liu P, Moran CA, Swisher SG, Truong MT, Marom EM. Can PET-CT Identify Patients with Advanced Stage Thymoma?. International Thymic Malignancy Group Conference, 2011. e-Pub 2011.
- Kim ES, He G, Chow CB, Fujimoto J, Kalhor N, Swisher SG, Wistuba II, Stewart DJ, Siddik ZH. Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer. IASLC 2011, 2011. e-Pub 2011.
- Pinto H, Change KJ, Reid T, Senzer N, Swisher SG, Hanna N, Chak A, Soetikno R. Final Report of a Phase I TNFerade Biologic plus chemoradiotherapy prior to esophagectomy for locally advanced resectable esopahgeal cancer. 2011 ASCO Meeting, 2011. e-Pub 2011.
- Gomez D, Kim E, Komaki R, Cox C, Walsh GL, Swisher SG, Hong WK. Invasive thymoma treated with induction cyclophosphamide, adriamycin (CAP) chemotherapy, surgical resection, and adjuvant radiation therapy: an institutional update. International Thymic Malignancy Interest Group Conference, 2011. e-Pub 2011.
- Gold KA, Lee JJ, Ping Y, Behrens C, Liu D, Lee HY, Koo JS, Lotan R Solis L, Rinsurongkawong W, Stewart DJ, Hofstetter WL, Swisher SG, Lippman SM, Wistuba II, Hong WK, Kim ES. Biologic risk model for recurrence in resected early stage non-small cell lung cancer. 2011 ASCO Meeting, 2011. e-Pub 2011.
- Therasse P, Vansteenkiste JF, Zielinski M, DePas TM, Atanackovic D, Swquist LV, Vallieres E, Swisher SG, Adams S, Passlick B, Eberhardt WEE, Grunenwald D, Mok T, Boyer M, Katz A, Douillard JY, Debois M, Brichard VG, Altorki NK. MAGRIT phase III trial: MAGE-A3 antigen-specific cancer immunotherapy (ASCI) as adjuvant therapy in patients with completely resected stage IB-IIIA NSCLC. 2011 ASCO Meeting, 2011. e-Pub 2011.
- Hayashi Y, Ajani JA, Correa A, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutgani M, Lin SH, Welsh J, Maru DM, Swisher SG. The association between body mass index and baseline clinical stage of esophageal carninoma. 2011 ASCO Annual Meeting, 2011. e-Pub 2011.
- Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer. ASTRO 2011 Anual Meeting, 2011. e-Pub 2011.
- Harvin JA, Lahat G, Correa A, Lee J, Maru D, Ajani J, Marom E, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant Chemoradiation followed by Surgery for Esophageal Adenocarcinoma: Significance of Microscopically Positive Circumferential Margins. AATS, 2011. e-Pub 2011.
- Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the p38 signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. AACR, 2011. e-Pub 2011.
- Gold KA, William WN, Lee JJ, Vaporciyan AA, Herbst RS, Tse W, Stewart D, Hofstetter WL, Wistuba II, Swisher SG, Lippman SM, Kim ES. Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with resectable non-small cell lung cancer (NSCLC). Targeted Therapies for Lung Cancer Annual Meeting, 2011. e-Pub 2011.
- Pataer A, He Y, Correa AM, Fang B, Roth JA, Wistuba II, Swisher SG. PKR signaling pathway plays an important role in prognosis for non-small cell lung cancer. Proc Am Assoc Cancer Res, 2011. e-Pub 2011.
- Estrella JS, Hofstetter W, Correa AM, Ajani J, Swisher S, Rashid A, Maru D. Measurement of Depth of Invasion, Submucosal and Lymphovascular Invasion (LVI) Predicts Lymph Node (LN) Involvement in T1 Esophageal Adenocarcinoma (EAC). Invasion of Duplicated Muscularis Mucosae (MM) Has Similar Risk of LN Involvement as Mucosal Invasion. United States and Canadian Academy of Pathology 2011, 2011. e-Pub 2011.
- Kim JY, Correa AM, Swisher SG, Rice DC, Walsh GL, Vaporciyan AA, Mehran RJ, Roth JA, Bhutani M, Maru D, Welsh J, Ajani J, Rohren E, Hofstetter WL. Does the timing of esophagectomy after neoadjuvant chemoradiation affect outcome?. Society of Thoracic Surgeons:(#71), 2011. e-Pub 2011.
- Goodarzi M, Kanhere R, Corley L, Correa AM, Ajani J, Swisher SG, Hofstetter WL, Rashid A, Maru D. Sox-9 immunohistochemical stain demonstrates abnormal distribution of gastrointestinal stem cells in specialized and non-specialized Barrett's mucosa. United States and Canada Academy of Pathology Meeting, 2011. e-Pub 2011.
- Chang JY, Komaki R, Wen HY, Xiang Z, Allen PK, DeGarcia B, Bluett JB, Lu C, Tsao A, Swisher SG, Gillin M, Mohan R, Cox JD. Updates of phase II clinical studies of high-dose proton therapy in inoperable early stage or locally advanced non-small cell lung cancer. PTCOG 2011 Meeting, 2011. e-Pub 2011.
- Stewart DJ, Behrens C, Swisher SG, Roth JA, Heymach JV, Wistuba II. Factors associated with membrane carbonic anhydrase IX (mCAIX) expression in non-small cell lung cancer (NSCLC). 2011 ASCO Meeting:(#e21125), 2011. e-Pub 2011.
- Brouquet A, Vauthey JN, Contreras C, Walsh G, Vaporicyan AA, Swisher SG, Curley S, Mehran RJ, Abdalla E. Improved Survival After Resection of Liver and Lung Colorectal Metastases Compared to Resection of Liver-Only Metastases: A Study of 112 Patients with Limited Lung Metastatic Disease. Western Surgical Association Meeting, 2010. e-Pub 2010.
- Blackmon SH, Stephens EH, Correa AM, Roth JA, Hofstetter WL, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression Following Chemotherapy is a Novel Predictor of Poor Outcome Following Pulmonary Metastasectomy in Sarcoma Patients. J Amer Coll Surgs 211(3):S35, 2010. e-Pub 2010.
- Komaki R, Wei X, Allen P, Roth JA, Swisher SG, Rice DC, Walsh GL, Fossella FV, Erasmus JJ, Cox JD. Treatment for superior sulcus tumors (SST): Effect of surgery first followed by adjunct concurrent chemoradiotherapy on survival of patients with marginally resectable SST. J Clin Oncol 28 Suppl(521s):(#7026), 2010. e-Pub 2010.
- Hyaashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The influence of pretreatment body mass index on long-term prognosis of patients with esophageal carcinoma after surgery. 2010 ASCO Annual Meeting, 2010. e-Pub 2010.
- Bektas M, Orue N, Qiao W, Lee JH, Ross W, Ajani J, Hofstetter W, Swisher SG, Bhutani M. Which Technique Predicts Histopathologic Regression AFter Neoadjuvant Therapy for Esophageal Cancer?. Digestive Disease Week 2010, 2010. e-Pub 2010.
- Johnson ED, Hanneken JM, Taylor SH, Nunnelley MJ, Erasmus JJ, Swisher S, Gomez DR, Lippman SM, Karp DD. Non-small cell lung cancer (NSCLC) in patients under 50: A long-term follow-up from the M. D. Anderson Cancer Center tumor registry. ASCO 2010 Meeting, 2010. e-Pub 2010.
- He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant signal transduction and DNA damage response pathways in primary lung cancer. J Thorac Onc 6/Supp 2(S972):(P2.078), 2010. e-Pub 2010.
- Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Ajani JA, Erasmus J, Komaki R, Lee JHL, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Peters JH, Watson TJ, Swisher SG. A Clinical Nomogram Predicting Pathologic Lymph-Node Involvement in Esophageal Cancer Patients. American Surgical Association 130th Annual Meeting, 2010. e-Pub 2010.
- Pataer A, Lu X, Roth JA, Swisher SG. Inhibition of RNA-dependent kinase (PKR) enhances radiation sensitivity in lung cancer cells. AACR:(#1504), 2010. e-Pub 2010.
- Estrella J, Correa A, Swisher SG, Ajani J, Rashid A, Hofstetter WL, Maru D. Depth of invasion in millimeter in T1 Esophageal Adenocarcinoma (EAC) correlates with lymph node (LN) status and likelihood of LN+ in EAC invading into space between duplifated muscularis mucosa is similar to EAC with mucosl invasion. USCAP 2010 Annual Meeting, 2010. e-Pub 2010.
- Chang KJ, Senzer NN, Soetikno R, Swisher S, Reid TR, Mauer A, Pinto H, Chak A, Thornton MO, Forastiere AA. Long term survival analysis of multi-center clinical trial using endoscopy (END) adn endoscopic ultrasound (EUS) guided fine needle injection (FN1) of anti-tumor agent (TNFerade Biologic (TNF)) in patients with locally advanced esophageal cancer. 2010 Gastrointestinal Cancers Symposium, 2010. e-Pub 2010.
- Kim M, Correa AM, McLaughlin P, Erasmus JJ, Moran C, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA. Resection of Lung Cancer in Lymphoma Survivors. Society of Thoracic Surgeons 46th Annual Meeting:(#59), 2010. e-Pub 2010.
- Kim M, Hofstetter WL, Correa AM, Marom E, Maru D, Macapinlac H, Lee J, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AAA, Swisher SG. Pathologic T0N1 After Neoadjuvant Therapy and Surgery for Esophageal Cancer: an Orphan Status. Society of Thoracic Surgeons 46th Annual Meeting:(#44), 2010. e-Pub 2010.
- Katz RLI, He W, Khanna A, Fernandez RL, Zaidi TM, Krebs M, Caraway NP, Zhang HZ, Jiang F, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, Swisher SG, Roth JA, Morris JS, Etzel CJ, El-Zein R. Genetically Abnormal CirculatingCells in Lung Cancer Patients: An Antigen-Independent Fluorescebce In situ Hybridization-Based Case-Control Study. 2010 AACR, 2010. e-Pub 2010.
- Marom EM, Milito MA, Moran CA, Liu P, Kim ES, Swisher SG. CT findings predicting invasiveness of thymoma. Intl Thymic Malignancy Interest Group, 2010. e-Pub 2010.
- Gu J, Ajani JA, Hawk E, Ye Y, Lee JH, Bhutani M, Hofstetter WL, Swisher SG, Wang KK, Wu X. Chromosomal Aberrations Predict Malignant Progression of Esophageal Adenocarcinoma: a Genome-wide High-Density SNP Array Analysis. 2010 AACR, 2010. e-Pub 2010.
- Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. 2010 American Cancer Society, 2010. e-Pub 2010.
- Benveniste MK, Rosado de Christenson ML, Sabloff BS, Moran C, Swisher SG, Marom EM. Imaging, Staging Evaluation and Treatment Considerations in Thymoma. RSNA, 2010. e-Pub 2010.
- Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D. Video-assisted thorascopic surgery (VATS) versus open thoracotomy pulmonary lobectomy in a cohort of 13,619 patients. 56th Annual Meeting of the Southern Thoracic Surgical Association, 2009. e-Pub 2009.
- Swisher SG, Hofstetter WL Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru DM, Mehran RJ, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome With Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. Southern Thoracic Surgical Association, 2009. e-Pub 2009.
- 159Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D. Outcomes of video-assisted thorascopic surgery (VATS) versus open thoracotomy pulmonary lobectomy in a cohort of 13,619 patients. Southern Thoracic Surgical Association 2009 56th Annual Meeting:70, 2009. e-Pub 2009.
- Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporicyan AA, Rice TW, Swisher SG. Staging of Gastroesophageal Adenocarcinomas: A Comparison between Esophageal Staging, Gastric Staging, and a Novel Worldwide Esophageal Cancer Collaboration Staging System. STSA 56th Annual Meeting 2009, 2009. e-Pub 2009.
- Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The Influence of Pretreatment Body Mass Index on Long-Term Prognosis of Patients With Esophageal Carcinoma After Surgery. ISGIO 2009, 2009. e-Pub 2009.
- Correa AM, Hayashi Y, Hofstetter WL, Komaki R, Vaporciyan AA, Rice DC, Walsh GL, Lee JH, Bhutani MS, Ross WA, Liao Z, Swisher SG, Ajani JA. In Patients with Clinical T2N0M0 Esophageal Cancer, Surgery First or Preoperative Chemoradiotherapy?. 2009 Gastrointestinal Oncology Conference, 2009. e-Pub 2009.
- Tsao AS, Gil J, Rice D, Swisher S, Lippman S, Pisters K, Blumenschein G, Hong WK, Mehran R. Phase I trial of neoadjuvant dasatinib in patients with resectable malignant pleural mesothelioma. 2009 IASLC, 2009. e-Pub 2009.
- Gold KA, Lee JJ, Rice DC, Tse W, Stewart D, Wistuba I, Herbst RS, Swisher SG, Lippman SM, Kim ES. Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with stage I-III non-small cell lung cancer (NSCLC). 2009 ASCO, 2009. e-Pub 2009.
- Mehran RJ, Gil J, Rice DC, Swisher SG, Lee JJ, Lippman SM, Pisters K, Blumenschein G, Hong WK, Tsao A. Phase I trial of neoadjuvant dasatinib in patients with resectable malignant pleural mesothelioma. ASCO 2010 Meeting, 2009. e-Pub 2009.
- Marom EM, Moran C, Kim ES, Swisher SG. Thymoma size is not a predictor for extracapsular invasion. Society of Thoracic Radiology, 2009. e-Pub 2009.
- Blackmon S, Shah N, Correa AM, Benjamin P, Hofstetter WL, Lev D, Pollock R, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Complete Resection of Extra-Pulmonary Sarcomatous Metastases in Addition to Pulmonary Metastasectomy is Associated with Long-Term Survival. Society of Thoracic Surgeons 45th Annual Meeting:(#39), 2009. e-Pub 2009.
- Hu W, He C, Fang B, Swisher SG. Putative tumor-suppressor function of Krüppel-like lactor 4 in primary lung carcinoma. AACR 2009 Meeting, 2009. e-Pub 2009.
- Solis L, Behrens C, Bekele B, Ozburn N, Moran C, Minna J, Suraokar M, Stewart D, Swisher S, Corvalan A, Wistuba I. Keap1 and Nrf2 expression in non-small cell lung carcinoma correlates with clinico-pathological features. AACR 2009 Meeting, 2009. e-Pub 2009.
- Pataer A, Swisher SG, Roth JA, Logothetis CJ, Corn P. Inhibition of RNA-dependent protein kinase (PKR) leasds to cancer cell death and increases chemosensitivity. Proc Am Assoc Cancer Res:(#3879), 2009. e-Pub 2009.
- McAleer MF, Smith GL, Smith BD, Swisher SG, Ajani J, Komaki R, Cox JD, Buchholz TA. Radiotherapy increases cardiac events in esophageal cancer patients: Outcomes from the SEER-Medicare cohort with implicationsfor improvement of tumor targeting and role of post-treatment pharmacomodulation. American Radium Society 2009 Annual Meeting, 2009. e-Pub 2009.
- Maru DM, Correa AM, Tong Z, Wang H, Wu TT, Corley L, Krishnan S, Ajani JA, Swisher SG, Rashid A, Hofstetter WL, Guha S. Loss of Neutrophil Gelatinase Associated Lipocalin (NGAL) Expression in Esophageal Adenocarcinoma (EAC) Is Associated with Higher Pathologic Stage and Poor Survival. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
- Smith KD, Rice D, Blazer D, Wang X, Vaporicyan AA, Hunt KK, Swisher SG, Cormier J, Pisters PW, Pollock RE, Feig BW. Near-margin adventitial (NMA) vascular dissection is equivalent to en bloc vascular resection in soft tissue sarcomas (STS). Society of Surgical Oncology 2009, 2009. e-Pub 2009.
- Hofstetter WL, Maru DM, Correa A, Shah N, Lee JH, Ajani JA, Erasmus JJ, Komaki R, Anandasabapathy S, Swisher SG. Salvage resection for esophageal adenocarcinoma after failed definitive chemoradiation. ASCO GI Cancers Symposium, 2009. e-Pub 2009.
- Gaur R, Correa AM, Huang JL, Hofstetter WL, Maru D Mehran RJ, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Correlation of endoscopic tumor length with lymph node involvement and poor long-term survival in esophageal cancer patients. 2009 GI Cancers Symposium:(#14), 2009. e-Pub 2009.
- Rice DC, Lee JH, Jimenez C, Eapen G, Stewart J, Hofstetter WL, Mehran R, Vaporciyan AA, Walsh GL, Swisher, SG. Mediastinal Staging for Mesothelioma: Endoscopic Ultrasound or Mediastinoscopy?. Society of Thoracic Surgeons, 2009. e-Pub 2009.
- Katz RL, He W, Khanna A, Fernandez RL, Caraway NP, Zhang H, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, Swisher SG, Roth JA, Etzel C, El-Zein R. Levels of Genetically Abnormal Circulating Cells in Patients with Non-Small Cell Lung Cancer Correlate with Stage and Genetic Phenotype of Tumor, Recurrence and Survival: A FISH Based Case and Control Study. IASLC 13th World Conference on Lung Cancer:D8.3, 2009. e-Pub 2009.
- Deus HF, Stanislaus R, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Almeida JS. Data driven semantic integration of translational lung cancer research at MD Anderson Cancer Center. AMIA Ann Symp Proc 6(927), 2008. e-Pub 2008.
- Vaporciyan AA, Bashkar S, Correa AM, Mendoza T, Hofstetter WL, Rice DC, Mehran RJ, Swisher SG, Wang XS, Cleeland C. A novel system for measuring longitudinal postoperative symptom burden: proof of concept comparing VATS versus open lobectomy. ISMICS 2008 Annual Scientific Meeting, 2008. e-Pub 2008.
- Hu W, Fang B, Xie K, Swisher SG. Down-Regulation of Krueppel-Like Factor 4 (KLF4) in Human Lung Cancer and Its Possible Role in Malignancy. 2008 AACR Meeting, 2008. e-Pub 2008.
- Mehran R, Shah N, Correa A, Vaporciyan A, Rice D, Hofstetter W, Walsh G, Benjamin R, Swisher S, Pollock R, Roth J. Pulmonary Metastatectomy In Sarcoma Patients With Extra-Thoracic Metastases. 18th World Congress of the World Society of Cardio-Thoracic Surgeons, 2008. e-Pub 2008.
- Pataer A, Hu W, Lu X, Chada S, Roth, J, Hunt K, Swisher S. Adenoviral ER-targeted mda-7/IL-24 vector enhances cell killing and overcomes MDA-7/IL24 resistance. AACR 2008 Meeting, 2008. e-Pub 2008.
- Maru DM, Khurana H, Correa AM, Swisher SG, Ajani JA, Rashid A, Hofstetter WL. Clinicopathologic Features and Prognosis of High-Grade Neuroendocrine Carcinoma of Esophagus. United States and Canadian Academy of Pathology, 2008. e-Pub 2008.
- Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele N, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the Revised Lung Cancer Staging System (IASLC Staging Project) to a Cancer Center Population. 88th Annual Meeting of the Amer Assoc for Thorac Surg:(#32), 2008. e-Pub 2008.
- Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Long-term survival with surgical management for superior sulcus tumors wtih vertebral resection. 88th Annual Meeting of the Amer Assoc of Thorac Surg:(#16), 2008. e-Pub 2008.
- Bolton WD, Hofstetter WL, Francis A, Correa AM, Ajani, JA, Bhutani B, Erasmus JJ, Komaki R, Maru D, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Impact of tumor length and submucosal involvement on the long-term survival of pT1 early stage esophageal adenocarcinoma. 88th Annual Meeting of the Amer Assoc of Thorac Surg:(#20), 2008. e-Pub 2008.
- Chang K, Senzer N, Soetikno R, Swisher SG, Reid T, Mauer A, Vokes E, Pinto H, Chak A, Forastiere A. Survival Analysis of Multi-Center Clinical Trial Using Endoscopy and Endoscopic Ultrasound Guided Fine Needle Injection of Anti-Tumor Agent and Patients with Locally Advanced Esophageal Cancer. Digestive Disease Week:S27-S28, 2008. e-Pub 2008.
- Cen P, Ajani JA, Correa AM, Lee JH, Maru DM, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA. Adenocarcinoma of the Lower Esophagus with Barrett's or without Barrett's: Differences in Patients Survival After Preoperative Chemoradiation. ASCO 2008 Meeting, 2008. e-Pub 2008.
- Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. Development of Ad-mda7/IL-24-resistant lung cancer cells lines. Proc Am Assoc Cancer Res, 2008. e-Pub 2008.
- Swisher SG, Winters K, Komaki R, Ajani J, Wu TT, Hofstetter WL, Konski A, and Willett C. A Phase II study of a Paclitaxel based Chemoradiotherapy Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Carcinoma of the Esophagus. American Society for Therapeutic Radiology and Oncology 69(3):S106, 2007. e-Pub 2007.
- Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of Endoscopic Ultrasound Staging in Conjunction with Evaluation of Lymphovascular Invasion in Identifying Low-Risk Esophageal Carcinoma. Texas Society of Medical Oncology, 2007. e-Pub 2007.
- Tetzlaff ED, Correa AM, Komaki R, Swisher S, Maru D, Ross W, Ajani JA. The Significance of Thromboembolic Phenomena Occurring Before and During Chemoradiotherapy for Localized Carcinoma of the Esophagus and Gastroesophageal Junction. International Society of Gastrointestinal Oncology, 2007. e-Pub 2007.
- Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Maru D, Rashid A, Ajani JA. Lymphovascular Invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. International Society of Gastrointestinal Oncology, 2007. e-Pub 2007.
- Javeri HA, Arora R, Correa AM, Dixon DR, Komaki R, Hofstetter WL, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Lee JH, Bhutani M, Ross WA, Liao Z, Maru DM, Dekovich AA, Ajani JA. Comparison of the Outcomes of Patients with Localized Esophageal Carcinoma Receiving Bimodal Therapy versus Trimodal Therapy. International Society of Gastrointestinal Oncology, 2007. e-Pub 2007.
- Yendamuri S, Vaporciyan AA, Zaidi T, Fernandez R, Rice DC, Walsh GL, Swisher SG, Spitz M, Roth JA, Katz RL. Deletion of chromosome 10q detected by luorescent in situ hybridization (FISH) is a potential new tool for early detection of non small cell lung cancer (NSCLC). 12th World Conference on Lung Cancer 2(8):S357-S357, 2007. e-Pub 2007.
- Rice D, Correa A, Hofstetter W, Mehran R, Swisher S, Walsh G, Vaporciyan A, Roth J. Recent Survival Trends for Clinically Staged Stage I Lung Cancer. The Society of Thoracic Surgeons 43rd Annual Meeting, 2007. e-Pub 2007.
- Blackmon SH, Rice DC, Correa AM, Hofstetter W, Swisher SG, Mehran R, Vaporciyan AA, Walsh GL, Roth JA. Does A Gastrostomy Tube Versus Jejunostomy Tube Prior To Esophagectomy For Primary Esophageal Cancer Patients Have Additional Risk?. Society of Thoracic Surgeons 43rd Annual Meeting, 2007. e-Pub 2007.
- Karp DD, Hanneken JM, Taylor SH, Liu S, Johnson ED, Wistuba II, Swisher SG, Munden RF, Stewart DJ. Upper Lobe Lesions Dominate in Patients With Long Term Survival of Non-Surgically Treated Non Small Cell Lung Cancer. International Association for the Study of Lung Cancer, 2007. e-Pub 2007.
- Yendamuri S, Vaporciyan AA, Zaidi T, Fernandez R, Rice DC, Spitz M, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC). ASCO Annual Meeting Proceedings Part I Clinical Oncol 25(18S), 2007. e-Pub 2007.
- Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. Geldanamycin and its 17-allyl-amino-a7-demethoxy analogue overcome Ad-mda7 resistance in lung cancer. Proc Am Assoc Cancer Res:(#3326), 2007. e-Pub 2007.
- Liu H, Blackmon S, Gayed I, Wang S, Wei X, Tucker S, Liao Z, Hofstetter WL, Swisher S, Komaki R. Cardiac Toxicity From Chemoradiation With Or Without Surgery for Patients With Esophageal Cancers. ASTRO meeting 2006, 2006. e-Pub 2006.
- Izzo JG, Wu T, Malhotra U, Ensor J, Luthra R, Chao CK, Swisher S, Liao Z, Aggarwal BB, Hittleman WN, Ajani JA. Transcription factor NFkB a potential molecular marker for predicting and improving treatment efficacy in esophageal cancer. Proc Am Soc Clin Oncol 24(18S), 2006. e-Pub 2006.
- 135Rodney A, Siefker-Radtke A, Tannir NM, Swisher S, Walsh GL, Millikan RE, Pagliaro LC. Treatment outcomes of patients (Pts) with primary mediastinal germ cell tumors (PMGCT): The M. D. Anderson Cancer Center Experience. Proc Am Soc Clin Oncol, 2006. e-Pub 2006.
- Bakaeen F, Chu D, Correa AM, Rice D, McAllister R, Vaporciyan AA, Walsh G, Putnam JB, Swisher SG, Roth JA, Huh J, Smythe, WR. The Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis And Blood Product Utilization. Association of VA Surgeons Meeting, 2006. e-Pub 2006.
- Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, |BSwisher SG, Walsh GL, Roth JA, Mehran RJ. Increased Risk of Aspiration and Pulmonary Complications after Lung Resection in Head and Neck Cancer Patients. STS 42nd Annual Meeting:214, 2006. e-Pub 2006.
- Hofstetter WL, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu TT, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Swisher SG. Proposed modifications of nodal status (pN, pM1a, pM1b) in AJCC esophageal cancer staging system. Southern Thoracic Surgical Associations, 2006. e-Pub 2006.
- Rice DC, Stevens C, Forster K, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, and Smythe WR. Survival and recurrence patterns following extrapleural pneumonectomy and intensity modulated radiation therapy for malignant pleural mesothelioma. Southern Thoracic Surgical Association, 2006. e-Pub 2006.
- Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, and Vaporciyan AA. Propensity matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Southern Thoracic Surgical Association 53rd Annual Meeting, 2006. e-Pub 2006.
- Pataer A, von Holzen U, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. RNA-dependent protein kinase (PKR) indirect regulation of AKT in Ad-mda7 treated human lung cancer cells. Proc Am Assoc Cancer Res 47(712), 2006. e-Pub 2006.
- Bruzzi JF, Erasmus JJ, Swisher SG, Truong M, Macapinlac H, and Munden R. Can restaging PET/CT predict suitability for resection of esophageal cancer following neoadjuvant chemoradiotherapy?. Proc R Coll Surgeons, Dublin, Ireland, 2006. e-Pub 2006.
- Albarracin CT, Resetkoval E, Wang H, Anderson P, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, and Wu TT. Expression of Annexin A1 in the esophageal and esophogastric junction adenocarcinomas: association with poor outcome. United States and Canadian Academy of Pathology Annual Meeting, 2006. e-Pub 2006.
- Liang J, Rashid A, Wu TT, Correa AM, Maru D, Corley LJ, Hofstetter WL, Swisher SG, Ajani JA, Hamilton SR, and Wang H. High level of nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (hTERT) is associated with better prognosis in patients with esophageal and esophagogastric junction adenocarcinomas. American Association for Cancer Research, 2006. e-Pub 2006.
- Wu TT, Chirieac LR, Abraham SC, Krasinskas A, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma following preoperative chemoradiation in esophageal carcinoma: A reliable predictor for patient outcome. Mod Pathol 19(1):124A, 2006. e-Pub 2006.
- Jeter MD, Zhu G, Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Guerrero T, Stevens CW, Vaporciyan A, Komaki R. Induction Chemotherapy Improves Long-Term Survival of Patients With Resectable Esophageal Cancer Receiving Chemoradiotherapy Followed by Surgery. ASTRO 2005 Annual Meeting, 2005. e-Pub 2005.
- Malhotra U, Hittelman WN, Wu TT, Luthra R, Swisher S, Luthra M, Correa A, Aggarwal BB, Ajani JA, Izzo JG. Association of activated NF-kB, altered cyclin D1 and poor outcome in esophageal adenocarcinoma. American Association for Cancer Research 46:548, 2005. e-Pub 2005.
- Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. STS 2005, 2005. e-Pub 2005.
- Suh YJ, McKenzie Y, Liu Y, Swisher SG, Lucci A, Hunt KK. Synergism between Ad-E2F1 and celecoxib results in increased rates of apoptotic cell death in breast cancer cells. Proc Am Soc Clin Oncol:236s, 2005. e-Pub 2005.
- Liu L, Hofstetter W, Rashid A, Swisher S, Correa A, Hamilton S, Wu TT. Significance of the Depth of Tumor Invasion in Early (T1) Esophageal Adenocarcinoma. Mod Pathol 18(1):110A, 2005. e-Pub 2005.
- Rohatgi P, Swisher S, Correa A, Wu TT, Liao X, Komaki R, Walsh G, Vaporciyan A, Rice DC, Roth JA, Ajani JA. Degree of pathologic response after preoperative chemoradiotherapy correlates with failure patterns and outcome of patients with carcinoma of the esophagus. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, SG||B |. The Addition of Induction Chemotherapy to Preoperative Concurrent Chemoradiotherapy Improves Tumor Response in Patients with Esophageal Adenocarcinoma. Western Thoracic Surgical Association, 2005. e-Pub 2005.
- Fanale MA, Vorburger SS, Liu Y, McKenzie TS, Swisher SG, Hunt KK. AdhTERT-E2F-1 can induce selective apoptosis of breast cancer cells through multiple mechanisms. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Choi IS, An C, Swisher SG, Correa AM, Ajani JA, Rashid A, Hamilton SR, Wu TT. Frequent CpG island methylation in resected esophageal adenocarcinomas. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Bocangel DB, Holzen UV, Chada S, Pataer A, Takada Y, Raju U, Aggarwal BB, Barber GN, Chiao P, Milas L, Hunt KK, Swisher SG. Threshold for radiation sensitization induced by adenoviral delivery of TNF-alpha: Role of the double stranded RNA activated protein kinase (PKR). Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Malaisrie SC, Correa AM, Ajani JA, Komaki RR, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus. Proc Am Assoc Thorac Surg:102, 2005. e-Pub 2005.
- Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Walsh GL. Long segment supercharged pedicled jejunal flap for total esophageal reconstruction. Proc Am Assoc Thorac Surg:98, 2005. e-Pub 2005.
- von Holzen UW, Pataer A, Bocangel D, Lu X, Barber GN, Roth JA, Hunt KK, Swisher SG. Role for double-stranded RNA activated kinase PKR in Ad-TNFalpha gene therapy. Proc Soc Univ Surg, 2005. e-Pub 2005.
- Rice DC, Vaporciyan AA, Stevens C, Wu J, Walsh GL, Swisher SG, Hofstetter WL, Erasmus JJ, and Smythe WR. Extended surgical staging for potentially resectable malignant mesothelioma. Proc Soc Thorac Surg, 2005. e-Pub 2005.
- Swisher SG, Macapinlac HJ, Erasmus J, and Munden R. FDG-PET imaging in esophageal cancer. Proc Am Mol Imag, 2005. e-Pub 2005.
- Wang S, Liao L, Vaporciyan AA, Tucker SL, Liu HH, Wei X, Mohan R, Swisher SG, Ajani JA, Cox JD, and Komaki R. Dose-volume analyses of postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. ASTRO, 2005. e-Pub 2005.
- Liu Y, Keyomarsi K, Swisher SG, and Hunt KK. Small interfering (siRNA) inhibits the expression of the elafin gene and induces low molecular weight forms of cyclin E in breast epithelial cells. Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications Conference, 2005. e-Pub 2005.
- von Holzen U, Pataer A, Bocangel D, Raju U, Vorburger SA, Liu Y, Lu X, Barber GN, Aggarwaal BB, Keyomarsi K, Hunt KK, Swisher SG. Lack of expression of the double-stranded RNA activated protein kinase PKR sensitizes mouse embryo fibroblasts to ionizing radiation. AACR-NCI-EORTC, 2005. e-Pub 2005.
- Wu X, Spitz MR, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Chiang SS, Milas L, Hittelman WN, Ajani JA. Genetic variations in chemotherapy drug action pathways modulate therapeutic response in esophageal cancer. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- von Holzen UW, Bocangel D, Pataer A, Takada Y, Liu Y, Aggarwal BB, Barber GN, Hunt KK, Swisher SG. Apoptosis of Esophageal Cancer Cells following Ad-TNFa gene therapy: the role of the double-stranded RNA activatedprotein kinase (PKR) and the nuclear factor kappa B (NF-kB). Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Liu Y, Keyomarsi K, Lu X, Swisher SG, Hunt KK. Induction of apoptosis in human breast cancer cells following adenovirus-mediated Elafin gene expression in vitro. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Martin LW, Swisher SG, Hofstetter WL, Correa AM, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Amer Surg Assoc 64, 2005. e-Pub 2005.
- Abraham SC, Krasinkas AM, Hofstetter WL, Swisher SG, and Wu TT. Seedling mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are very common in the esophagoastric region. United States and Canadian Academy of Pathology Annual Meeting, 2005. e-Pub 2005.
- Lu X, Pataer A, Hunt KK, Chada S, Swisher SG. ER targeting of Ad-MDA-7/IL-24 vectors increases apoptosis induction in esophageal and lung cancer cells. American Association for Cancer Research, 2005. e-Pub 2005.
- Swisher S, Macapinlac H, Ersamus J, Munden R. 2-deoxy-2 [18F]fluoro-d-glucose-positron emission tomography imaging in esophageal cancer. Mol Imaging Biol:95, 2005. e-Pub 2005.
- Sun B, Swisher SG, Keyomarsi K, Hunt KK. Absence of pRb facilitates E2F1-induced cell death in breast cancer cells. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Suh YJ, Chada S, McKenzie T, Lui Y, Swisher S, Lucci A, Hunt KK. Synergistic tumoricidal effect between celecoxib and melanoma differentiation-associated gene 7 on human breast cancer cells. Proc Soc Univ Surg, 2005. e-Pub 2005.
- Suh YJ, Raju U, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK. Enhanced radiosensitization of breast cancer cells in vitro by combining Adenovirus-mediated delivery of melanoma differentiation-associated gene-7 (Ad-mda7) and celecoxib. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Senzer N, Swisher SG, Reid T, Mauer A, Posner M, Pinto H, Chang KJ, Forastiere A, Soetikno R, Macko J, and Nemunaitis J. Long-term outcome in esophageal cancer after endoscopically delivered intratumoral (IT) injections of TNFerade combined with neoadjuvant chemoradiotherapy (CRT). American Society of Clinical Oncology GI, 2005. e-Pub 2005.
- Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter W, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagastric junction adenocarcinoma treated with preoperative chemoradiation. Proc Am Soc Clin Oncol:319s, 2005. e-Pub 2005.
- Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of Adenoviral mda-7 mediated cell killing in human lung cancer cells by geldanamycin and its 17-allylamino-17-demethoxy analogue. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- McKenzie TS, Lui Y, Keyomarsi K, Holzen UV, Y-J S, Fanale M, Swisher S, Chada S, Hunt K. Adenoviral mediated delivery of the melanoma differentiation-associated gene-7 (Ad-mda7) regulates the Wnt signaling pathway in breast cancer cells. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
- Martin LW, Swisher SG, Hofstetter WL, Correa AM, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Outcomes for resected stage IIIa Non-small cell lung cancer: over 15 years at a single institution. Proc Am Assoc Thorac Surg:72, 2005. e-Pub 2005.
- Izzo JG, Wu TT, Luthra R, Luthra MG, Swisher S, Aggarwal BB, Bresalier RS, Milas L, Liao Z, Hittelman WN, Ajani J. Association of activated transcription factor NF-kappaB with chemo-radiotherapy resistance and poor outcome in esophageal adenocarcinoma. Proc Am Assoc Cancer Res 23(16S), 2005. e-Pub 2005.
- Hong DS, Lunagomez S, Kim E, Morris J, Swisher SG, Bresalier R, Ajani JA. The number of abnormalities on pre-treatment PET scan predicts for overall survival of patient with localized esophageal and GE junction carcinoma (E/GEJC). Proc Am Soc Clin Oncol 22(14A), 2004. e-Pub 2004.
- Phan AT, Rashid A, Luthra R, Lopez-Alvarez E, Swisher S, Komaki R, Bresalier R, Ajani JA. Molecular predictors of patients with localized upper gastrointestinal cancers after chemoradiation. Proc Am Assoc Clin Oncol 22(14S), 2004. e-Pub 2004.
- Wu TT, Chirieac LR, Swisher SG, Komaki RU, Correa AM, Roth J, Rashid A, Hamilton SR, Ajani JA. Post-chemoradiation surgical pathologic stage accurately predicts outcome of patients with esophageal or gastroesophageal junction carcinoma. Proc Am Soc Clin Oncol:319, 2004. e-Pub 2004.
- Fanale MA, Liu Y, Vorburger S, McKenzie T, Swisher S, Theriault R, Hunt K. Utility of hTERT-driven overexpression of E2F-1 to induce selective apoptosis of human breast cancer cells. Proc Am Assoc Clin Oncol:234, 2004. e-Pub 2004.
- Hanna N, Senzer N, Reid T, Chung T, Chang KJ, Kessler P, Mauer A, Posner M, Nemuniatis J, Swisher S. TNFerade combined with chemoradiation in resectable esophageal cancer. Proc Am Assoc Clin Oncol, 2004. e-Pub 2004.
- Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth J, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphisms of Thymidylate Synthase Gene Predict Local Or Distant Recurrence After Preoperative Chemoradiation In Esophageal Cancer. Proc Semin Oncol, 2004. e-Pub 2004.
- Swisher SG, Maish M, Erasmus J, Correa AM, Rice D, Putnam JB, Smythe WR, Walsh G, Vaporciyan A, Roth J. Utility of PET, CT, and EUS to Identify Pathologic Responders In Esophageal Cancer. Proc Soc Thorac Surg:170-171, 2004. e-Pub 2004.
- Liu Y, McKenzie T, Fanale M, Swisher SG, Chada S, Hunt KK. Increased apoptosis in HER2/NEU overexpressing breast cancer cells by combination therapy of Ad-mda7 and Herceptin. Proc Am Assoc Cancer Res:301, 2004. e-Pub 2004.
- Komaki R, Putnam JB, Roth JA, Allen P, Swisher S, Walsh G, Kies M, Fossella FV, Hong WK, Herbst R, Oh YW, Liao Z, Vaporciyan A, Rice D, Smythe R, Munden R, Cox JD. Does surgery and preoperative treatments improve the outcome of patients with locally advanced superior sulcus tumor (SST)?. Proc Am Radium Soc, 2004. e-Pub 2004.
- Wei X, Liao Z, Swisher SG, Wu TT, Correa AM, Ajani JA, Komaki RR, Cox JD, Milas L. Cyclooxygenase-2 (COX-2) overexpression was associated with improved survival in patients with respectable esophageal cancer treated with neoadjuvant chemoradiation followed by esphagectomy. Proc Am Soc Ther Radiol Oncol, 2004. e-Pub 2004.
- Pataer A, Chada S, Roth JA, Swisher SG. Adenoviral MDA-7 induces apoptosis in p53 resistant lung cancer cells. Proc Soc Univ Surg, 2004. e-Pub 2004.
- Pataer A, Vorburger SA, Balachandran S, Barber GN, Chada S, Roth JA, Hunt KK, Swisher SG. Melanoma differentiation associated gene-7 protein physically associates with the double-stranded RNA activated protein kinase PKR in vitro. Proc Am Assoc Cancer Res 45((#872)):20, 2004. e-Pub 2004.
- Pan J, Hittelman WN, Wu TT, Bresalier R, Swisher S, Correa AM, Ajani J, Izzo JG. Cyclin D1 A870G polymorphism is associated with early onset and shorter disease-free survival in esophageal adenocarcinoma. Proc Int Soc Gastrointest Oncol, 2004. e-Pub 2004.
- Pan J, Ceron TL, Babenko IM, Wu TT, Swisher S, Correa AM, Ajani J, Hittelman WN, Izzo JG. Cyclin D1 A870G plymorphism is associated with early onset of Barrett's adenocarcinoma. Proc Am Assoc Cancer Res 45, 2004. e-Pub 2004.
- McKenzie T, Liu Y, Swisher S, Pataer A, Chada S, Fanale M, Hunt K. Combination therapy of Herceptin and Ad-mda7 inhibits growth of Her-2/neu overexpressing breast cancer in vivo. Proc Soc Surg Oncol, 2004. e-Pub 2004.
- McKenzie T, Liu Y, Fanale M, Swisher S, Chada S, Hunt K. Combination therapy of Ad-mda7 and Herceptin inhibits tumor growth in nude mice and increases apoptosis in Her2/neu overexpressing breast cancer cells. Proc Am Assoc Cancer Res:346, 2004. e-Pub 2004.
- Chen Y, Liao Z, Chen Y, Zang Z, Jin J, Ajani J, Swisher SG, Chang JY, Guerrero T, Jeter M, Allen PK, Cox JD, Komaki R. Treatment outcome of irradiated esophageal cancer. Proc Am Soc Ther Radiol Oncol, 2004. e-Pub 2004.
- Senzer N, Swisher SG, Reid T, Mauer A, Posner M, Pinto H, Chang KJ, Macko J, Kessler P, Hanna N, Kleinberg L, Forastiere A, Soetikno R, Nemunaitis J. Pathologic complete response rate in esophageal cancer after endoscopically delivered intratumoral (IT) injections of TNFerade combined with neoadjuvant chemoradiotherapy: a Phase I/II trial. Proc Am Assoc Cancer Res, 2004. e-Pub 2004.
- Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Roth J, Rashid A, Hamilton SR, Wu TT. Residual Tumor Status Predicts the Survival Of Patients with Treated Esophageal Carcinoma. Mod Pathol 17(1):112A, 2004. e-Pub 2004.
- Vaporciyan AA, Lee H, Cox J, Swisher SG, Komaki R, Smythe WR, Walsh GL, Rice DC, Roth JA, Putnam JB, Jr. The impact of chemoradiotherapy on pulmonary morbidity after esophagectomy. Proc Am Assoc Thorac Surg, 2004. e-Pub 2004.
- Chada S, Mhashilkar A, McKenzie T, Liu Y, Swisher SG, Hunt K. Combination therapy of Ad-mda7 and Herceptin increases cell death in her-2/neu positive breast cancer cells. Proc Am Soc Gene Ther, 2004. e-Pub 2004.
- Chen Y, Liao ZX, Chen YZ, Ajani J, Chang JY, Guerrero T, Jeter M, Allen P, Swisher S, Cox JD, Komaki R. Outcome of patients with cervical/upper thoracic esophageal cancer treated with concurrent chemotherapy and radiotherapy. Proc Am Soc Ther Radiol Oncol, 2004. e-Pub 2004.
- Swisher SG, Erasmus J, Maish M, Correa AM, Ajani J, Cox J, Komaki R, Lee HK, Macapinlac H, Putnam JB, Rice D, Smythe WR, Vaporciyan A, Walsh G, Hong D, Wu TT, Pollock R, Roth J. PET predicts pathologic response and long-term survival following preoperative chemoradiation in esophageal cancer. Proc Am Soc Clin Oncol - GI Symposium, 2004. e-Pub 2004.
- Swisher SG, Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA. Impact of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation (CRT). Proc South Surg Assoc:55, 2004. e-Pub 2004.
- Senzer N, Hanna N, Chung T, Hecht JR, Vogel S, Rosemurgy A, Javle M, Ried T, Chu K, Kessler P, Swisher S, Forastierre A, Posner M, Chang K, Nemunaitis J. TNFerade combined with chemoradiation in gastrointestinal cancer: phase I/II studies in unresectable locally advanced pancreatic cancer and resectable esophageal cancer. Proc Gene Ther Cancer, 2004. e-Pub 2004.
- Phan AT, Rashid A, Luthra R, Lopez-Alvarez E, Swisher SG, Komaki RR, Bresalier RS, Ajani J. Oncogene/tumor suppressor gene expression impacts overall survival of patients with localized upper gastrointestinal cancers. Proc Am Soc Clin Oncol, 2004. e-Pub 2004.
- Swisher SG, Ajani JA, Komaki RR, Nesbitt JC, Cox J, Lahoti S, Martin F, Jr PJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Final results of phase II trial evaluating chemotherapy, concurrent chemoradiation and surgery in locoregionally advanced esophageal cancer. American College of Surgeons South Texas Chapter Annual Meeting, 2003. e-Pub 2003.
- Liu Y, Vorburger SA, Swisher SG, Chada S, Feig BW, Hunt KK. Cancer growth suppressor gene mda-7 induces apoptosis and potential affects the pathway of APC/ß-catenin in human breast cancer. Proc Am Assoc Cancer Res 44:497-498, 2003. e-Pub 2003.
- Bekele BN, Swisher S, Zhou X, Cooksley C, Elting LS. Relationship between postoperative in-hospital mortality and hospital volume of esophagectomy: the effect of centers of experience in Texas. Poster Presentation, Am Soc Clin Oncol 22:526, 2003. e-Pub 2003.
- Rice DC, Kim HW, Putnam JB, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Lee JJ, Sabichi A, Lippman SM, Roth JA. The risk of second primary lung cancer after resection of stage I non-small cell lung cancer. Proc Soc Thor Surg 29:108, 2003. e-Pub 2003.
- Agarwal B, Swisher S, Kelly K, Ajani J, Komaki R, Molke K, Lehman J, Walsh G, Correa A, Ho LN, Liao ZX, Lynch P, Rice D, Smythe R, Steven C, Vaporciyan AA, Yao J, Roth J. Pre-operative chemoradiation downstages esophageal adenocarcinoma and abolishes differences in post-operative survival between T3N0 and T3N1 esophageal cancers. Gastroenterology 124:A652, 2003. e-Pub 2003.
- Rice DC, Swisher SG, Correa AM, Ajani JA, Putnam JB, Smythe WR, Walsh GL, Vaporciyan AA, Roth JA. Induction chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg:266-267, 2003. e-Pub 2003.
- Putnam JB, Jr, Robersonan SL, Lewin S, Correa AM, Swisher SG, Walsh GL, Rice DC, Vaporciyan AA, Roth JA, Smythe WR. Risk analysis for pneumonia following esophagectomy. Proc Soc Thor Surg:258, 2003. e-Pub 2003.
- Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Jr PJ. Identification of risk factors associated with atrial fibrillation after thoracic surgery: prospective analysis of 2,335 patients. Proc Am Assoc Thorac Surg 22:78, 2003. e-Pub 2003.
- Yang Q, Cleary KR, Houlihan PS, Yao JC, Swisher SG, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Prevalence and clinical significance of neuroendocrine differentiation in esophageal and gastroesophageal junction adenocarcinomas. Mod Pathol 16:137a, 2003. e-Pub 2003.
- Vorburger SA, Gu J, Fang B, Pataer A, Yoshida K, Liu Y, Feig B, Swisher SG, Hunt KK. Tumor-specific E2F-1 overexpression from the human telomerase reverse transcriptase (HTERT) promoter allows systemic treatment of colon cancer metastases. Proc Am Assoc Cancer Res 44:1488-1489, 2003. e-Pub 2003.
- Swisher SG, Roth JA. Gene Therapy for Lung Cancer. 2nd Kyoto Lung Cancer Forum, 2003. e-Pub 2003.
- Swisher S, Ajani J, Komaki R, Putnam J, Walsh G, Liao Z, Yao J, Faust J, Wu TT, Roth J, Study Group MER. CPT-11-Taxotere-5-FU regimen for induction ;and concurrent chemoradiotherapy prior to surgery in patients with resectable esophageal or GEJ carcinoma. Proc Am Soc Clin Oncol 22:272, 2003. e-Pub 2003.
- Putnam JB, Jr, Correa A, Swisher SG, Smythe WR, Rice DC, Roth JA, Vaporciyan AA, Walsh GL. A model for prospective quality improvement in thoracic surgical oncology. Texas Surg Soc, 2003. e-Pub 2003.
- Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe RW, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications following preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram. 44th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, 2002. e-Pub 2002.
- Jin J, Liao ZX, Zhang Z, Ajani JA, Swisher SG, Cox JD, Komaki R. Induction chemotherapy increased survival of patients with cancer of the esophagus treated with preoperative chemoradiation followed by surgery. ASTRO 2002 Annual Meeting, 2002. e-Pub 2002.
- Pataer A, Chada S, Hunt KK, Roth JA, Swisher SG. Adenoviral MDA-7 induces apoptosis in lung cancer cells through mitochondrial permeability transition independent cytochrome c release. Proc Am Assoc Thorac Surg 82(40), 2002. e-Pub 2002.
- Agarwal B, Swisher SG, Hunt K, Lynch PM, Kaw M, Ajani J, Komaki RR, Putnam JB, Jr, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Rice DC, Smythe WR, Stevens C, Vaporciyan AA, Yao J, Roth JA. Role of EUS performed after preoperative chemo XRT in esophageal cancer patients. Proc Am Gastroenterol Assoc, 2002. e-Pub 2002.
- Aggarwal B, Swisher SG, Hunt K, Jr P, JB, Ajani J, Komaki RR, Molke KL, Lehman J, Bismark M, Walsh GL, Correa AM, Ho L, Liao Z, Lynch P, Rice D, Smythe WR, Stevens C, Vaporciyan AA, Yao J, Roth JA. Determinants of response to chemoradiation in patients with esophageal cancer. Proc Am Gastroenterol Assoc, 2002. e-Pub 2002.
- Lazo G, Yao JC, Najam AA, Swisher SG, Putnam JB, Roth JA, Mansfield PF, Pisters PW, Ajani JA. Clinical risk factors for peritoneal metastases in esophagogastric junction carcinoma (GEJC). Proc Am Soc Clin Oncol 21:141a, 2002. e-Pub 2002.
- Liu Y, Nishikawa T, Vorburger SA, Meyn RE, Swisher SG, Chada S, Mirza N, Hunt KK. Adenoviral-mediated expression of the MDA-7 gene sensitizes breast carcinoma cells to ionizing radiation. Proc Am Assoc Cancer Res 43:646, 2002. e-Pub 2002.
- Agarwal B, Swisher SG, Ajani J, Kelly KK, c F, Komaki RR, Putnam JB, Abu-hamda I, Molke KL, Walsh GL, Correa AM, Ho L, Liao ZX, Lynch PM, Rice DC Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Ja R. Persistent malignant lymphadenopathy after preoperative chemoradiation identifies patients with poor postoperative survival. Gastointest Endosc S110, 2002. e-Pub 2002.
- Yao JC, Najam AA, Rashid A, Lynch P, Gagneja H, Aggarwal B, Giacco G, Putnam J, Swisher SG, Roth JA, Ajani JA. Clinical and pathologic features of patients with carcinoma associated with Barrett’s metaplasia: an analysis of 1,162 patients with esophageal or esophagogastric junction cancer. Proc Am Soc Clin Oncol 21:137a, 2002. e-Pub 2002.
- Vorburger SA, Gu J, Fang B, Pataer A, Swisher SG, Hunt KK. Tumor-specific E2F-1 gene overexpression from the human telomerase reverse transcriptase (HTERT) promoter enables targeted apoptosis in colon cancer in-vivo. Proc Soc Univ Surg, 2002. e-Pub 2002.
- Vorburger SA, Pataer A, Barber GN, Liu Y, Swisher SG, Hunt KK. Adenoviral gene transfer of E2F-1 induces apoptosis through upregulation of the DSRNA activated protein kinase PKR. Proc Am Assoc Cancer Res 43:662, 2002. e-Pub 2002.
- Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Jr. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Proc South Thorac Surg, 2002. e-Pub 2002.
- Hofstetter WL, Swisher SG, Correa AM, Putnam JB, Jr, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Evolving treatment outcomes of resected esophageal cancer over three decades for 951 patients at a single institution. Proc Am Surg Assoc 100, 2002. e-Pub 2002.
- Pataer A, Vorburger SA, Barber GN, Chada S, Balachandran S, Mhashilkar AM, Helena YX, Roth JA, Hunt KK, Swisher SG. MDA-7 induces apoptosis via upregulation of the double-stranded-RNA dependent protein kinase (PKR). Proc Am Assoc Cancer Res 43:1099, 2002. e-Pub 2002.
- Xiong Q, Yao JC, Phan A, Gliacco G, Hess K, Roth JA, Putnam JB, Jr, Walsh GL, Swisher SG, Mansfield PF, Pisters PW, Feig BW, Ajani JA. Frequency of esophagogastric junction involvement among upper gastrointestinal cancers. Proc Am Soc Clin Oncol 20:430a, 2001. e-Pub 2001.
- Vaporciyan AA, Rice DC, Correa AM, Walsh GL, Swisher SG, Smythe WR, Putnam JB, Roth JA. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass (CPB). Proc Eur Assoc Cardiothorac Surg, 2001. e-Pub 2001.
- Swisher SG, Ajani JA, Komaki RR, Walsh GL, Nesbitt JC, Martin FD, Lahoti S, Smythe WR, Vaporciyan AA, Putnam JB, Jr, Roth JA. Improved long-term survival in esophageal cancer following the novel strategy of induction chemotherapy prior to concurrent chemoradiation and surgery. Proc West Thorac Surg Soc 66:22, 2001. e-Pub 2001.
- Swisher SG, Roth JA, Komaki R, Hicks M, Ro J, Hong WK, Ahrar K, Correa A, Dolomente M, Dreiling L, Fang B, Fossela F, Francisco R, Glisson R, Herbst R, Huaringa A, Gu J, Kelly J, Kemp B, Khuri F, Kurie J, Lee JJ, Lee JS, Liao Z, Merritt J, Morice R, Morello F, Mosheim M, Munden R, Papadoupolous V, Pisters K, Jr P, JB, Sarabia AJ, Shelton T, Stevens C, Shin D, Smythe WR, Vaporciyan A, Walsh GL, Yin M, Yver A. Induction of pro-apoptotic mediators and tumor regression following intratumoral delivery of adenoviral p53 (RTR/INGN 201) and radiation therapy in patients with non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 20:257a, 2001. e-Pub 2001.
- Swisher SG, Wynn P, Mosheim MB, Putnam JB, Jr, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Is surgical salvage indicated for recurrent esophageal tumors following definitive chemoradiation?. Proc Am Assoc Thorac Surg 146:46, 2001. e-Pub 2001.
- Pataer A, Nutt L, Yu R, Mhashilkar A, Chada S, McConkey DJ, Hunt KK, Roth JA, Swisher SG. MDA-7 induces apoptosis by caspase activation through mitochondrial cytochrome C release. Proc Am Assoc Cancer Res 42:449, 2001. e-Pub 2001.
- Nutt LK, Pataer A, McConkey DJ, Swisher SG. Expression of adenoviral BAK and BAX induces depletion of endoplasmic reticular calcium. Proc Am Assoc Cancer Res 42:306, 2001. e-Pub 2001.
- Kim ES, Putnam JB, Jr, Komaki R, Walsh GL, Ro JY, Shin HJ, Lee JJ, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. A phase II study of a multidisciplinary approach with induction chemotherapy (IC), followed by surgical resection (SR), radiation therapy (RT) and consolidation chemotherapy (CC) for unresectable malignant thymomas: final report. Proc Am Soc Clin Oncol 20:310a, 2001. e-Pub 2001.
- Ajani J, Komaki R, Walsh G, Putnam JB, Jr, Swisher SG, Lahoti S, Ho L, Faust J, Roe J, Smythe R, Vaporciyan A, Pisters P, Kelly J, Stevens C, Roth JA. CPT-11 plus cisplatin as induction chemotherapy followed by chemoradiotherapy in resectable carcinoma of the esophagus and GE junction. Proc Am Soc Clin Oncol 20:131a, 2001. e-Pub 2001.
- Swisher SG, Roth JA, Komaki R, Hicks M, Ro J, Dreiling L, Yver AB, Stevens C, Putnam JB, Jr, Smythe WR, Vaporciyan AA, Walsh GL. A phase II trial of adenoviral mediated p53 gene transfer (RPR/INGN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer (NSCLC). Am Soc Clin Oncol 19:461a, 2000. e-Pub 2000.
- Swisher SG, Pataer A, Yu R, Nishizaki M, Fang B, Hunt KK, Roth JA. Enhancement of adenoviral mediated p53 (Adp53) tumor killing with amiforstine induced Cdc2 kinase activation. J Am Coll Surg 191:S88-S89, 2000. e-Pub 2000.
- Pataer A, Smythe WR, McDonnell T, Roth JA, Fang BL, Swisher SG. Adenovirus-mediated bak gene transfer induces apoptosis in mesothelioma cell lines. Proc Am Assoc Thorac Surg 3:184-185, 2000. e-Pub 2000.
- Walsh GL, Davis BM, Swisher SG, Vaporciyan AA, Smythe WR, Roth JA, Putnam JB, Jr. A single-institution, multidisciplinary approach to primary sarcomas involving the chest wall requiring full thickness resections. Proc Am Assoc Thorac Surg 23:82-83, 2000. e-Pub 2000.
- Siegenthaler MP, Pisters KM, Merriman KW, Swisher SG, Roth JA, Walsh GL, Vaporciyan AA, Smythe WR, Putnam JB, Jr. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Proc Soc Thorac Surg, 2000. e-Pub 2000.
- Shin DM, Walsh GL, Smythe WR, Ro JY, Shin HJ, Swisher SG, Lu C, Fossella FV, Khuri FR, Yalamanchilli A, Hong WK, Khokhar A, Perez-Solar R. Pathologic response of liposomal-entrapped cisplatin analog (L-NDDP) administered in patients (pts) with malignant pleural mesothelioma (MPM): phase II clinical study. Lung Cancer, 2000. e-Pub 2000.
- Schnirer II, Komaki R, Yao JC, Swisher SG, Putnam JB, Jr, Pisters PW, Roth JA, Yan M, Janjan N, Mansfield PF, Feig BW, Ajani JA. A study of concurrent 5FU/paclitaxel and radiotherapy in patients with carcinoma of the upper gastrointestinal tract. Proc Am Soc Clin Oncol 19:472a, 2000. e-Pub 2000.
- Roth JA, Swisher SG, Mukhopadhay T, Fang B, Ramesh R, Lin J. Local and system gene replacement for cancer: p53 and beyond. Lung Cancer 29:S20-S21, 2000. e-Pub 2000.
- Roth JA, Swisher SG, Fang B, Ji LX, Mukhopadhyay T, Ramesh R, Templeton N. Local and systemic pro-apoptotic gene replacement for non-small cell lung cancer. Lung Cancer 29:136-137, 2000. e-Pub 2000.
- Putnam JB, Jr, Benjamin RS, Rha SJ, Walsh GL, Swisher SG, Vaporciyan AA, Smythe WR, Roth JA. Early results of isolated single lung perfusion for treatment of unresectable sarcomatous metastases. Proc Am Assoc Thorac Surg 21:78-79, 2000. e-Pub 2000.
- Pataer A, Fang B, Yu R, Kagawa S, Hunt KK, McDonnell T, Roth JA, Swisher SG. Adenoviral bak overexpression mediates caspase-dependent tumor killing. Proc Am Assoc Cancer Res 41:731, 2000. e-Pub 2000.
- Munden RF, Truong M, Swisher SG, Roth JA. CT evaluation of non-small cell lung cancer undergoing gene therapy with adenoviral p53. Proc Radiol Soc N Am 323:173, 2000. e-Pub 2000.
- Komaki R, Roth JA, Walsh GL, Putnam JB, Jr, Swisher SG, Vaporciyan AA, Lee JS, Fossella F, Chasen M, Cox JD. Multidisciplinary approach for 143 patients with superior sulcus tumors treated at The University of Texas M. D. Anderson Cancer Center. J Jap Soc Thorac Radiol 12:110, 2000. e-Pub 2000.
- Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, El-Naggar AK, Hong WK, Mack M, Weill D, Merritt JA, Jr PJ, Walsh G. Outcome of intralesional adenoviral p53 gene replacement with or without cisplatinum in patients with advanced non-small cell lung cancer. Proc Am Assoc Thorac Surg:79, 1999. e-Pub 1999.
- Gandhi S, Walsh GL, Komaki R, Gokaslan Z, Putnam JB, Jr, Roth J, Merriman K, Vaporciyan AA, Swisher SG. An aggressive multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion can lead to long-term. Proc Soc Thorac Surg 35:90-91, 1999. e-Pub 1999.
- Kagawa S, Ji L, Xu K, McDonnell T, Swisher SG, Roth JA, Fang B. Induction of bax gene expression by adenoviral mediated gene codelivery. Proc Am Assoc Cancer Res 40:218, 1999. e-Pub 1999.
- Kagawa S, Gu J, Swisher SG, Ji L, McDonnell TJ, Roth JA, Fang B. Induction of bax gene expression by adenoviral mediated gene co-transfer elicited apoptosis in cancer cells and suppressed tumor growth in animals. Texas Medical Center Gene Therapy Symposium, 1999. e-Pub 1999.
- Perez-Soler R, Walsh GL, Swisher SG, Shin HJC, Kemp BL, Terry K, Khuri FR, Fossella FV, Hong WK, Lopez-Berestein G, Khokhar AR, Shin DM. Phase II study of a liposome entrapped cisplatin analog (L-NDDP) administered intrapleurally in patients (PTS) with malignant pleural mesothelioma (MPM). Proc Am Soc Clin Oncol 18:421, 1999. e-Pub 1999.
- Swisher SG, Deford L, Merriman K, Hunt KK, Walsh G, Vaporciyan A, Smythe WR, Morris M, Roth J, Putnam JB, Jr. Impact of operative volume on morbidity, mortality and hospital usage following esophagectomy for esophageal cancer. Proc West Thorac Surg Assoc, 1999. e-Pub 1999.
- Swisher S, Hu M, Holmes EC, Hunt K, Ajani J, McFadden D, Nelson S, Nesbitt J, Putnam JB, Vaporciyan A, Walsh G, Zinner M, Roth JA. Impact of number of involved lymph nodes on long-term survival in esophageal cancer. Cancer Symp 51:64, 1998. e-Pub 1998.
- Spitz FR, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Swisher SG, Cristiano RJ, Roth JA. Apoptotic mechanisms following adenovirus-mediated p53 replacement gene therapy. Cancer Symp 51:21, 1998. e-Pub 1998.
- Pearson AS, Fang B, Hunt KK, Yu R, Wilson-Heiner M, McDonnell TJ, Sarkiss M, Bruckheimer E, Roth JA, Swisher SG. Adenoviral mediated overexpression of Bax induces apoptosis in breast cancer: correlation with BCL-2 status. Proc Am Assoc Cancer Res 51:9, 1998. e-Pub 1998.
- Swisher SG, Roth JA, Neumanitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors C, El-Nagger AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Nesbitt JC, Nguyen D, Pisters KMW, Jr PJ, Schrump DS, Shin DM, Perez-Soler R, Walsh GL. Adenoviral mediated p53 gene transfer in patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Onco 17:431a, 1998. e-Pub 1998.
- Nemunaitis J, Swisher SG, Roth JA, Merritt J. Adenoviral mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer (NSCLC). Proc of the First American Society for Gene Therapy Meeting, 1998. e-Pub 1998.
- Pearson S, Fang B, Hunt K, Yu R, Wilson-Heiner M, McDonnell T, Sarkiss M, Bruckheimer E, Roth JA, Swisher S. Induction of apoptosis in human breast cancer by adenoviral mediated overexpression of the proapoptotic gene bax. Cancer Symp 51:9, 1998. e-Pub 1998.
- Timmons T, Burt K, Chema D, Tigelaar B, Hanvy P, Wilson J, Swisher SG, Nemunaitis J, Roth JA, Merritt J, Wilson D. Biodistribution of Ad-p53 (INGN 201) in a phase I/II trial of gene therapy for non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 17:431a, 1998. e-Pub 1998.
- Swisher SG. Multimodality therapy of lung cancer. Proc Chemother Foundation Symp, 1998. e-Pub 1998.
- Swisher SG. Gene therapy approaches to lung cancer. Proc New Front Res Treat Aerodigest Tract Cancers 41:103-104, 1998. e-Pub 1998.
- Shin DM, Walsh GL, Swisher SG, Khokhar AR, Wimberly A, Shin HJ, Ro JY, Kong WK, Perez-Soler R. Antitumor activity of a liposome entrapped cisplatin analog (L-NDDP) administered intrapleurally in patients (pts. with malignant pleural mesothelioma (Mpm). 10th NCI-EORTC Symp. New Drugs Cancer Ther 59:19, 1998. e-Pub 1998.
- Nesbitt JC, Ajani A, Komaki R, Walsh G, Jr P, JB, Swisher SG, Pisters P, Lynch P, Raijman I, Pazdur R, Delclos M, Martin F, Roth JA. Preoperative taxol-based chemotherapy (CT) followed by chemoradiation therapy (CTRT) in patients (PTS) with potentially resectable esophageal carcinoma (EC). Proc Am Soc Clin Oncol 17:282a, 1998. e-Pub 1998.
- Ajani JA, Nesbitt J, Komaki R, Walsh GL, Putnam JB, Jr, Swisher SG, Pisters P, Lynch P, Pazdur RR, Delclos M, Martin F, Roth JA. Three-step paclitaxel-based therapy in patients with resectable esophageal carcinoma. Proc Invest Taxol Workshop, 1998. e-Pub 1998.
- Nesbitt JC, Whitehead WE, Darwish AA, Walsh GL, Schrump DS, Swisher SG, Willis KD, Roth JA, Jr PJ. Survival and operative risk following pneumonectomy. American College of Chest Physician:8S-9S, 1997. e-Pub 1997.
- Merritt JA, Clayman G, Swisher SG, Nemunaitis J, El-Naggar A, Timmons T, Laurence D, Kemp B, Frederick M, Connors D, Bruso P, Geopfert H, Hong WK, Roth JA. Clinical gene therapy strategies: Phase 1/II results with adenoviral p53 (INGN 201) gene transfer in advanced head and neck and non-small cell lung cancers. 3rd European Conference on Gene Therapy of Cancer:4, 1997. e-Pub 1997.
- Swisher SG, Roth JA, Lawrence D, Kemp B, Carrasco C, Fossella F, Glisson B, Hong WK, Khurie F, Kurie J, Nesbitt J, Pisters K, Putnam JB, Schrump D, Shin D, Walsh G. Persistent transgene expression following repeated injections of a recombinant adenovirus containing the p53 wild-type gene in patients with non-small cell lung cancer. Proc Am Assoc Cancer Res 38:342, 1997. e-Pub 1997.
- Spitz FR, Kataoka M, Sarkiss M, Meyn R, McDonnell TJ, Swisher S, Cristiano RJ, Roth JA. An investigation of apoptotic responses following adenovirus-mediated p53 gene delivery. Proc Am Assoc Cancer Res 38:137, 1997. e-Pub 1997.
- Swisher SG, Roth JA, Lawrence DD, Kemp BL, Carrasco CH, Fossella FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters KM, Putnam JB, Schrump DS, Shin DM, Walsh GL. Adenoviral-mediated p53 gene transfer in patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 16:437a, 1997. e-Pub 1997.
- Walsh GL, Gokaslan ZL, McCutcheon I, Yasko A, Mineo MT, Swisher SG, Schrump DS, Nesbitt JC, Putnam JB, Jr, Roth JA. Anterior approaches to the thoracic spine in patients with cancer: indications and results. Proc Soc Thorac Surg:240-241, 1997. e-Pub 1997.
- Swisher SG, Holmes EC, Hunt KK, Zinner MJ, McFadden DW. Short and long-term outcomes following esophagogastrectomy in elderly patients. Proc Soc Surg Oncol 49:60, 1997. e-Pub 1997.
- Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Jr P, JB, Schrump DS, Shin DM, Walsh GL. Gene therapy strategies for lung cancer. Lung Cancer 18:141, 1997. e-Pub 1997.
- Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Jr, Schrump DS, Shin DM, Walsh GL. Gene replacement for lung cancer. Lung Cancer 18:76, 1997. e-Pub 1997.
- Nesbitt JC, Ferson DZ, Walsh GL, Schrump DS, Swisher SG, Putnam JB, Jr. The laryngeal mask airway: a valuable adjunct for laser bronchoscopy of obstructive for tumors of the tracheobronchial tree. Proc South Thorac Surg Assoc, 1997. e-Pub 1997.
- Nesbitt JC, Ferson DZ, Walsh GL, Schrump DS, Swisher SG, Nesbitt KK, Jr P, JB. The laryngeal mask airway: a valuable adjunct for laser bronchoscopy of obstructive tumors. Chest 112:595, 1997. e-Pub 1997.
- Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Feig BW, Hung MC. Adenoviral mediated E2F-1 overexpression induces apoptosis in human breast cancer with paradoxical upregulation of Bcl-2. Breast Cancer Res Treat 46:28, 1997. e-Pub 1997.
- Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Apoptosis induced by overexpression of E2F-1 in breast cancer cells cannot be blocked by pretreatment with a recombinant adenovirus overexpressing pRb. Proc Am Assoc Cancer Res 38:423, 1997. e-Pub 1997.
- Hunt K, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Adenovirus-mediated gene transfer of the transcription factor E2F-1 induces apoptosis in human breast cancer. Proc Soc Surg Oncol, 1997. e-Pub 1997.
- Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Overexpression of the transcription factor E2F-1 leads to apoptosis in human breast and ovarian cancer cell lines. Proc Am Assoc Cancer Res, Programmed Cell Death, 1996. e-Pub 1996.
- Swisher SG, Holmes EC, Hunt KK, Doty JE, McFadden DW. The role of neoadjuvant therapy and surgical resection in esophageal cancer. Proc Pacific Coast Surg Assoc, 1996. e-Pub 1996.
- Toloza E, Hunt KK, Lau R, Rhoades K, Swisher SG, McBride W, Glaspy J, Economou J. Cytokine gene therapy of human melanoma and murine fibrosarcoma mediated by adenovirus vectors. Proc Soc Surg Oncol, 1995. e-Pub 1995.
- Toloza E, Hunt KK, Swisher SG, Rhoades K, McBride W, Lau R, Atha T, Pang S, Belldegrun A, Glaspy J, Economou J. Interleukin-2 gene therapy of human melanoma and murine fibrosarcoma using recombinant adenovirus. Proc Soc Surg Oncol, 1995. e-Pub 1995.
- Swisher SG, Hunt KK, Holmes EC, Zinner M, McFadden D. Perioperative blood product transfusions decrease long-term survival in esophageal cancer. Proc Soc Surg Oncol, 1995. e-Pub 1995.
- Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Obstetric Gynecol Surv 50:497-498, 1995. e-Pub 1995.
- Schmit PJ, Hiyama DT, Swisher SG, Thompson JE. Post-appendectomy intra-abdominal abscess; analysis of risk factors. Proc Management Periop Comp Gastrointest Surg, 1994. e-Pub 1994.
- Bennion RS, Thompson JE, Schmit PJ, Swisher SG. Variation of appendicitis with temperature. Proc South Calif Chap Am Coll Surg:23, 1994. e-Pub 1994.
- Hunt KK, McBride WH, Toloza E, Swisher SG, Rhoades KL, Drake TA, Economou JS. In vivo gene transfer into tumors using a recombinant adenovirus vector. Proc Soc Surg Oncol, 1994. e-Pub 1994.
- Swisher SG, Hunt KK, Holmes EC, Zinner MJ, McFadden DW. Surgical management of esophageal cancer: trends over the last three decades. Proc Soc Surg Aliment Tract, 1994. e-Pub 1994.
- Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy: a surgical disorder. Proc South Surg Congr:45, 1994. e-Pub 1994.
- Swisher SG, Hunt KK, Schmit PJ, Hiyama DT, Bennion RS, Thompson JE. Management of pancreatitis complicating pregnancy. Proc South Calif Chap Am Coll Surg:27, 1994. e-Pub 1994.
- Swisher SG, Cates JA, Hunt KK, Bennion RS, Thompson JE, Roslyn JJ, Reber HA. Pancreatitis associated in choledochal cysts in adults. Proc Soc Surg Aliment Tract:121, 1993. e-Pub 1993.
- Lee JD, Swisher SG, Minehart EH, McBride WH, Economou JS. Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells. . Proc Am Assoc Cancer Res:31, 1990. e-Pub 1990.
- Economou JS, Hoban M, Lee JD, Swisher SG, Essner R, McBride W, Hoon D, Morton DL. Cytokine production in IL-2 treated melanoma patients. Proc Am Assoc Cancer Res:31, 1990. e-Pub 1990.
- Swisher SG, Anderson T, Wen DR, Stene M, Cochran A, Golub S, Holmes EC. Immunopathologic features of human lung tumors following pre-operative interleukin-2 therapy. Proc Am Soc Clin Oncol 9:229, 1990. e-Pub 1990.
- Swisher SG, Economou JS, Shau H, Holmes EC, Golub SH. IL-4 down-regulation of IL-2 induced IFN-gamma protein production correlates with IL-4 suppression of bak activity. J Leuk Biol Suppl, 1989. e-Pub 1989.
- Swisher SG, Economou JS, Holmes EC, Golub SH. Gamma interferon and tumor necrosis factor reverse interleukin-4 suppression of lymphokine activated killer induction. Proc Am Assoc Cancer Res 30:340, 1989. e-Pub 1989.
- Hansbrough J, Soderberg C, Brahme J, Swisher SG, Field T, Zapata-Sirvent R, Gadd M, Tonks M. Analysis of murine splenic lymphocyte subpopulations after burn injury by monoclonal antibodies and flow cytometry. Proc Am Burn Assoc 19:12, 1982. e-Pub 1982.
- Francisco-Cruz A, Parra ER, Krishnan SN, Barua S, Jiang M, Fujimoto J, Peterson CB, Das P, Chow CW, Ridriguez-Canales J, Behrens C, Kalhor N, Weissferdt A, Heymach J, Swisher SG, Sepesi B, Rao A, Lee JJ, Moran C, Futreal PA, Zzhang J, Wistuba II. Impact of the spatial analysis of tumor-associated lymphocytes and tumor-associated macrophages on recurrence at early stage of non-small cell lung carcinoma. AACR.
- Van Haren R, Rajaram R, Correa A, Sepesi B, d R, Hofstetter W, Roth J, Swisher SG, Walsh G, Vaporciyan A, Mehran R, Antonoff M. Hospital Readmissions after Pulmonary Resection: Post-Discharge Nursing Telephone Assessment Identifies High Risk Patients.
- Nelson D, Mitchell K, Wang J, Fujimoto J, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan A, Hofstetter W, Mehran R, Rice D, Walsh G, Swisher SG, Moran C, Kalhor N, Weissferdt A, Wistuba I, Roth J, Antonoff M. Immune Regulatory Markers of Lepidic-Pattern Adenocarcinomas Presenting as Ground Glass Opacities.
- Dibaj SS Vailati Negrao M, Zhang J, Lee JJ, Heymach JV, Roarty EB, Rinsurongkawong W, Lewis J, Sepesi B, Simon G, Papadimitrakopiulou V, Reuben A, Futreal A, Glissin BS, Gibbons DL, Blumenschein G, Wistuba II, Roth JA, Swisher SG. Spatial and temporal heterogeneity of PD-L1 and its impact on benefit from immune checkpoint blockade in non-small cell lung cancer (NSCLC). ASCO.
- Skoulidis F, Arbour KC, Hellmann MD, Patil P, Marmarelis ME, Owen D, Swad MM, Murray J, Levy B, Hellyer J, Gainor JF, Stewart T, Goldberg S, Dimou A, Bestvina C, Cummings AL, Elamin YY, Lam VK, Zhang J, Shu CA, Riess JW, B lakely C Pecot C, Mezquita L, Tabbo F, Sacher A, Scheffler M, Bicciuti B, Venkatraman D, Rizvi H, Liu C Johnston RP, Ni Y, Azok J, Kier M, Katz S, Davies K, Segal J, Ritterhouse L, Shaish H, Laroix L, Memmott RM, Madrigal JR, Goldman JW, Lau S, Carter B, Woodcock M, Roth JA, Swisher SG, Leighl N, Wolf J, Scagliotti GV, Planchard D, Besse B, Bivona T, Gandara DR, Garon EB, Rizvi N, Camidge R, Schalper K, Herbst RS, Shaw A, Neal J, Wakelee HA, Brahmer J, Janne P, Carbone DP, Aggarwal C, Pennell N, Rudin C, Papadimitrakopoulou V, Heymach JV. STK11/LKB1 genomic alterations are associated with inferior clinical outcomes with chemo-immunotherapy in non-squamous NSCLC. World Lung.
- Nagrao MV, Skoulidis F, Montesion M, Schulze K, Bara I, Shen V, HuS, Elamin YY, Le X, Goldberg ME, Wu CJ, Zhang J, Barreto DS, Rinsurongkawong W, Simon G, Roth J, Swisher SG, Lee JJ, Tsao A, Papadimitrakopoulou V Gibbons DL, Glisson BS, Va M, Alexander BM, Frampton GM, Albacker LA, Shames DS, Zhang J, Heymach JV. BRAF mutations are associated with increased benefit from PD-1/PD-L1 blockade compared with other oncogenic drivers in non-small cell lung cancer.
- Sepesi B, Bodoy MCB, William Jr WN, Vaporciyan AA, Lin H, Leung CH, Lee J, Mitchell KG, Weissferdt A, Le X, Lam VK, Fossella FV, Swisher SG, Heymach JV, Cascone T. Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy In Non-Small Cell Lung Cancer. WLCC.
- Gay CM, Diao L, Ca S, Zi Y, Cardnell RJ, Swisher SG, Roth JA, Glisson B, Wang J, Heymach JV, Byers LA. ASCL1, NEUROD1, and POU2F3 drive distinct subtypes of small cell lung cancer with unique therapeutic vulnerabilities. WLCC.
- Reuben A, Zhang J, Gittelman R, Chiou SH, Li J, Fujimoto J, Behrens C, Kheradmand F, Chow CW, Bernatchez C, Eterovic AK, Benzeno S, Vignali M, Wu X, Ye Y, Cascone T, Rerbst R, Swisher SG, Kadara H, Moran C, Zhang J, Scheet P, Vaporciyan A, Sepesi B, Gibbons D, Robins H, Hwu P, Heymach J, Sharma P, Allison J, Lee J, Davis M, Wistuba I, Futreal A, Zhang J. Comprehensive characterization of the T cell repertoire in non-small cell lung cancer. WCLC.
- Swisher S. High Mutational Concordance Between Next Generation Sequencing Profiles of Colorectal Cancer and Pulmonary Metastases. Society of Thoracic Surgeons.
- Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am j Cancer Res.
- Nelson D, Niu J, Mitchell K, Sepesi B, Vaporciyan A, Hofstetter W, Walsh G, Swisher SG, Roth J, Antonoff M, Mehran R, Rice D. Persistent Opioid Use Among The Elderly After Lung Resection: A SEER-Medicare Study.
- Corsini E, Mitchell K, Mehran R, Rice D, b S, Walsh G, Swisher SG, Roth J, Hofstetter W, Vaporciyan A, Morris V, Antonoff M. Primary Colorectal Cancer Sidedness Predicts Survival After Pulmonary Metastasectomy.
- Corsini E, Mitchell K, Mehran R, Rice D, b S, Walsh G, Swisher SG, Roth J, Hofstetter W, Vaporciyan A, Morris V, Antonoff M. Primary Colorectal Cancer Mutations Predict Survival and Recurrence After Pulmonary Metastasectomy.
- Cascone T, William Jr WN, Weissferdt A, Leung CH, Federico L, Haymaker C, Bernatchez C Fossella FV, Mott FE, Papadimitrakopoulou V, Byers LA, Lam VK, Godoy M, Carter B, Lee JJ, Vaporciyan A, Gibbons DL, Swisher SG, Heymach JV, Sepesi B. Neoadjuvant nivolumab (N) or nivolumab plus ipilumumab (NI) for resectable non-small cell lung cancer (NSCLC).
- Skoulidis F, Elamin YY, Lam VK, Zhang J, Lewis J, Rinsuroungkawong W, Lee JJ, Roth JA, Swisher SG, Papadimitrakopoulou VA, Heymach JV. Impact of STK11/LKB1 genomic alterations on clinical outcomes with chemo-immunotherapy in non-squamous NSCLC.
- Weissferdt A, Cascone T, Pataer A, Antonoff M, Walsh G, Bernatchez C, Gibbons D, Wistuba II, Roth J, Zhang J, Roarty E, Landry L, Vaporciyan AA, Heymach JV, Swisher SG, Sepesi B. Histopathologic parameters define features of treatment response to neoadjuvant chemotherapy in non-small cell lung cancer.
- Negrao MV, Reuben A, Robichaux JP, LE X, Nilsson M, Elamin YY, Wu CJ, Zhang J, Landry LL, Roarty E, Rinsurongkawong W, Swisher SG, Simon G, Glisson BS, Futreal A, Zhang J, Heymach JV. Driver mutations are associated with distinct patterns of response to immune checkpoint blockade in non-small cell lung cancer. WCLC.
- Xiang Y, Xiaoshan Z, Li W, Zhang R, Xingxiang P, Shuhong W, Lei L, Tong P, Wang J, Qinghe M, Luc G, Minna J, Roth JA, Swisher SG, Heymach JV, Bingliang F. Synthetic lethality therapy for cancers with compromised glutathione homeostasis. Lung SPORE Workshop.
- Williams LA, Dibaj SS, Chandwani S, Vaghani V, Shi Q, Hirschmann M, Lacerda L, Roarty E, Zhag J, Rinsurongkawong W, Lewis J, Burke T, Cleeland C, Lee J, Roth J, Swisher SG, Heymach J, Simon G. Real-World Patient-Reported Outcome Symptom Assessment of Patients with Metastatic Non-Small Cell Lung Cancer Prior to Treatment.
- Marcus RK, Lillemoe HA, Caudle AS, Weinberg JS, Gidley PW, Skibber JM, Levenback CF, Swisher SG, Aloia TA. Structured Review of Surgical Innovations Decreases Time to Implementation and Avoids Patient Complications.
- Negrao MV, Reuben A, robichaux JP, Le X, Nilsson MB, Wu C, Zhang J, Lacerda L, Roarty E, Rinsurongkawong W, Swisher SG, Simon GR, Futureal A, Glisson BS, Zhang J, Heymach J. EGFR and HER-2 exon 20 mutations are associated with distinct patterns of response to immune checkpoint blockade in non-small cell lung cancer. ASCO.
- Vaghani V, Chandwani S, Hirschmann M, Dibaj S, Lacerda L, Roarty E, Zhang J, Rinsurongkawong W, Lewis J, Lee JJ, Roth JA, Swisher SG, Heymach J, Ta B, Simon GR. Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic landscape. ASCO.
- Van Haren R, Mehran R, Correa A, Antonoff M, Baker C, Hofstetter W, Mena G, Roth J, Sepesi B, Swisher SG, Vaporciyan A, Walsh G, Rice D. Enhanced Recovery After Surgery (ERAS) Pathway Decreases Perioperative Morbidity Following Thoracotomy for Primary Lung Cancer.
- Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Close Surgical Margins and Risks of Local Treatment Failure after Wedge Resection of Colorectal Pulmonary Metastases. AATS.
- Federico L, Haymaker C, Forget MA, Ravelli A, Bhatta A, Karpinets T, Zang R, Fang B, Zhang J, Wagner H, Bogatenkova E, Wistuba I, Sepesi B Heymach J, Gibbons D, Bernatchez C, Weissferdt A, Vaporciyan A, Futreal A, Zhang J, Lizee G, Talukder A, Roszik J, Tran H, Wagner H, Behrens C, Parra E, Caneles JR, Fujimoto J, Allison J Sharma P, Vence L, Roth J, Meraz I, Roarty E, Lacerda L, Byers L, &S, William Jr W. A Preclinical study on the feasibility of adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes as a T cell-based immunotherapy treatment for NSCLC.
- Goltsov A, Fang B, Pandita TK, Maru DM, Swisher SG, Hofstetter WL. HER2 confers resistance to foretinib inhibition of MET-amplified esophageal adenocarcinoma cells. The Annals of Thoracic Surgery.
- Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Occult Stage IIIA-N2 Patients have Excellent Overall Survival with Initial Surgery in Multidisciplinary Treatment Plan.
- Pataer A, Ozpolat B, Shao R, Lin SH, Cashman NR, Samuel CE, Hao C Kabil NN, Correa AM, Majidi M, Fang B, Roth JA, Behrens C, Rodriguez JC, Vaporciyan AA, Wistuba II, Hung MC, Swisher, SG. Treatment of PKR associated diseases by compounds.
- Robichaux J, Elamin Y, Zhang J, Futreal A, Roarty E, Rinsurongkawong W, Lewis J, Train H, SG &, Heymach J. Identification of novel, potentially targetable genomic alterations associated with acquired resistance to EGFR inhibitors via NGS of paired tumors.
- Ta A, Caudle AS, Hayes-Jordan A, Lai S, Mehran RJ, Moon BS, Prabhu SS, Reece G, Schmeler KM, Skibber JM, Ward JF, Chemaly RF, Anderson JJ, Segal C, Ca P, Fleming JB, Swisher SG, Levenback CF. Postoperative urinary tract infection quality assessment and improvement: The S.T.O.P. UTI program and its impact on hospital wide UTI rates.
- Chandwani S, Vaghani V, Hirschmann M, Laerda L, Roarty E, Zhang J, Shi Q, Rinsurongkawong W, Lewis J, Williams L, Cleeland C, Burke T, Lee J, Roth J, SG &, Heymach J, Simon G. Computing the Impact of Immunotherapy on NSCLC landscape: The Advanced Non-Small Cell Lung Cancer Holistic Registry (ANCHoR). IASLC WCLC 2017.
- Hu X, Fujimoto J, Ying L, Reuben A, Chen R, Chow CW, Canales JR, Sun W, Hu J, Parra Cuentas ER, Behrens C, Wu CJ, Swisher SG, Zhang J, Heymach J, Hong WK, Wistuba II, Futreal PA, Su D, Zhang J. Investigation of genomic and TCR repertoire evolution of AAH, AIS, MIA to invasive lung adenocarcinoma by multiregion exome and TCR sequencing.
- Lapid D, Nelson D, Correa A, Sepesi B, Hofstetter W, Rice D, Roth J, Swisher SG, Walsh G, Mehran R, Vaporciyan A, Antonoff M. Perioperative Outcomes Following Lobectomy for Stage I Non-small Cell Lung Cancer: Differences Between Men and Women. STS.
- Atay S, Van Haren R, Niu J, Giodana S, Antonoff M, Hofstetter W, Mehran R, Rice D, Vaporciyan A, Walsh G, Roth J, Swisher SG, Sepesi B. Pathologic Treatment Response is Associated with Increased Overall Survival in Patients Undergoing Neoadjuvant Chemotherapy Followed by Pneumonectomy. STS.
- Van Haren R, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Rice D. Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer.
- Nelson D, Tayob N, Nguyen Q, Antonoff M, Hofstetter W, Sepesi B, Walsh G, Vaporciyan A, SG &, Roth J, Rice D, Mehran R. Local Failure after Stereotactic Radiation or Wedge Resection for Colorectal Pulmonary Metastases.
- Nelson D, Tayob N, Nguyen Q, Antonoff M, Hofstetter W, Sepesi B, Walsh G, Vaporciyan A, Swisher SG, Roth J, Rice D, Mehran R. Use of Natural Language Processing to Track Outcomes after Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer. STS.
- Vah Haren RM, Sorrell LP, Sepesi B, Rice D, Hofstetter W, Roth J, Swisher SG, Walsh G, Vaporciyan AA, Mehran RJ, Antonoff MB. Analysis of Postdischarge Nursing Telephone Assessment and Hospital Readmissions after Pulmonary Resection.
- Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs B, Wang J, SG &, Fujimoto J, Wistuba I, Komaki R, Heymach J, Lin S. RAD50 expression is associated with poor clinical outcomes after radiotherapy for resected non-small cell lung cancer.
- a S, Ziao L, Hayashi Y, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Maru D, Rice DC, Hofstetter WL, Erasmus JJ, SG &, Ajani JA. Nomograms for prognostication of patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. J Clin Oncol. PMID: 27982800.
- Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, SG &, Hofstetter WL, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. J Clin Oncol. PMID: 27983438.
- Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein Jr GR, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS. A Bayesian Adaptive-Randomization Trial of Passive-Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer. The Lancet Oncology.
- Zhou N, Corsini E, Antonoff M, Hofstetter W, Mehran R, Rajaram R, Roth J, Sepesi B, Swisher S, Vaporciyan A, Walsh GL, Rice D. The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience.
- Bostock I, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, S &, Vaporciyan A, Walsh GL, Antonoff M. Travel Distance as a Barrier for Surveillance Imagingin Early Stage Lung Cancer.
- Zhou N, Rice D, Corsini E, Antonoff M, Hofstetter W, Rajaram R, Roth J, Swisher S, Vaporciyan A, Walsh GL, Mehran R, Sepesi B. Perioperative and Long Term Survival of Extrapleural Pneumonectomy and Extended Pleurectomy/Decortication in Epithelioid Mesothelioma.
- Corsini EM, Mitchell KG, Zhou N, Sepesi B, Swisher S, Roth JA, Mehran RJ, Walsh GL, Rajaram R, Antonoff MB, Rice DC, Vaporciyan AA, Hofstetter WL. Barrett's Esophagus is Rare after Ivor Lewis Esophagestomy. Digestive Diseases.
- Lazcano R, Catao A, Solis LM, Jiang M, Tamegnon A, Fujimoto J, Chow C, Rodriguez-Canales J, Behrens C, Kalhor N, Weissferdt A, Heymach J, Swisher S, Sepesi B, Lee J, Moran C, Futreal A, Zhang J, Rarra ER, Wistuba II, Francisco-Cruz A. Histomorphometry Evaluation and Classification of Tertiary Lymphoid Structures in Non-Small Cell Lung Carcinoma. AAC.
- Stewart A, Gay CM, Xi Y, Sivajothi S, Fujimoto J, Hartsfield PM, Tran H, Swisher S, Roth JA, Zhang J, Glisson B, Heymach JV, Wistuba I, Robson P, Wang J, Byers LA. Paired, single-cell profiling of circulating tumor cell-derived xenograft models of small cell lung cancer reveals intratumoral heterogeneity and emergence of new cell clusters following treatment relapse. AACR.
- Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi M, Stroehlein JR, Mehran RJ, Walsh G, Vaporciyan A Swisher SG, Hofstetter WL. Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-year Experience. ACG.
- Wang Y, Gudikote J, Yan J, Deng W, Jiang W, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH. RAD50 expression is associated with poor clinical outcomes after radiotherapy in resected non-small cell lung cancer.
- Tang M, Kalhor N, Ramineni M, Fujimoto J, Zhang J, Li J, Chow CW, Mao X, Song X, Little L, Gumbs C, Behrens C, William Jr WN, Weissferdt A, Lee JJ, Swisher SG, Heymach J, Wistuba II, Futreal A, Zhang J. Histology determination of lung cancers: a report on genomic profiling of lung cancer of mixing histology.
- Elamin Y, Dr G, Papadimitrakopoulou V, Tran HT, Rinsurongkawong W, Lewis J, Lacerda L, Roarty E, Lee JJ, roth JA, Swisher SG, Zhang J, HeymachJ. Local consolidation therapy (LCT) after first line tyrosine kinase inhibitor (TKI) for patients with EGFR mutant metastatic non-small cell lung cancer (NSCLC).
- a R, Gittelman R, Zhang J, Yusko E, WuCJ, Emerson RO, Zhang J, Tipton C, Vignali M, Fujimoto J, Rodriguez-Canales J, Swisher SG, Heymach J, Robins H, Lee JJ, Futreal A, Wistuba II, Zhang J. TCR repertoire sequencing of 254 resected non-small cell lung cancers reveals higher TCR clonality in normal tissues than tumor tissues.
- Jalali A, Wang J, Lee WC, Zhang J, Wu CC, Gibbons D, Tang X, Kahlor N, Izo J, Behrens C, Fossella F, Tsao A, Lee JJ, Swisher SG, Heymach J, Futreal PA, Wistuba I, Herst R, Papadimitrakopoulou V, Zhang J. Interplay between immune infiltration and tumor progression and survival in non-small cell lung cancer: an analysis of institutional and public data. ASCO.
- Lee WC, Diao L, Wang J, Zhang J, Roarty E, Chow W, Fujimoto J, Behrens C, Cascone T, Peng W, Kalhor N, Moran C, Johnson FM, William Jr WN, Swisher SG, Heymach J, Wistuba II, Futreal A, Zhang J. Multiregion gene-expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.
- Lee WC, Gomez DR, Ahang J, Jalali A, Roh W, Reuben A, Lu W, Chow CW, Wu CC, Fujimoto J, Antonoff M, Moran C, Sulman EP, Rao G, Swisher SG, Heymach J, Wistuba II, Futreal A, Zhang J. Comprehensive molecular and immune profiling of non-small cell lung cancer and matched distant metastases suggests distinct molecular mechanisms underlying metastasis.
- Fujimoto J, Chow CW, Zhang J, Behrens C, Moran C, Little LD, Gumbs C, Antonoff MB, Vaporciyan AA, Swisher SG, Heymach JV, Lee JJ, Hong WK, Wistuba II, Futreal A. Preneoplastic Lung lesions. ASCO.
- Quek YLK, Li J, Fujimoto J, Zhang J, Chow CWB, Behrens C, Mao X, Correa A, Song X, Zhang J, Roarty EB, Thornton RL, Coyle MD, Antonoff MB, Kalhor N, Moran C, Weissferdt A, William Jr WN, Swisher SG, Lee JJ, Heymach JV, Wistuba IV, Futreal A, Zhang J. Intratumor heterogeneity of stage IA lung adenocarcinoma by multiregion whole exome sequencing: an association with survival. ASCO.
- Chang JY, Zhang W, Komaki R, Choi NC, Chan S, Gomez D, O'Reilly M, Jeter M, Gillin M, Zhu X, Zhang X, Mohan R, Swisher SG, Hahn S, Cox JD. Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. NCBI. PMID: 28139305.
- Antonoff MB, Shewale J, Nelson DB, Rice D, Sepesi B, Hofstetter W, Mehran RJ, Vaporciyan AA, Walsh G, Swisher S, Roth J. Natural History of Ground Glass Lesions Among Patients with Previous Lung Cancer: Predictors of Progression. AATS Centennial 2017.
- Antonoff M, Correa A, Sepesi B, Rice D, Hofstetter W, Mehran R, Vaporciyan A, Walsh G, Swisher S, Roth J. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence with Use of Natural Language Processing. AATS 2017.
- Nelson DB, Dc R, Niu J, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Fa R, Giordano S, Mehran R, Sepesi B. Predictors of Therapy and Treatment Trends for Malignant Pleural Mesothelioma. ESTS 2017.
- Spicer JD, Shewale JB, Bott MJ, Jones DR, Vaporciyan AA, Darling GE, Swisher SG, Sepesi B. Multi-modality Therapy For Stage IIIa N2 Non-small Cell Lung Cancer: Does The Answer Lie In The Components?. ASA.
- Wu CC, Zhang J, Fujimoto J, Song X, Mao X, Sun H, Seth S, Thornton RL, Coyle MD, Little LD, Gumbs C, Behrens C, Chow CWB, Sulman EP, Rao G, Futreal A, Swisher SG, Wistuba II, Heymach JV, Gomez D, Zhang J. Impact of Gender on Patient-Reported Symptoms Following Pulmonary Resection. AACR.
- Swisher SG. Oncologic Outcomes of Primary Chest Wall Tumors – 15 Years Single Institution Experience. STSA.
- Cox JD, Hahn S, Komaki R, Swisher SG, Gomez D, OReilly M, Jeter M, Gillin M, Zhu XR, Zhang X, Chang J. Final report with long-term outcome of phase I/II prospective study of dose escalated/accelerated proton therapy for early stage NSCLC. PTCOG.
- Gomez D, Swisher SG, Heymach J. Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study. ASCO.
- Rice DC, Mehran RJ, Correa AM, Antonoff M, Hofstetter W, Roth JA, Sepesi B, Swisher SG, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy? A Single Institution Comparison With 631 Contemporaneous VATS And Open Lobectomies. AATS.
- Mitchell KG, Parra ER, Zhang J, Nelson DB, Corsini EM, Lee JJ, Vaporciyan AA, Hofstetter WL, Mehran RJ, Swisher SG, Dc R, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran CA, Skoulidis F, Wistuba II, Fujimoto J, Roth JA, Antonoff MB. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations with Patterns of Recurrence. Society of Thoracic Surgeons.
- Yan X, Zhang X, Wang L, Zhang R, Pu X, Wu S, Li L, Pan T, Wang J, Meng Q, Girard L, Minna J, Roth JA, Swisher SG, Heymach JV, Fang B. Synthetic lethality therapy for lung cancers with compromised glutathione homeostasis. UT Lung SPORE Workshop 2018.
- Zhang R, Zhang X, Wang L, Ren C, Zhang J, Xi Y, Wang J, Chen H, Liu S, Baladandayuthapani V, Heymach JV, Gibbons D, Roth JA, Swisher SG, Fang B. 1070ung Cancer PDX Models: Molecular annotation and translational application. UT Lung SPORE Workshop 2018.
- Sepesi B, Ye Y, Zhang L, Gu J, Ji L, Antonoff M, Hofstetter W, Rice D, Mehran R, Walsh G, Vaporciyan A, Swisher SG, Roth JA, Wu X. Genetic Variants in Cytokine Signaling Pathway with Clinical Outcome in Early Stage Lung Cancer Patients. AATS 2017.
Book Chapters
- Erasmus, JJ, Nguyen, Q, Stewart, DJ, Swisher, SG. Lung Cancer, 57-78, 2022.
- Gomez DR, Heymach JV, SG &. Role of Surgery in Oligometastatic NSCLC. In: Sugarbaker's Adult Chest Surgery. 3rd. McGraw-Hill, 733-737, 2020.
- Hofstetter W, Marks J, Swisher SG. Salvage Esophagectomy in the Management of Recurrent or Persistent EC. In: Thoracic Surgery Clinics. Elsevier, 2013.
- Blackmon SH, Hofstetter W, Swisher SG. Thoracic Approaches to Esophagectomy. In: Mastery of Cardiothoracic Surgery. 3rd. Lippincott, Williams & Wilkins, 2013.
- Erasmus JJ, Stewart DJ, Komaki R, Swisher SG. Lung Cancer. In: Chest, 35-61, 2012.
- Swisher SG, Hofstetter WL, Miller MJ. The Supercharged Microvascular Jejunal Interposition. In: Semin in Thorac Cardiovasc Surg. 1. Elsevier, 56-65, 2007.
- Swisher SG, Komaki R, Lynch PM, Ajani JA. Esophageal Cancer, Chap 15. In: M. D. Anderson Cancer Care Series, Gastrointestinal Cancer. Springer-Verlag, 232-245, 2005.
- Swisher SG, Ajani JA, Komaki RK, Ferguson MK. Neoplasms of the Esophagus: update. In: Cancer Medicine. B.C. Decker, Inc, 2005.
- Roth JA, Grammer SF, Merritt JA, Swisher SG. Gene therapy clinical trials for cancer: replacement of tumor suppressor gene, p53, Chap 8. In: Gene and Cell Therapy. 2nd. Marcel Dekker, Inc, 743-752, 2004.
- Komaki R, Liu H, Murshed H, Cox JD, Swisher S, Macapinlac H, Liao Z, Mohan R. Intensity modulated radiation therapy (IMRT) for lung cancer. In: Practical Essentials of IMRT. 2nd. Lippincott Williams & Wilkins, 2004.
- Hofstetter W, Swisher SG. Lymph Node Dissection in Esophageal Cancer. In: Current Therapies in Thoracic and Cardiovascular Surgery. Mosby, Inc, 360-363, 2004.
- Vaporciyan AA, Swisher SG. Thoracic malignancies: an update, Chap 7. In: The M. D. Anderson Surgical Oncology Handbook. 3rd. Lippincott, Williams and Wilkins, 124-144, 2003.
- Hittelman W, Kurie J, Swisher SG. Molecular events in lung cancer and implications for therapy. In: Anderson Associates Monograph on Lung Cancer, 280-298, 2003.
- Parikh AA, Vaporciyan AA, Swisher SG. Esophageal carcinoma, Chap 8. In: The M. D. Anderson Surgical Oncology Handbook. 3rd. Lippincott, Williams and Wilkins, 145-157, 2003.
- Swisher SG, Jr P, JB, Feig BW, Miller MJ, Walsh GL. Staging and surgery of esophageal carcinoma, Chap 25. In: Atlas of Cancer. Lippincott, Williams and Wilkins, 178-187, 2003.
- Swisher SG, Ajani JA, Komaki RK, Ferguson MK. Neoplasms of the Esophagus, Chap 98. In: Cancer Medicine 6. B.C. Decker, Inc, 1499-1514, 2003.
- Swisher SG. Surgical treatment of locally advanced non-small cell lung cancer, Chap 7. In: M. D. Anderson Cancer Care Series: Lung Cancer. Springer Verlag, 118-141, 2002.
- Swisher SG, Roth JA. The role of Ad p53 in combined modality therapy, Chap 19. In: Chemoradiation in Cancer Therapy. Humana Press Inc, 349-358, 2002.
- Swisher SG, Grammer S, Roth JA. Ad-p53 gene transfer strategies for non-small cell lung cancer. In: Am. Soc. Clin. Oncol. Edu. Book, 412-417, 2001.
- Vaporciyan AA, Swisher SG. Esophageal carcinoma. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott, Williams and Wilkins, 130-138, 1999.
- Vaporciyan AA, Swisher SG. Thoracic malignancies. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott, Williams and Wilkins, 109-129, 1999.
- Swisher SG, Mansfield P. Esophageal carcinoma: management. In: Neoplasms of the Digestive Tract: Imaging, Staging and Management. Lippincott-Raven, 71-82, 1998.
- Swisher SG, Roth JA. Role of gene therapy in lung cancer. In: Advanced Therapy in Thoracic Surgery. B.C. Decker Inc, 139-145, 1998.
Books (edited and written)
- Hunt KK, Vorburger SA, Swisher SG. Gene Therapy for Cancer. Humana Press, 2007.
Letters to the Editor
- Ajani JA, Bhutani MS, Swisher SG. Oesophageal preservation in locally advanced oesophageal cancer. Lancet Oncol 19: e430, 2018.
- Swisher SG, Ajani A, Correa A, Komaki R, Hofstetter W. Minimally invasive versus open oesophagectomy for oesophageal cancer. Lancet 380: 885-886, 2012.
- Benviste MF, Sabloff BS, Marom EM, Moran CA, Swisher SG, Rosado-de-Christenson ML. Role of Imaging in the Diagnosis, Staging, and Treatment of Thymoma. Radoigraphics 31: 1863, 2011.
- Ajani JA, Blum MA, Welsh J, Hofstetter WL, Swisher SG. Celebrate or Calibrate? We Say Calibrate. J Clin Oncol 29: 2732; author reply 2732-3, 2011.
- Ajani JA, Correa AM, Swisher SG, Wu TT. For localized gastroesophageal cancer, you give chemoradiation before surgery but then what happens?. J Clin Oncol 25: 4315-6, 2007.
- Hofstetter WL, Swisher SG, Ajani JA. Author reply to Correspondence. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 109: 1449, 2007.
- Swisher SG. Article Discussion on paper presented by Rice TW, T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 133: 323-324, 2007.
- Swisher SG. Commentary on Flavopiridol enhances depsipeptide-mediated apoptosis in lung and esophageal cancer cells via activation of mitochondrial death signal pathways. J. Thorac. Cardiovasc. Surg 125: 1142, 2003.
- Swisher SG. Commentary on Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinoma: Results of a 10-year prospective study. J. Thorac. Cardiovasc. Surg 125: 1130, 2003.
- Swisher SG. Commentary on: Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. J. Thorac. Cardiovasc. Surg 125: 95, 2003.
- Swisher SG. Commentary on Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein. J. Thorac. Cardiovasc. Surg 124: 174, 2002.
- Swisher SG. Commentary on Inhibition of nuclear factor kB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation. J. Thorac. Cardiovasc. Surg 123: 317, 2002.
- Swisher SG. Commentary on Viral Oncolytic Treatment of Cancer. Clin. Lung Cancer 1: 56, 1999.
- Swisher SG, Putnam JB, Jr. Influence of lymph node dissection on survival in esophageal cancer. J Surg Oncol 69: 117-8, 1998.
Patents
- Compositions and Methods Involving Mda-7 for the Treatment of Cancer. Patent Number: INGN: US0/MDA05-050.
- Induction of Apoptotic or Cytotoxic Gene Expression by Adenoviral Mediated Gene Codelivery. Patent Number: 6899870.
Patient Reviews
CV information above last modified April 10, 2026
Photo Gallery
